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Abstract 
Antibiotic resistance may have the potential to spread from animals to humans through 
the food chain. It has been observed that prebiotics such as mannan rich fraction 
(MRF) improve broiler growth and performance in a similar manner to antibiotic 
growth promotors. They have also been linked to a reduction in antibiotic resistance 
gene numbers. It was hypothesised that MRF has the ability to decrease resistance by 
reducing the variety or transfer of plasmids.  
 
The most effective and efficient method to extract plasmids from the complex broiler 
caecum was investigated, and determined to be the exogenous plasmid isolation 
method. Analysis into the plasmids present in the broiler caecum was performed for a 
greater understanding of the genetic basis of this resistance. Plasmids were identified 
that matched to previously isolated plasmids from animal and human samples from 
locations worldwide. The microbiome and mobile resistome was assessed over time. 
A more stabilised microbiota was found to develop as the birds age, which may be 
better established to harbour the increased number of resistance plasmids identified in 
the older birds.  
 
The effect of MRF on the metagenome of broilers was examined. No significant 
changes were observed in the microbiome, which we attributed to the already resident 
community of beneficial bacteria. Changes in the abundance of the resistome was 
observed at day 27, which may be the result of MRF, but high levels of variability 
were noted within the sampled groups. A study incorporating both metagenomic and 
plasmid based analysis concluded that MRF may have the ability to restore the 
microbiome of broilers after antibiotic treatment. A lower percentage of multi-drug 
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resistance plasmids and a reduced profile of resistance was observed in birds that had 
received MRF. Mannan rich fraction may have the ability to decrease the conjugative 
capability of the plasmids, and thus reduce the spread of antibiotic resistance
1 
 
Chapter 1 
Introduction 
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1.1 Antibiotic discovery and emergence of resistance 
 
The discovery of the first antimicrobial, Salvarsan, in 1909 by Dr. Paul Ehrlich, altered 
the impact of infectious disease on human life1. Salvarsan was  successfully used to 
treat syphilis until the discovery of penicillin by Sir Alexander Fleming in 1928, and 
its subsequent mass production and distribution in 19452. Antibiotics are the only class 
of medicinal agents whose main target is not human tissue or its products3. Antibiotics 
have not only drastically reduced rates of morbidity and mortality from infectious 
diseases, but have also had a crucial role in accomplishing key advances in medicine 
and surgery, such as organ transplantations and cancer chemotherapy, in their ability 
to control infection4. Shortly after its introduction, penicillin resistance became a 
significant clinical problem5.   
 
However, this was not the beginning of bacterial resistance to antibiotics. Resistance 
has been detected in samples that are over 30,000 years old6. Most antibiotics in 
clinical use are produced by bacteria themselves. For example, Actinomycetes produce 
streptomycin, tetracycline, chloramphenicol, erythromycin and vancomycin 
antibiotics. This requires the bacteria to be resistant themselves to avoid succumbing 
to their own metabolites7. It was rather the overuse and misuse of antibiotics to treat 
non-bacterial infections, and inadequate antibiotic stewardship in clinical settings that 
has been attributed to the escalation of the development and spread of resistance8.  
 
The ‘golden era’ of antibiotic discovery spanned from the 1950s to the 1970s9.  During 
this time it was believed that infectious diseases would soon become a controlled 
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public health issue as was the rapid rate of antibiotic discovery10, with multiple new 
classes of antibiotics introduced over the two decades11.  Subsequently, antibiotic 
discovery came to a halt, while resistance continued to exacerbate. In 2016, at least 
700,000 deaths worldwide were caused by resistant infections12. 
 
1.2 Plasmid-mediated antibiotic resistance 
 
Antibiotic resistance occurs through several mechanisms, the central ones being 
enzymatic degradation or alteration of the antibiotic, alteration of the target proteins 
for the antibiotic and changes in the membrane permeability to antibiotics13. Some 
bacteria are intrinsically resistant to certain classes of antibiotics14. However, it is 
acquired resistance that is of the greatest concern, whereby a previously susceptible 
population of bacteria becomes resistant to an antibiotic15.  
 
Plasmids are small, extrachromosomal pieces of DNA and are one of the main drivers 
in the spread of antibiotic resistance. They have the ability to self-replicate and many 
are conjugative, allowing them to easily transfer to other bacteria16. Broad host range 
plasmids also possess the ability to transfer to taxonomically distant species while 
stably maintaining the genes that they harbour17. Plasmids often carry antibiotic 
resistance genes, which can provide a benefit to the host bacterial cell under antibiotic 
pressure. However, these genes may also incur a high fitness cost, and so may not be 
continually maintained by the same host18. Multi-drug resistance occurs by the 
accumulation of resistance genes, each coding for resistance to a specific antibiotic, 
usually on plasmids19. Multi-drug resistance has grave consequences for health, 
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particularly if harboured by a pathogen, as the options for treatment are greatly 
limited20.   
 
Resistance to antibiotics which were previously only chromosomally encoded are 
being identified on plasmids. These include the qnr genes that confer resistance to 
quinolones, which were first detected only in 199421. Similarly, the mcr genes were 
first identified in 2016; these genes confer resistance to the polymyxin colistin22. Even 
more concerning is that colistin is considered an antibiotic of last resort for the 
treatment of multi-drug resistant infections caused by Gram-negative bacteria23.       
 
1.3 Antibiotics in agriculture 
 
The rapid rise in resistance cannot be confined to just a clinical context. Antibiotics 
are administered to animals for the treatment of disease, but also to prevent and control 
the spread of disease. In 2013, it was estimated most of the 100,000-200,000 tonnes 
of antibiotics manufactured every year goes to the agricultural, horticultural, and 
veterinary sectors24. It is important to note that the antibiotics which are used in 
agriculture have the same modes of action or belong to the same antibiotic classes as 
those used in human medicine25.  
 
In the 1950s, it was discovered that sub-therapeutic quantities of antibiotics could 
enhance the feed-to-weight ratio for poultry, swine, and beef cattle26. These antibiotic 
growth promotors (AGP) reduce normal microbial communities present in the animal 
gut, which compete with the host for nutrients. They also reduce the abundance of 
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harmful bacteria that may reduce performance by causing subclinical disease27. In 
combination, this results in an increase in growth. However, towards the end of the 
1960s, plasmid-encoded oxytetracycline resistance was identified in the zoonotic 
pathogen Salmonella Typhimurium in farm animals28. In 1975, a study on a chicken 
farm using oxytetracycline as an AGP found not only the chickens but also the farm 
family to be colonised by resistant strains of Escherichia coli29. In 1993, Bates et al., 
linked the emergence of vancomycin resistant enterococci, which was causing huge 
clinical concern, with the use of the AGP avoparcin30. In 2005, Hershberger et al., 
found that there was a significant reservoir of antibiotic-resistant enterococci among 
farm animals that were administered antibiotics31.    
 
Due to these concerns in the increases of antibiotic resistance, AGPs were banned by 
the European Union in 200632, and later in America in 201733. However, Casewell et 
al., highlighted the important prophylactic activity of AGPs and associated their 
withdrawal with a deterioration in animal health. This included reports of increased 
diarrhoea, weight loss and mortality due to infections with Escherichia coli and 
Lawsonia intracellularis in pigs, and clostridial necrotic enteritis in broiler chickens34. 
Therefore, products with a similar growth-promoting and pathogen-reducing effect are 
required for the maintenance of animal health in the absence of AGPs.    
 
1.4 Antibiotic resistance in poultry production and the risk to human health 
 
Poultry meat is the main driver of growth in total meat production globally35. As the 
human population continues to increase, so too will the demand for poultry meat, 
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which is one of the most widely consumed protein sources for humans36. Large-scale 
intensive farming is expected to upscale to meet this demand, however this often 
involves housing a large quantity of birds in cramped conditions37. This allows for 
disease, but also resistance, to spread rapidly throughout the flock. Antibiotics are used 
therapeutically, prophylactically, metaphylactically or as growth promotors (in certain 
countries) within poultry production, with the antibiotic generally being administered 
to the entire flock38. This has been a factor that has contributed to the ability of modern 
production facilities to produce market ready chickens in six weeks39.  
 
There is a risk of resistance transfer from animals to humans through the food chain. 
Consumers may be exposed to resistant bacteria through the consumption of animal 
products. Foods from numerous different animal sources and at all stages of 
production contain abundant quantities of antibiotic resistant bacteria and genes40. 
Randall et al., found that the use of fluoroquinolones in broilers resulted in resistant 
Campylobacter that was linked to 10% of human Campylobacter infections in the 
same area41. Sorensen et al., demonstrated that glycopeptide-resistant Enterococcus 
faecium, that was ingested via chicken or pork, persisted in human stool for up to 14 
days after ingestion42. Commensal bacteria in food animals may also serve as a 
reservoir for resistance-encoding plasmids, the proportion of which is enhanced by the 
use of antibiotics in agriculture. When ingested by humans, the animal commensals 
can transfer their resistance to bacteria in the human microbiome43.    
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1.5 An alternative to antibiotic growth promotors 
 
Prebiotics are feed supplements that provide benefits to the host. The non-digestible 
products stimulate specific changes in the composition or activity, or both, of the 
intestinal microbiota that confers benefits to the host44. Unlike normal sugars, they are 
not digested by the host, and act as an energy source for bacteria45. Prebiotics can be 
fermented by beneficial bacteria in the intestine and produce lactic acid, short-chain 
fatty acid or even some antibacterial substances against pathogenic species. This has 
the potential to benefit the intestinal microbiota while improving the integrity of 
intestinal epithelial cells. This results in increased absorption of nutrients and 
therefore, enhanced growth performance of animals46. Prebiotics are therefore 
regarded as an alternative to antibiotic growth promotors (AGPs).  
 
Mannan-oligosaccharides (MOS) are yeast cell wall fragments that are derived from 
Saccharomyces cerevisiae47. MOS are extracted by a process of opening the yeast cell 
wall, followed by steps of centrifugation, spray drying and alkaline extraction to α-
mannoproteins, which are concentrated by membrane ultrafiltration and spray 
drying48. MOS has been found to reduce pathogenic bacteria, enhance beneficial 
bacteria, increase villus height and decrease crypt depth, modulate immune response 
and improve performance in broiler chickens49.   
 
Disturbances to the intestinal microbiome have been shown to lead to susceptibility to 
infection in the host. Prebiotics have been demonstrated, by increasing the commensal 
bacteria in the microbiome, to increase the hosts ability to inhibit pathogens50. MOS 
8 
 
has been shown to enhance the abundance of beneficial bacteria in the intestines of 
broilers. This effect has mainly been seen in Lactobacillus and Bifidobacteria 
species51. Baurhoo et al. found that MOS boosted the population of Bifidobacteria spp. 
in the intestines of broilers by increasing goblet cells and mucin production52.   
 
Many Gram-negative bacteria, such as Escherichia coli and Salmonella, use mannose-
specific fimbriae to attach to the intestinal epithelium of the host53. MOS provides 
competitive binding sites for the fimbriae on pathogenic bacteria, and thus prevents 
them from attaching to the gut wall. This prevents their stabilisation, colonisation and 
multiplication within the host and therefore their potential to cause disease54. As MOS 
is not enzymatically digested, the bacteria which become bound to MOS are likely to 
exit the intestinal tract without attaching to the epithelium55. Due to this, MOS is seen 
as a viable option for use in antibiotic-free farming as an alternative to growth 
promotors54.  
 
Mannan rich fraction (MRF) is the next generation of MOS technology, developed 
from particular sugars present in the cell wall of a specific strain of Saccharomyces 
cerevisiae56. It can be added to diets at lower inclusion rates while still providing the 
same benefits as MOS including enhancing nutrient utilisation, maintaining digestive 
function and enzyme activity, and controlling inflammation. A study by Smith et al., 
found that MRF reduced E. coli adherence to intestinal porcine epithelial cells57. 
M'Sadeq et al., discovered that MRF was effective in preventing performance decline 
from necrotic enteritis in broiler chickens58. The MRF is more purified than MOS, 
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allowing for greater attachment of pathogens56, providing it with enhanced suitability 
as an alternative to in-feed antibiotics. 
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Chapter 2 
  
11 
 
A Comparison of Methods for the Extraction of Plasmids Capable of 
Conferring Antibiotic Resistance in a Human Pathogen from Complex Broiler 
Caecal Samples 
 
Sarah Delaney1,2*, Richard Murphy2, Fiona Walsh1 
 
1Antimicrobial Resistance and Microbiome Research Group, Department of Biology, 
Maynooth University, Maynooth, Co. Kildare, Ireland.  
2Alltech European Bioscience Centre, Sarney, Summerhill road, Dunboyne, Co. 
Meath, Ireland. 
 
*Correspondence: sarah.delaney@mu.ie 
 
Keywords: Plasmids, Extraction Methods, Broiler, Antibiotic Resistance, Pathogen 
 
Published: Delaney, S., R. Murphy, R. & Walsh, F. (2018). A Comparison of Methods 
for the Extraction of Plasmids Capable of Conferring Antibiotic Resistance in a 
Human Pathogen From Complex Broiler Cecal Samples. Front. Microbiol. 9, 1731. 
 
12 
 
2.1 ABSTRACT 
 
The direct extraction of plasmid DNA containing antibiotic resistance genes from 
complex samples is imperative when studying plasmid-mediated antibiotic resistance 
from a One Health perspective, in order to obtain a wide representation of all the 
resistance plasmids present in these microbial communities. There are also relatively 
few bacterial species from natural environments which can be cultured in vitro. 
Extracting plasmids from the cultivable fraction of these complex microbiomes may 
only represent a fraction of the total antibiotic resistance plasmids present. We 
compared different methods of plasmid extraction from broiler caecal samples, whose 
resistance could be expressed in a human pathogen - Escherichia coli.  We found that 
kits designed for DNA extraction from complex samples such as soil or faeces did not 
extract intact plasmid DNA. Commercial kits specific for plasmid extraction were also 
generally unsuccessful, most likely due to the complexity of our sample and intended 
use of the kits with bacterial culture. An alkaline lysis method specific for plasmid 
extraction was ineffective, even with further optimisation. Transposon-aided capture 
of plasmids (TRACA) allowed for the acquirement of a small range of resistance 
plasmids. Multiple displacement amplification provided the broadest range of 
resistance plasmids by amplifying all extracted circular plasmid DNA, but the results 
were not reproducible across all samples. Exogenous plasmid isolation enabled the 
extraction of resistance plasmids from the microbial fraction by relying on the mobility 
of the plasmids in the sample. This was the most consistent method from which we 
obtained a range of resistance plasmids from our samples. We therefore recommend 
the use of the exogenous plasmid isolation method in order to reliably obtain the 
greatest representation of the total antibiotic resistance plasmidome in complex 
13 
 
samples. While this method has limitations, it is one which will vastly increase our 
current knowledge of antibiotic resistance plasmids present in complex environments 
and which are capable of transferring to a human and animal pathogen and 
environmental contaminant.   
14 
 
2.2 INTRODUCTION 
 
The rapid rise of antibiotic resistance has led to further studies into mobile genetic 
elements. Plasmids have been shown to be central vectors of gene sharing amongst 
bacteria1, and therefore play a key role in microbial evolution and the spread of 
antibiotic resistance, leading to the rise of multi-resistant pathogenic bacteria2. 
Bacterial plasmids allow resistance genes to transfer horizontally between taxa and 
between animals and humans3. It is the mobility of these antibiotic resistance plasmids 
that is causing the most concern, as it is probably the most common mechanism for 
the dissemination of resistance genes4, and many plasmids have the ability to move 
from a non-clinical environment to clinical pathogenic or human commensal bacteria. 
 
To study the antibiotic resistance plasmidome of a microbial population, there must 
be efficient methods of extracting the plasmid population directly from the sample 
being examined. However, plasmids make up only a small proportion of the total DNA 
present in complex samples5, and the cultivable component of the sample is even 
smaller. Traditional culture-based methods are less than ideal for working with animal 
or environmental samples as only a small fraction of these bacteria can be cultured in 
a laboratory environment5. Therefore, a large proportion of the plasmids present in 
such samples are missed if relying solely on culture-based methods. Additionally, the 
use of metagenomics-based sequencing methods also has its limitations. The 
sequencing depth is usually insufficient to extract whole plasmids from the data, 
assembly is difficult due to the small size of the fragments, and genes present in low 
abundances are missed6. Also, plasmids often contain repeat sequences that are shared 
with genomic DNA, making assembly from short-read data difficult7. Therefore, there 
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is a need to determine what methods are capable of extracting these resistance 
plasmids directly from complex samples and which will provide a wide representation 
of the antibiotic resistance plasmid population present in the microbial environment.  
 
In this study, we examined six methods of plasmid extraction and used broiler caecal 
samples as representatives of complex samples. The gastrointestinal tract of broilers 
hosts a complex microbial community of hundreds of bacterial species8. The plasmid 
DNA was transformed into Escherichia coli and selected on antibiotics to identify 
resistance plasmids. This allowed us to identify antibiotic resistance that could be 
expressed in a human pathogen, and further analyse the resistance mechanism in a 
well-characterised pathogen. There are also other plasmid extraction methods which 
have not been evaluated in this study but show good results. For example, Sentchilo 
et al., (2013)9 used a CsCl-EB method to isolate a variety of plasmids from activated 
sludge systems.     
 
At present, there are no commercial kits designed to extract plasmid DNA directly 
from complex samples. Current plasmid extraction kits are intended to work with pure 
bacterial culture, which is less than ideal when dealing with complex environmental 
samples. Kits which are devised for use with complex samples such as soil or faeces 
target only genomic DNA. Alkaline lysis10 is a widely used method for the extraction 
of plasmid DNA by separating it from chromosomal DNA based on the small size and 
supercoiled nature of plasmids. However, it is also only intended for use with bacterial 
culture, not with complex samples which contains other material as well as bacteria.  
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Exogenous plasmid isolation works by capturing the plasmids directly from the 
complex sample in biparental matings using a recipient bacteria. While this method 
allows for plasmids to be obtained directly from the sample, it relies strongly on the 
plasmid being stably maintained in the host, and on the conjugative ability of the 
plasmids present in the sample. Therefore, this method may give a misrepresentation 
of the total plasmids present in the sample, as the non-conjugative fraction may not be 
extracted with this method11. However, plasmids can become mobilised by a self-
transmissible plasmid12, and could therefore also be captured by this method. 
Additionally, the exogenous method can in general also isolate linear plasmids, which 
are frequently found in diverse microbial environments11.  
 
The Transposon-aided capture (TRACA) of plasmids allows for the acquirement of 
antibiotic resistance plasmids from complex samples13. It works by removing any 
contaminating chromosomal DNA from a total DNA sample, and then inserting a 
transposon onto the plasmids with a known selectable marker. Linear plasmids may 
not be captured by this method, as the Tn5 origin of replication is not capable of 
replicating their extreme termini, and they could be degraded by the exonuclease 
unless specialised enzymes are used14. The main advantage of this method is that it 
has the capability to capture plasmids that do not have a selectable marker for E. coli 
and may not have the ability to replicate. It has been noted that this method favours 
the isolation of small plasmids, so it may give a misrepresentation of the total plasmid 
population15.  
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The multiple displacement amplification method works by removing all sheared 
genomic DNA from a total DNA sample with plasmid-safe DNase. The remaining 
circular plasmid DNA is amplified by phi29 DNA polymerase, which has a rolling-
circle mechanism. In short, by using random hexamers, phi29 allows for the unspecific 
amplification of the circular plasmid DNA present. The benefit of this method is that 
even when plasmids are present in very small numbers compared to the total DNA in 
the sample, this method allows for the generation of large amounts of plasmid DNA5. 
Similarly, this method also favours the selection of small plasmids15, and like TRACA, 
disregards linear plasmids, some of which could be degraded by DNase treatment11. It 
should also be noted that large plasmids could be sheared during the extraction, by 
which they may also be degraded by the exonuclease treatment. Norman et al., 
(2014)16 described an electroelution step which could be applied prior to amplification 
to attempt to increase the number of large-sized plasmids obtained.        
 
Our study compared these methods to identify which extracted the largest variety of 
antibiotic resistance plasmids (based on the banding patterns and resistance profiles of 
transformants or transconconjugants) present in the complex broiler caecal samples. 
We found that the exogenous isolation method best met these criteria, in both a time-
efficient and consistent manner. While this method does not remove all bias, it does 
allow for the acquirement of antibiotic resistance plasmids which can be further 
phenotypically tested.   
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2.3 MATERIALS & METHODS 
 
2.3.1 Samples 
 
The broiler caecal samples were collected from a commercial poultry production unit 
in the United Kingdom. Samples were lyophilised and stored at -80°C. Each of the 
plasmid extraction methods were carried out with the same caecal sample (Sample A). 
All methods were also carried out with Escherichia coli NCTC 13400 containing 
plasmid pEK499 as a control.  
 
2.3.2 Plasmid Extractions and Identifications 
 
2.3.2.1 Culture Dependent Method 
 
Caecal sample (0.01 g) was mixed with 0.1 mL of 0.85% NaCl. The 0.1 mL mix was 
spread on a Muller-Hinton (Merck) agar plate and incubated overnight at 37°C. All 
bacterial growth on the plate was scraped off, inoculated into 6 mL of non-selective 
Muller-Hinton broth and incubated overnight at 37°C with shaking at 225 rpm. 
Plasmid DNA was extracted from this bacterial culture using the NucleoSpin Plasmid 
Kit (Macherey-Nagel, Germany) according to the manufacturer’s guidelines. The 
resulting DNA samples were visualised on a 1% agarose gel stained with 1X GelRed 
(Biotium) and run at 70 volts for 60 minutes.  
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2.3.2.2 Commercial DNA Extraction Kits 
 
A. DNA was extracted from 0.05 g of caecal sample using the Mobio PowerSoil DNA 
Extraction Kit (now Qiagen), according to the manufacturer’s guidelines.  
B. DNA was extracted from 0.01 g of caecal sample using the Qiagen Plasmid Mini 
Kit, according to the manufacturer’s guidelines. 
C. DNA was extracted from 0.01 g of caecal sample using the Macherey-Nagel 
NucleoSpin Plasmid Kit, according to the manufacturer’s guidelines.  
 
Extracted DNA was visualised on a 1% agarose gel stained with 1X GelRed and run 
at 70 volts for 60 minutes. The DNA was electroporated into E. coli DH5α, selected 
on ampicillin (32 mg/L), tetracycline (16 mg/L), kanamycin (25 mg/L), colistin (16 
mg/L) or ciprofloxacin (4 mg/L), and incubated at 37°C overnight. Plasmid DNA was 
extracted from the transformants using the Machery-Nagel NucleoSpin Plasmid kit 
and digested with EcoRI restriction enzyme. Plasmids were visualised on a 1% agarose 
gel stained with 1X GelRed. Antibiotic susceptibility testing via the disk diffusion 
method was carried out on transformants according to the Clinical and Laboratory 
Standards Institute (CLSI) guidelines (2016)17.    
 
2.3.2.3 Alkaline Lysis Method 
 
Plasmid DNA was extracted using an alkaline lysis method10. The caecal sample (0.03 
g) was resuspended in 100 µL ice-cold resuspension buffer (50 mM glucose, 25 mM 
TrisCl (pH 8.0), 10 mM EDTA (pH 8.0)). Bacterial cells were lysed with 200 µL lysis 
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solution (0.2 N NaOH, 1% (wt/vol) sodium dodecyl sulfate (SDS)) for 4 minutes and 
neutralised with 150 µL of chilled 3 M potassium acetate, pH 4.8. The samples were 
centrifuged at 14000 rpm for 10 minutes at 4°C. The supernatant containing the 
plasmid was mixed with an equal volume of isopropanol and incubated at -20°C for 
15 minutes. Samples were centrifuged at 14000 rpm for 30 minutes at 25°C. The 
supernatant was removed and 500 µL of 70% ethanol was added to the pellet and 
centrifuged at 14000 rpm for 5 minutes at 25°C. The pellet was resuspended in 50 µL 
MilliQ water. Extracted DNA was visualised on a 1% agarose gel stained with 1X 
GelRed and run at 70 volts for 60 minutes. The DNA was electroporated into E. coli 
DH5α, selected on ampicillin (32 mg/L), tetracycline (16 mg/L), kanamycin (25 
mg/L), colistin (16 mg/L) or ciprofloxacin (4 mg/L), and incubated at 37°C overnight. 
Plasmid DNA was extracted from the transformants using the Machery-Nagel 
NucleoSpin Plasmid kit and digested with EcoRI restriction enzyme. Plasmids were 
visualised on a 1% agarose gel stained with 1X GelRed run at 70 volts for 60 minutes. 
Antibiotic susceptibility testing via the disk diffusion method was carried out on 
transformants according to CLSI guidelines17.    
 
2.3.2.4 Exogenous Plasmid Isolation 
 
Plasmid DNA was exogenously isolated in biparental matings18. Caecal sample (0.01 
g) was added to 0.9 mL of non-selective Tryptic Soy Broth (TSB) (Sigma Aldrich) 
and incubated at 20°C with shaking at 50 rpm overnight. The supernatant containing 
the bacterial fraction (0.8 mL) was centrifuged at 2800 ×g for 10 mins at room 
temperature (RT). The pellet was resuspended in 80 µL of TSB. This comprised the 
donor culture. A culture of rifampicin resistant E. coli DH5α was grown overnight at 
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28°C and shaking at 180 rpm. The bacterial content was pelleted by centrifugation at 
2800 ×g for 5 minutes at RT, washed in 140 µL LB broth (Duchefa-Biochemie) and 
resuspended in 140 µL LB broth. This comprises the recipient culture. Donor and 
recipient culture (50 µl each) were mixed and centrifuged at 2800 ×g for 5 mins at RT. 
The supernatant was removed and the pellet resuspended in 50 µl of TSB. This was 
applied to a 0.2 µm filter on an LB agar plate and incubated at 28°C for 20 hours. The 
filter was removed from the plate and the cells resuspended in 0.85% NaCl by 
vortexing. A volume of 100 µL was plated on Eosin Methylene Blue (EMB) agar 
(Sigma) with rifampicin (100 mg/L) and one of the following  antibiotics: ampicillin 
(32 mg/L), tetracycline (16 mg/L), kanamycin (25 mg/L), colistin (16 mg/L) or 
ciprofloxacin (4 mg/L). Plates were incubated at 28°C for 1-2 days until 
transconjugant colonies appeared. Plasmids were extracted from each of the colonies 
using the Macherey-Nagel NucleoSpin Plasmid Kit and digested with EcoRI 
restriction enzyme. Plasmids were visualised on a 1% agarose gel stained with 1X 
GelRed run at 70 volts for 60 minutes. Antibiotic susceptibility testing via the disk 
diffusion method was carried out on transconjugants according to CLSI guidelines17.     
 
2.3.2.5 Transposon-Aided Capture of Plasmids (TRACA) 
 
Transposon-Aided Capture of plasmids (TRACA) was carried out as previously 
described13. TRACA is based on the insertion of a transposon with a known origin of 
replication and antibiotic resistance marker into the plasmids, which can then 
subsequently be “captured”. Bacterial cells were separated from the caecal samples by 
adding 0.1 g of caecal sample to 0.9 mL of non-selective TSB and incubating at 20°C 
and 50 rpm overnight. The supernatant (0.8 mL) was centrifuged at 2800 ×g for 10 
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mins at RT and DNA was extracted by performing alkaline lysis (as previously 
described) on the pellet. 
 
The removal of sheared chromosomal DNA prior to performing the TRACA reaction 
ensures that the transposon is only inserted onto plasmid DNA. DNA was treated with 
Plasmid-Safe DNase (Epicentre), according to the manufacturer’s guidelines. 
Amplification of the 16S rRNA genes by PCR was performed to ensure the ratio of 
plasmid:chromosomal DNA in the sample was reversed. This was carried out using 
the following primers19:  
 
Forward  
5’- 
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCA
G-3’ and Reverse  
5’-
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATC
TAATCC-3’; and under the following conditions: 95°C for 3 minutes; 35 cycles of: 
95°C for 30 seconds, 55°C for 30 seconds, 72°C for 30 seconds; and finally 72°C for 
5 minutes.   
 
TRACA was performed using the EZ-Tn5 <R6Kγori/KAN-2> Insertion Kit 
(Epicentre), according to the manufacturer’s guidelines. The 50 µL reaction was 
diluted with 450 µL sterile water and purified with Vivaspin 500 MWCO 100,000 
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Protein Concentrator Spin Columns (GE Healthcare Life Sciences) which reduced the 
reaction volume to 10 µL. 5 µL was electroporated at 1.8 kV into 100 µL TransforMax 
EC100D pir-116 Electrocompetent E. coli (Epicentre). The transformed cells were 
spread onto LB agar plates with 50 mg/L kanamycin to select for EZ-Tn5. Plasmid 
DNA was extracted from TRACA clones using the Qiagen HiSpeed Plasmid Midi kit 
and visualised on a 1% agarose gel stained with 1X GelRed, run at 70 volts for 60 
minutes. Bands of plasmid DNA (B1 and B2) were harvested from a 1% agarose gel 
stained with SYBR Safe using the Cleaver Scientific runVIEW system run at the same 
conditions as before. The harvested DNA bands were electroporated into E. coli 
DH5α, selected on ampicillin (32 mg/L), tetracycline (16 mg/L), kanamycin (25 
mg/L), colistin (16 mg/L) or ciprofloxacin (4 mg/L), and incubated at 37°C overnight. 
Transformants were obtained on ampicillin, tetracycline and ciprofloxacin with DNA 
from band 2 and on ciprofloxacin with DNA from band 1. Plasmid DNA was extracted 
from the transformants using the Machery-Nagel NucleoSpin Plasmid kit and digested 
with EcoRI restriction enzyme. Plasmids were visualised on a 1% agarose gel stained 
with 1X GelRed. Antibiotic susceptibility testing via the disk diffusion method was 
carried out on transformants according to CLSI guidelines17.    
 
2.3.2.6 Multiple Displacement Amplification 
 
The multiple displacement amplification method utilises the rolling circle 
amplification mechanism of phi29 DNA polymerase to obtain large amounts of 
plasmid DNA from a complex sample. Plasmid DNA was extracted from the caecal 
sample by following protocol B from Kav et al., (2013)5, which was adapted from 
Hansen & Olsen (1978)20. The caecal sample (0.225 g) was resuspended in 8.1 mL of 
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25% sucrose, 50 mM Tris (pH 8). Lysozyme (10 mg/ml in 250 mM Tris (pH 8)) (0.6 
mL) was added and the reaction was incubated on ice for 5 minutes. 
Ethylenediaminetetraacetic acid (EDTA) (3 ml of 250 mM, pH 8) was added and 
incubated on ice for 5 minutes. Sodium dodecyl sulfate (SDS) (6 mL of 10%) was 
added and mixed by inversion. Samples were incubated for eight cycles of heat pulsing 
and mixing (15 seconds at 55°C, 15 seconds at RT). NaOH (3 mL of 3 M) was added 
and mixed by inversion for 3 minutes. Tris (6 mL of 2 M, pH 7.0) was added and 
mixed by inversion. SDS (7.92 mL of 10%) was added, followed immediately by 7.5 
mL of 5 M NaCl. Samples were incubated at 4°C overnight. Samples were centrifuged 
at 3000 ×g for 30 minutes at 4°C and the supernatant transferred to a new tube. 0.1 
volume of 3 M sodium acetate (pH 5.2) and 0.6 volume of isopropanol were added 
and samples incubated overnight at 4°C. 
 
As with TRACA, sheared chromosomal DNA was removed with plasmid-safe DNase 
prior to amplification to ensure only circular plasmid DNA was amplified. Removal 
of chromosomal DNA and amplification of plasmid DNA was carried out as described 
previously by Kav et al., (2013)5. A 50 µL reaction composed of 20 µL DNA, 24 µL 
MilliQ water, 1 µL ATP, 2.5 µL reaction buffer and 2.5 µL plasmid-safe DNase was 
incubated at 37°C overnight and deactivated at 70°C for 30 minutes. Amplification of 
the 16S rRNA genes by PCR as previously described was performed to ensure the 
ratio of plasmid:chromosomal DNA  was reversed in the sample, i.e. high plasmid to 
low chromosomal DNA ratio. If bands were visible the assay was repeated. 0.1 
volumes of 3 M sodium acetate (pH 5.2) and 0.6 volumes of isopropanol were added 
and incubated overnight at 4°C. Samples were centrifuged at 14000 rpm 4°C for 30 
min. The supernatant was removed and 70% ethanol added. Samples were mixed and 
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centrifuged at 14000 rpm 4°C for 15 min. The supernatant was removed and the pellet 
resuspended in 10 μl MilliQ water.  
 
Plasmid DNA was amplified by adding 1 μl of 10 μM Exo-Resistant Random Primer 
(Thermo Scientific), 2 μl phi29 DNA Polymerase Reaction Buffer (New England 
Biolabs) and 8.2 μl of MilliQ water to 5 μl of the purified treated DNA. Samples were 
incubated at 95°C for 5 min and immediately chilled on ice for 5 min. 1.6 μl phi29 
DNA polymerase (New England Biolabs), 0.02 μl of inorganic pyrophosphatase (from 
yeast) (New England Biolabs) and 2 μl of dNTPs (10 mM) (Thermo Scientific) were 
added and incubated at 30°C for 16 hours.  
 
Amplified plasmid DNA (5 µL) was electroporated at 1.8 kV into 15 µL of E. coli 
DH5α cells. Transformants were plated on LB agar plates with one of the following 
antibiotics: ampicillin (32 mg/L), tetracycline (16 mg/L), kanamycin (25 mg/L), 
cefotaxime (16 mg/L), colistin (16 mg/L) or ciprofloxacin (16 mg/L). Plasmids were 
extracted using the Qiagen HiSpeed Midi kit and digested with EcoRI restriction 
enzyme. Plasmids were visualised on a 1% agarose gel stained with 1X GelRed run at 
70 volts for 1 hour. Antibiotic susceptibility testing via the disk diffusion method was 
carried out on transformants according to CLSI guidelines17.  
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2.4 RESULTS 
 
2.4.1 Culture Dependent Method 
 
All cultivable bacteria grew on a non-selective rich medium and the DNA was 
extracted using a commercial plasmid extraction kit. Several bands were visible on an 
agarose gel (Fig 1), however when transformation was carried out it failed to yield any 
transformants on antibiotic plates. This could indicate that the plasmids present in the 
cultivable fraction did not harbour any resistance genes to the antibiotics tested. The 
plasmid pEK499 in E. coli was used as a pure bacterial culture control, and was 
successfully extracted using this method (Fig S1).  
 
2.4.2 Commercial DNA Extraction Kits 
 
The MoBio kit resulted in a single band of DNA located near the top of the agarose 
gel (Fig 2). Initially we thought that this band was genomic DNA or large plasmids. 
However, as no transformants were obtained after electroporation on any antibiotic 
plates (ampicillin (32 mg/L), tetracycline (16 mg/L), kanamycin (25 mg/L), colistin 
(16 mg/L) and ciprofloxacin (4 mg/L)) we concluded that this was genomic DNA. We 
also used this kit with 5 ml of E. coli culture harbouring our control plasmid pEK499, 
which resulted in a very bright band (Fig S2). It appears that as the DNA is at such a 
high concentration, and pEK499 is a large plasmid which diffuses slowly through the 
agarose gel, it is likely present along with genomic DNA.  
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The Qiagen Plasmid Mini kit and the Machery-Nagel NucleoSpin Plasmid kit are both 
designed for the extraction of plasmids from bacterial culture. Both kits work well for 
this purpose, which can be seen in Fig S2, where they both extracted our control 
plasmid pEK499 from E. coli culture. However, when we used these kits with our 
caecal sample, we did not obtain clear bands of plasmid DNA. The NucleoSpin kit 
resulted in a smear on the gel (Fig 2), and yielded transformants on ciprofloxacin and 
tetracycline selective plates only. After subjecting these tranformants to a further 
plasmid extraction, digestion and antibiotic susceptibility testing, they had the same 
banding pattern and resistance profile. The Qiagen plasmid kit did not appear to 
retrieve any DNA from our samples (Fig 2) and did not yield any transformants on 
any antibiotic selective plates (ampicillin (32 mg/L), tetracycline (16 mg/L), 
kanamycin (25 mg/L), colistin (16 mg/L) and ciprofloxacin (4 mg/L)).  
 
Plasmid DNA extracted from the caecal sample using the Macherey-Nagel 
NucleoSpin Plasmid kit was transformed into E. coli DH5α. Transformants grew on 
ciprofloxacin (4 mg/L) and tetracycline (16 mg/L) plates only (Fig 3). Antibiotic 
susceptibility testing via a disk diffusion assay provided the resistance profile of the 
resulting transformants (Table 1).  
 
2.4.3 Alkaline Lysis Method 
 
A smear of DNA on a gel was detected after performing alkaline lysis directly on the 
caecal sample (Fig 4). This was the best result, even after reducing the amount of 
sample used (0.03 g), adding additional bead beating steps at varying time lengths, 
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and the addition of varying concentrations of RNase A, proteinase K and lysozyme at 
different time points and incubation temperatures. We obtained transformants on 
ciprofloxacin (4 mg/L), which had similar banding patterns (Fig 5) and resistance 
profiles to the transformants selected on ciprofloxacin obtained with the NucleoSpin 
kit. The extracted DNA was electroporated into E. coli DH5α, selected on 
ciprofloxacin (4 mg/L), extracted from the transformants and digested with EcoRI (Fig 
5). The method was repeated with control plasmid pEK499 (Fig S3). 
 
2.4.4 Exogenous Plasmid Isolation 
 
The exogenous plasmids were obtained by the recipient in biparental matings, and 
selected on ampicillin (32 mg/L), tetracycline (16 mg/L), kanamycin (25 mg/L), 
colistin (16 mg/L) and ciprofloxacin (4 mg/L). Transformants were isolated from the 
plates containing ampicillin, tetracycline (with two colony morphologies; big colonies 
(BC) and small colonies (SC)) and kanamycin. This method isolated plasmids 
obtained from the caecal sample and control plasmid pEK499 (Fig 6; Fig S4).  
 
2.4.5 Transposon-Aided Capture of Plasmids (TRACA) 
 
TRACA allowed for the acquisition of plasmids from the caecal samples by inserting 
a transposon with a selectable resistance marker and transforming the DNA into E. 
coli.  The two largest bands of plasmid DNA were extracted directly from the gel (Fig 
7) (B1- lower band; B2- higher band) and electroporated into E. coli. Transformants 
were selected on ampicillin (32 mg/L), tetracycline (16 mg/L), kanamycin (25 mg/L), 
colistin (16 mg/L) and ciprofloxacin (4 mg/L), with ampicillin, tetracycline and 
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ciprofloxacin plates yielding transformants (Fig 8). We found that all but one of the 
transformants tested had a similar banding pattern and resistance profile to the 
plasmids extracted using the alkaline lysis and NucleoSpin kit.  
 
2.4.6 Multiple Displacement Amplification 
 
The multiple displacement amplification method allows for unspecific but selective 
amplification of circular DNA after DNase digestion (Fig 9), through which we 
acquired antibiotic resistance plasmids from a caecal sample. This method gave us the 
largest range of plasmids from our caecal samples. That is, the greatest number of 
antibiotic plates (ampicillin (32 mg/L), tetracycline (16 mg/L), kanamycin (25 mg/L) 
and ciprofloxacin (16 mg/L)) which yielded transformants and each antibiotic plate 
transformants had a different banding pattern after digestion with EcoRI (Fig 10) and 
resistance profile (Table 1). However, the results shown are from a different caecal 
sample (Sample B) as the method was unsuccessful for sample A.     
 
Antibiotic susceptibility testing via a disk diffusion method gave the resistance profile 
of the plasmids (Table 1). This, along with the banding patterns of the digested 
plasmids on agarose gels, allowed for the identification of the variety of plasmids 
obtained from each extraction method. It also allowed for a comparison of the 
plasmids acquired using the different methods from the same sample, to determine if 
the same or different plasmids were obtained. There was no single antibiotic that 
selected for transformants using all methods. However, plasmids with identical 
antibiotic resistance patterns were identified using the different methods. 
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Transformants isolated using the exogenous method had four different antibiotic 
susceptibility patterns, suggesting the presence of at least four different plasmids. The 
exogenous transformants had the widest range of resistance, with three transformants 
resistant to four different classes of antibiotics. T_B1_Cip transformant had the same 
resistance profile as M_Kan and M_Cip selected transformants. Based on visual 
analysis of the banding patterns (Fig 11) and antimicrobial susceptibility patterns 
(Table 2) combined, the plasmids identified in MN_Cip, MN_Tet, A_Cip, T_B2_Cip 
and T_B2_Tet are probably the same plasmids or highly similar. Further analysis 
methods, such as sequencing, are required to confirm that these plasmids are identical. 
The remaining transformants had unique resistance profiles. 
  
31 
 
2.5 DISCUSSION 
 
Plasmids isolated from complex samples have previously been examined using 
methods such as gradient gel resolution of PCR products, quantification of 
incompatibility groups using qPCR21 or Southern blotting22. Recently, the study of 
plasmids involves the extraction of plasmid DNA followed by various sequencing 
approaches15. However, if multiple plasmids are present in a sample or if they are at 
low copy number, these won’t be identified via sequencing due to the depth of current 
metagenomic sequencing technologies. Similarly, assembly is difficult with short-
reads, especially if plasmids are present in low copy numbers or if the reads match to 
genomic DNA23. We performed this work to identify a method suitable for the 
extraction of plasmids harbouring antibiotic resistance genes from complex broiler 
caecal samples, which could be transformed into a human pathogen, in this case 
Escherichia coli. This would then allow for further analysis, sequencing and assembly 
of the plasmid in a well-defined bacterium. The variety of resistance plasmids obtained 
was determined by analysis of the banding patterns (shown in figures) and resistance 
profiles (shown in tables) of the transformants or transconjugants obtained.   
 
In order to carry out studies on the overall resistance plasmid population present in a 
complex sample, the method to extract plasmid DNA must be optimised to give as 
best a representation as possible of the total resistance plasmids present. The first 
method we performed was a culture-dependent method on non-selective media. 
Another way of performing a more specific culture-dependent extraction would be to 
use selective agars. This would assist in the identification of which bacterial species a 
certain plasmid may have come from. However, this would introduce a bias to the 
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results, as one would be choosing which agars and, hence, which bacteria to select. 
The main disadvantage of a culture-dependent method for complex samples is that 
only a small number of environmental bacteria can currently be cultured in the 
laboratory24. This means that by using only a culture-based method, it would greatly 
limit the number of plasmids isolated. Therefore, the representation of results from a 
culture-dependent study would give a limited view of the total resistance plasmidome. 
Our experiment did not yield any transformants on antibiotic plates, indicating that the 
plasmids present in the cultivable fraction did not harbour any resistance genes to the 
antibiotics tested. 
 
The MoBio PowerSoil DNA Isolation kit is specifically designed to extract DNA from 
complex soil samples. This kit did not extract any plasmids harbouring antibiotic 
resistance genes from our caecal sample as we failed to obtain any transformants, 
indicating it is more suitable for studies analysing chromosomal DNA or fragmented 
DNA, rather than intact plasmid DNA. The Qiagen Plasmid Mini kit and the Machery-
Nagel NucleoSpin Plasmid kit are both designed for the extraction of plasmids from 
bacterial culture. It seems that the caecal samples are too complex for these kits. The 
sample blocked the spin columns used in these kits, therefore little to no DNA was 
retrieved. Minimal success resulted with these commercial plasmid extraction kits, as 
few antibiotic resistance plasmids were obtained. It thus appears that these kits were 
not capable of dealing with the complexities associated with our samples.       
 
The alkaline lysis method10 is a common method of plasmid extraction, on which most 
commercial plasmid extraction kits are based. A benefit of using this method is that 
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the chemicals used and their concentrations in the solutions can be decided upon and 
adapted for individual needs. There are standard protocols available for constituting 
resuspension, lysis and neutralisation buffers, but, for example, additional enzymes 
can be added to the buffers. This type of adaptation is difficult with commercial kits 
as most do not share the components of their buffers. This is also why the alkaline 
lysis method and two commercial plasmid extraction kits were tested in this study, as 
they cannot be directly compared. However, this method still yielded few antibiotic 
resistance plasmids, even after additional modifications (as mentioned in methods 
section) to the protocol. 
  
The exogenous method of plasmid isolation is based on the capture of conjugative 
plasmids directly from a complex sample, via a recipient bacteria in biparental 
matings18. This method captured resistance plasmids with different resistance profiles 
and was also the most consistent and not overly time-consuming. The disadvantages 
of this method are that it relies on the mobility of plasmids in the donor sample and 
the donor sample comprises an overnight culture of the total bacterial community. 
Therefore, the non-mobile plasmids present in the sample may not be captured with 
this method and the bacteria not capable of growth at the specific conditions will not 
be included as donors. However, many resistance plasmids are conjugative, and others 
can be mobile when assisted by a conjugative plasmid also residing in the same 
bacterial cell25. We are suggesting this method, not as a solution to all plasmid analysis 
problems, but rather as a first step in optimising the analysis of antibiotic resistance 
plasmids from complex samples. 
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TRACA allowed for the acquisition of resistance plasmids from our sample but with 
similar banding patterns and resistance profiles. Therefore, it seems the expense 
associated with this method is not justified given the small variety of plasmids 
captured. Three of the four plasmids isolated using TRACA were also isolated using 
the alkaline lysis method or the Macherey-Nagel NucleoSpin Plasmid kit.  
 
The multiple displacement amplification method allowed plasmids with the greatest 
range of resistance profiles to be obtained from our complex caecal samples. However, 
it should be noted that there were also difficulties and inconsistencies with this 
method. While good results were achieved using this method on Sample B (shown in 
results), many difficulties arose while carrying out the method on both Sample A and 
the control sample. The DNase step can be variable and time consuming, working well 
after one or two treatments at some times and not working after several more at other 
times. This also led to further downstream complications, as the more DNase 
treatments the sample was subjected to, the more salt that was present in the sample. 
This caused difficulties when performing electroporation, where salt concentration 
must be low. Therefore, the plasmid DNA isolated from both Sample A and control 
plasmid pEK499 did not transform into E. coli.   
 
Plasmids now encode resistance to almost all classes of antibiotics currently in clinical 
use25. Therefore, the study of plasmids is crucial to fight the battle against antibiotic 
resistance that we are currently facing. Our comparative study shows the advantages 
and disadvantages of six methods for the extraction of plasmids harbouring antibiotic 
resistance genes from complex broiler caecal samples, which can be applied to other 
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complex environmental samples. This will assist researchers with the selection of the 
best method to use in their plasmid studies. Different Gram-negative bacteria other 
than E. coli could be used for similar studies and the isolated plasmid DNA could be 
transformed into a Gram-positive bacterium to further broaden the study.  The 
exogenous plasmid isolation method was the best for obtaining a range of multi-drug 
resistance plasmids in a realistic timeframe with consistent results. However, even this 
method only resulted in a small range of resistance plasmids being isolated.  
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2.6 CONCLUSION 
 
Overall, the multiple displacement amplification method provided the greatest range 
of resistance plasmids from the investigated caecal samples. However, due to the 
inconsistencies of the results and the difficulties experienced with this method, it is 
not the ideal protocol to use when working with a large volume of samples under short 
deadlines. The commercial kits, alkaline lysis method and TRACA did not provide a 
wide range of resistance plasmids from our sample compared to the others tested. 
Therefore, the exogenous plasmid isolation method resulted in the widest range of 
resistance plasmids with ease of application and consistency across samples. While 
this method relies on the conjugative ability of the plasmids present, it is both an 
efficient (plasmids can be obtained in a short time-frame) and effective (a good range 
of plasmids can be acquired) method which worked with all of the caecal samples 
tested. Therefore, we recommend the exogenous plasmid isolation method when 
extracting antibiotic resistance plasmids of clinical relevance from a large number of 
complex samples.  
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2.7 TABLES  
 
Table 1. Disk diffusion results of resistant transformants obtained from each of the extraction methods. Red= Resistant, Yellow= Intermediate, 
Green= Susceptible; determined according to the CLSI guidelines (2016). MN= Machery Nagel kit, A= Alkaline Lysis, E=Exogenous Isolation, 
T=TRACA, M=MDA. Amp = selected on ampicillin, Tet = selected on tetracycline, Kan = selected on kanamycin, Cip = selected on ciprofloxacin. 
B1 = Lower band on gel, B2 = Higher band on gel; both extracted and electroporated into E. coli DH5α. (BC) And (SC) refer to the two different 
colony morphologies, big or small colonies, present on the same antibiotic plate. 
                          Sample  Ampicillin Tetracycline Kanamycin Cefotaxime Nalidixic Acid Ciprofloxacin Imipeniem 
Commercial Kits (A) MN_Cip I R I S R R S 
 MN_Tet I R I S R R S 
Alkaline Lysis (A) A_Cip I R I S R R S 
 E_Amp R R R R R R S 
Exogenous Isolation 
(A) E_Tet_BC R R R S S R S 
 E_Tet_SC R R I S S S S 
 E_Kan R R R I R R S 
 T_B1_Cip R R R S R R S 
TRACA (A) T_B2_Cip I R I S R R S 
 T_B2_Amp R S S S I R S 
 T_B2_Tet I R I S R R S 
 M_Amp_BC R R I I R R S 
 M_Amp_SC R R S S R R S 
MDA (B) M_Tet_BC R R R R R R S 
 M_Tet_SC R R S S S S S 
 M_Kan  R R R S R R S 
 M_Cip R R R S R R S 
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Table 2. Transformants with identical resistance profiles from a disk diffusion assay. Along with a similar banding pattern, this indicates the 
strains are probably harbouring the same plasmids.  
Red= Resistant, Yellow= Intermediate, Green= Susceptible; determined according to the CLSI guidelines (2016).  
MN= Machery Nagel kit, A= Alkaline Lysis, T=TRACA. Tet = selected on tetracycline, Cip = selected on ciprofloxacin. B2 = Higher band on 
gel; extracted and electroporated into E. coli DH5α. 
 
Sample  Ampicillin Tetracycline Kanamycin Cefotaxime Nalidixic Acid Ciprofloxacin Imipeniem 
Commercial Kits (A) MN_Cip I R I S R R S 
 MN_Tet I R I S R R S 
Alkaline Lysis (A) A_Cip I R I S R R S 
TRACA (A) T_B2_Cip I R I S R R S 
 T_B2_Tet I R I S R R S 
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2.8 FIGURES 
 
 
 
 
Fig 1. Agarose gel image of the plasmids extracted using the culture-dependent 
method from the broiler caecal sample, which was grown on non-selective Mueller-
Hinton media and extracted with the Macherey-Nagel NucleoSpin Plasmid kit. 
 1 = 1 kb ladder; 2 = DNA extracted from the cultivable fraction of the caecal sample.  
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Fig 2. Agarose gel image of DNA extracted from caecal samples using commercial 
kits. 
1= 1 kb ladder; 2 = DNA extracted from the caecal sample using the MoBio PowerSoil 
DNA Isolation Kit; 3 = DNA extracted from the caecal sample using the Qiagen 
Plasmid Mini Kit; 4 = DNA extracted from the caecal sample using the Macherey-
Nagel NucleoSpin Plasmid Kit.   
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Fig 3. Agarose gel image of digested plasmid DNA extracted from transformants, 
which were obtained by electroporating the DNA from the direct extraction with the 
Macherey-Nagel NucleoSpin Plasmid kit into E. coli and digested with EcoRI 
restriction enzyme. 
1= 1 kb ladder; Digested plasmid DNA extracted from transformants selected on agar 
plates containing 2 = tetracycline 16 mg/L (MN_Tet), 3 = ciprofloxacin 4 mg/L 
(MN_Cip). 
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Fig 4. Agarose gel image of DNA extracted from the caecal sample using the alkaline 
lysis method. 
1= 1 kb Ladder; 2= DNA extracted from the caecal sample using the alkaline lysis 
method.  
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Fig 5. Agarose gel image of digested plasmids which were obtained by transforming 
E. coli with plasmid DNA extracted using the alkaline lysis method and selected on 
ciprofloxacin 4 mg/L (A_Cip) and digested with EcoRI.  
1= 1 kb ladder; 2= digested plasmid DNA extracted from the transformant (alkaline 
lysis method) and selected on ciprofloxacin 4 mg/L (A_Cip). 
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Fig 6. Agarose gel image of exogenously isolated plasmids from the caecal sample 
digested with EcoRI restriction enzyme. 
1=1 kb ladder and DNA extracted from the caecal sample using the exogenous plasmid 
isolation method. Digested plasmid DNA extracted from transformants selected on 
agar plates containing 2= ampicillin 32 mg/L (E_Amp); 3= tetracycline (SC) 16 mg/L 
(E_Tet_SC); 4= tetracycline (BC) 16 mg/L (E_Tet_BC); and 5= kanamycin 25 mg/L 
(E_Kan). BC and SC refer to the two different colony morphology types, big or small 
colonies, on the same antibiotic plate. 
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Fig 7. DNA extracted from caecal sample using the TRACA method of plasmid 
isolation. 
1= DNA extracted from transformants selected on kanamycin 50 mg/L after TRACA 
reaction and 2= 1 kb ladder.  
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Fig 8.  Digested plasmid DNA extracted from E. coli transformed with plasmid DNA 
from TRACA clones and selected on antibiotics. 
1= 1 kb ladder and bands of plasmid DNA extracted from a 1% SYBR safe gel and 
transformed into E. coli. Digested plasmid DNA extracted from transformants selected 
on agar plates containing: 2= B1 ciprofloxacin 4 mg/L (T_B1_Cip); 3= B2 ampicillin 
32 mg/L (T_B2_Amp); 4= B2 tetracycline 16 mg/L (T_B2_Tet) and 5= B2 
ciprofloxacin 4 mg/L (T_B2_Cip). 
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Fig 9. Plasmid DNA from the caecal sample after amplification with phi29 
polymerase. 
 1= 1 kb ladder and 2= Plasmid DNA amplified with Phi29 DNA polymerase. 
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Fig 10. Digested plasmid DNA extracted from E. coli transformants after 
electroporation with the phi29 polymerase amplified DNA.  
 1= 1 kb ladder; Plasmid DNA extracted from transformants selected on agar plates 
containing: 2= ampicillin 32 mg/L (M_Amp_BC); 3= ampicillin 32 mg/L 
(M_Amp_SC); 4= tetracycline 16 mg/L (M_Tet_BC); 5= tetracycline 16 mg/L 
(M_Tet_SC); 6= kanamycin 25 mg/L (M_Kan); 7= ciprofloxacin 16 mg/L (M_Cip). 
BC and SC refer to the two different colony morphology types, big or small colonies, 
on the same antibiotic plate. There were no transformants on colistin or cefotaxime 
selective plates.  
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Fig 11.  Transformants from different isolation methods with identical banding 
patterns after plasmid digestion. Along with similar resistance profiles, this indicates 
the strains are probably harbouring the same plasmid. 1= 1 Kb Ladder; 2= MN_Tet; 
3= MN_Cip; 4= A_Cip; 5= T_B1_Cip; 6= T_B2_Cip; 7= T_B2_Tet.  
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2.10 SUPPLEMENTARY DATA 
 
 
 
 
 
Fig S1. Agarose gel image of the pEK499 plasmid extracted from the cultured E. coli 
using the culture dependent method.  
1= 1 Kb ladder; 2= DNA extracted from E.coli harbouring the pEK499 plasmid.  
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Fig S2. Agarose gel image of the control plasmid pEK499 extracted using commercial 
kits. 
1= 1 Kb ladder; 2= control plasmid pEK499 extracted using the MoBio PowerSoil 
DNA Isolation kit; 3= control plasmid pEK499 extracted using the Qiagen Plasmid 
Mini kit; 4= 1 Kb ladder; 5= control plasmid pEK499 extracted using the Macherey- 
Nagel NucleoSpin Plasmid kit.  
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Fig S3.  Agarose gel image of pEK499 extracted using the alkaline lysis method. 
1= 1 Kb ladder; 2= control plasmid pEK499 extracted using the alkaline lysis method.  
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Fig S4. Agarose gel image of pEK499 isolated using the exogenous method.  
1= 1 Kb ladder; Control plasmid pEK499 extracted using the exogenous plasmid 
isolation method- plasmid DNA extracted from transformants and selected on agar 
plates containing: 2= ampicillin 32 mg/L; 3= tetracycline 16 mg/L; 4= kanamycin 25 
mg/L; and 5= ciprofloxacin 4 mg/L.  
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3.1 ABSTRACT 
 
Plasmids are well-known for their involvement in increasing the genetic diversity and 
adaptability of prokaryotes. This is through their ability to replicate independently of 
the chromosome and their capacity to self-transfer. This has also contributed to the 
rapid development and spread of antibiotic resistance. We isolated five antibiotic 
resistance plasmids from the caecum of broiler chickens using the multiple 
displacement amplification method. These plasmids were sequenced using Oxford 
Nanopore MinION technology. The plasmid sizes ranged from 42,654 bp to 151,806 
bp. All of the plasmids carried antibiotic resistance genes, while three possessed 
conjugative machinery. The plasmids were highly similar to other plasmids isolated 
worldwide, from chicken, pig and human samples. This highlights the importance of 
the ‘One Health’ initiative, and the interlinking spread and dissemination of antibiotic 
resistance between humans and animals.  
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3.2 INTRODUCTION 
 
Antibiotic resistance poses a serious threat to the health of humans, animals, and the 
environment worldwide. The development and spread of antibiotic resistance has been 
attributed to certain factors including the excessive use of antibiotics both in humans 
and animals, the availability of antibiotics over-the-counter in certain countries, 
release into the environment of non-metabolized antibiotics or their residues through 
manure, poor sanitation and increased international travel1. Bacteria acquire resistance 
to antibiotics via chromosomal mutations or through the acquisition of mobile genetic 
elements such as plasmids2.  
 
Plasmids are key drivers in the spread of antibiotic resistance. Not only do they have 
the ability to obtain and maintain resistance genes, they also have the ability to spread 
to other bacteria. The majority of plasmids have the capability to replicate within the 
species of at least one genus, and are therefore readily disseminated between species 
of that genus. However, broad‐host‐range plasmids boast the ability to replicate within 
the species of many genera3. Accessory genes, such as antibiotic resistance genes, are 
frequently associated with small mobile elements such as transposons, which 
facilitates intracellular mobilisation amongst plasmids4. 
 
The widespread use of antibiotics in agricultural settings as therapeutics, prophylaxis, 
metaphylaxis and growth promotion has created a selective pressure and driven the 
increase of resistant bacteria present in food-producing animals5. Antibiotic resistant 
pathogens often lead to treatment failure in the animals, leading to economic losses. 
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However, they could also be regarded as a source of resistant bacteria that may 
represent a risk to human health6. Several studies have documented the animal-to-
human spread of antibiotic resistance. This is through direct or indirect contact with 
animals, contaminated food and water, or manure application7. Previous work has 
linked the consumption of food harbouring resistant bacteria with antibiotic resistant 
infections in humans8. Jensen et al., identified the satA gene, which confers resistance 
to streptogramin- a treatment for vancomycin resistant Enterococcus faecium, in both 
human and animal E. faecium isolates9. Ho et al., found that the aacC2 gene in isolates 
from food-producing animals in Hong Kong was also present in urinary tract infection 
isolates10. Bertrand et al. tracked the blaCTX-M-2 gene in Salmonella enterica from 
poultry flocks, to poultry meat, through to human isolates in Belgium11. In animals, it 
is the resistant zoonotic enteropathogens including Salmonella enterica and 
commensals such as Escherichia coli that are most likely to be transferred through the 
food chain to humans12. New advances in molecular technologies have allowed for 
further investigations into the epidemiology of such transfer events13.  
 
Sequencing of plasmid DNA has previously been a rather troublesome and 
unsuccessful endeavour. The small fragments of DNA and repeat regions of DNA 
characteristic of plasmids have led to the difficulties in assembling reads from high-
throughput short-read sequencing, such as those generated using Illumina 
technologies, meaning that complete plasmid sequences may not be accurately 
reconstructed14. This is because plasmids frequently contain many small mobile repeat 
structures such as insertion sequences and transposable elements, that extend beyond 
the current insert size of paired-end short-read sequencing (~300–500 bp), preventing 
complete plasmid assembly15. This therefore hindered the localisation of resistance 
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genes to specific plasmids. PacBio long-read sequencing technology is capable of 
spanning repetitive sequences and closing gaps from short-read data, however it incurs 
high costs that are prohibitive to many laboratories16. The Oxford Nanopore MinION 
sequencer is a relatively new, rapid, long-read sequencing technology. The main 
benefits include lower costs when compared to other technologies, making it more 
accessible for many; but more importantly is its sensitive detection abilities from 
limited starting material. High concentrations of plasmid DNA can be difficult to 
obtain, particularly from environmental samples, where plasmids are often present in 
low-copy numbers17. While single-read error rates have been noted to be higher for 
MinION than those for Illumina short-reads, the generation of consensus sequences 
from multiple reads allows for a higher accuracy to be attained18.  
 
While this is only a recently developed technology, some studies have already 
employed MinION sequencing to characterise plasmids carrying antimicrobial 
resistance (AMR) genes from clinical isolates. Power et al., characterized an IncL/M-
like plasmid containing a blaOXA-48-encoding gene from a clinical isolate of Klebsiella 
pneumoniae19. Liao et al., obtained 12 chromosomes and 36 plasmids from three 
Acinetobacter nosocomialis, five A. pittii, and four Staphylococcus aureus isolates 
from clinical samples20. Lemon et al., utilised MinION sequencing to identify AMR 
genes from extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli 
and Klebsiella pneumoniae clinical isolates18. There have also been some reports of 
the utilisation of MinION sequencing for examining samples of animal origin. Taylor 
et al., characterised plasmids from Salmonella enterica subsp. enterica serovar 
Bareilly isolated from shrimp and Escherichia coli O157:H7 isolated from ground 
beef21. Hadziabdic et al., sequenced blaNDM-1-carrying IncA/C2 plasmids from 
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Salmonella corvallis isolates from chicken faecal samples22. However, the work 
undertaken here is to our knowledge the first report of plasmids from the caecum of 
broiler chickens sequenced using MinION sequencing.   
 
In this study, we describe the sequences of five antibiotic resistance plasmids, four of 
which were multi-drug resistant. They were isolated from the caecum of a broiler 
chicken, which are raised for meat production, and sequenced using MinION 
technology. We identified the resistance genes present and compared them to similar 
plasmids that have been isolated in previous studies.   
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3.3 MATERIALS AND METHODS 
 
3.3.1 Samples 
 
The broiler caecal sample was obtained from a commercial poultry production unit in 
the European Union. Samples were lyophilised and stored at -80°C before analysis. 
 
3.3.2 Plasmid Isolation, Antibiotic Susceptibility Testing and Plasmid 
Extraction 
 
Plasmids were isolated from a caecal sample using a protocol for direct extraction, the 
multiple displacement amplification (MDA) method as previously described23. 
Plasmids were then maintained in an antibiotic-susceptible Escherichia coli DH5α 
host. Antibiotic susceptibility testing to ampicillin, tetracycline, kanamycin, 
cefotaxime, ciprofloxacin and imipenem was performed via a disk diffusion method 
according to CLSI guidelines24. Recipient E. coli isolates showing a multi-drug 
resistance phenotype were selected. Plasmid DNA was extracted using the Qiagen 
HiSpeed Midi kit. Plasmid DNA concentrations and purity were checked using an 
Invitrogen Qubit Fluorometer (dsDNA high-sensitivity assay kit) and a DeNovix DS-
11 spectrophotometer. Plasmids were visualised on a 1% agarose gel stained with 1X 
GelRed (Biotium) and run at 70 volts for 1 hour.  
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3.3.3 Plasmid Sequencing 
 
Plasmids were sequenced using an Oxford Nanopore MinION sequencer. The 1D 
genomic DNA protocol (SQK-LSK108) was followed for a barcoded run for 48 hours. 
Adapters were trimmed using PoreChop (v0.2.1, https://github.com/rrwick/Porechop). 
Albacore (https://github.com/dvera/albacore) basecalled and demultiplexed the reads. 
The reads were mapped against the reference strain E.coli 12_MG1655 in GraphMap25 
to remove bacterial host DNA. Reads were assembled using Unicycler26. Then, the 
raw reads were mapped back to the contigs from the assembly using GraphMap. 
Contigs with low and uneven coverage were discarded. The remaining contigs were 
aligned against each other using LastZ27 to remove duplicates due to barcode leakage. 
The remaining contigs were polished using Nanopolish28 and annotated with RAST29. 
Raw reads were aligned with Graphmap to the CARD30 database. Contigs with less 
than 10% coverage compared to the coverage of closed replicons were removed and 
antibiotic resistance genes were annotated. Plasmid maps were generated using 
SnapGene (https://www.snapgene.com/).    
 
The sequences are deposited in the European Nucleotide Archive (ENA) under the 
primary accession PRJEB38985 and secondary accession ERP122449.  
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3.4 RESULTS   
 
3.4.1 Plasmids isolated from sample A 
 
The E. coli containing the isolated plasmids from sample A was resistant to ampicillin, 
tetracycline, cefotaxime and kanamycin following a disk diffusion assay. The 
extracted plasmid DNA displayed four distinct bands on an agarose gel (Fig 1). This 
extracted plasmid DNA was sequenced using the MinION sequencer. A total of 40,418 
reads were obtained with a mean length of 5,212 bp. The extracted plasmid DNA 
comprised three plasmids; pBC01.1, pBC01.2 and pBC01.3.  
 
The first of the plasmids (pBC01.1), an IncF plasmid, was 151,806 bp in length with 
49% GC content. It carried the resistance genes MacA, MacB, TetR, TetA, TetD, 
aph(3’’)-I and aph(6)-Ic. It also contained conjugative machinery (Fig 2). MacA and 
MacB are membrane fusion proteins that form an antibiotic efflux complex with TolC 
and are associated with macrolide resistance. TetR is a tetracycline resistance 
repressor protein. TetA and TetD are tetracycline resistance proteins that confer 
resistance by efflux. The aph(3’’)-I and aph(6)-Ic genes are phosphotransferases that 
confer resistance to the aminoglycoside streptomycin and are also described as strA 
and strB genes31. The total plasmid DNA sequence had 99.64% identity and 97% 
query coverage with Salmonella enterica subsp. enterica serovar Kentucky str. 
CVM29188 plasmid pCVM29188_146. This plasmid was previously identified in a 
chicken breast sample in the United States of America (GenBank accession no. 
CP001122)32. TetD was not present on the pCVM29188_146 plasmid and was unique 
to the pBC01.1 plasmid.  
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The IncI1 plasmid pBC01.2 was 110,152 bp in length with 51% GC content. It 
harboured the antibiotic resistance genes aac(6’)-Ib, aph(3’’)-Ia, aadA5, dfrA17, sul2 
and blaCTX-M-1. The plasmid also contained conjugative machinery (Fig 3). The genes 
aac(6’)-Ib, aph(3’’)-Ia and aadA5 each confer aminoglycoside resistance to amikacin 
and kanamycin, streptomycin and spectinomycin respectively. The dfrA17 gene is a 
trimethoprim resistance gene. The sul2 gene confers sulphonamide resistance and 
blaCTX-M-1 is an ESBL producing gene. While blaCTX-M-15  is the dominant ESBL type 
in humans, the ESBL blaCTX-M-1  is the most common type in livestock
33,34 and blaCTX-
M-1, blaTEM-52 and blaSHV-12 being the most common ESBL-types in poultry
35. The 
plasmid had 99% identity to Escherichia coli plasmid pC49-108 with 100% query 
coverage. This plasmid has previously been isolated from a chicken faecal sample in 
Switzerland (GenBank accession no. KJ484638)36. The genes aac(6’)-Ib, aph(3’’)-Ia 
and sul2 were present only in pBC01.2 and not in pC49-108. 
 
The third IncFIB plasmid, pBC01.3 (Fig 4), identified in this sample was 97,991 bp 
long with 48% GC content. It carried a class A beta-lactamase, blaTEM-215. This 
plasmid matched to a section of the Klebsiella pneumoniae strain ST11 plasmid 
pKP12226 (267,645 bp) with 98.98% identity and 83% query coverage, a plasmid 
isolated from a human patient with bacteraemia in South Korea (GenBank accession 
no. KP453775)37.  Although the blaTEM gene identified in pKP12226 plasmid was 
blaTEM-1, not blaTEM-215. The antibiotic resistance phenotype of the E. coli containing 
the three plasmids could be accounted for by the AMR genes present on at least one 
of the three plasmids.   
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The transformant sample A was selected on tetracycline (16 mg/L). It resulted in the 
selection of pBC01.1 which harboured tet genes, but also of the plasmids pBC01.2 
and pBC01.3. Neither of these plasmids carried any determinants for tetracycline 
resistance, showing that the tetracycline allowed for the co-selection of 
aminoglycoside, macrolide, beta-lactam, trimethoprim and sulphonamide resistance.   
 
3.4.2 Plasmids isolated from sample B 
 
Escherichia coli containing the plasmids isolated from sample B was resistant to 
ampicillin, tetracycline, kanamycin and ciprofloxacin. The total extracted plasmid 
DNA had three distinct bands on an agarose gel (Fig 1). A total of 57,747 reads were 
attained with a mean length of 4,511 bp. Two plasmids, pBC02.1 and pBC02.2, were 
identified within the sequenced DNA. 
 
Plasmid pBC02.1 (Fig 5) was 135,664 bp in length with 49% GC content and belonged 
to the IncF incompatibility group. The plasmid harboured the aph(6), aph(3’’)-I, tetR, 
tetB and blaTEM-215 resistance genes; and conjugative machinery. Each of the AMR 
genes, except tetB were also detected on plasmids isolated from sample 1. This 
indicates that while the genes are contained on different plasmids within the two 
samples, certain AMR genes are mobile and common to more than one plasmid. It had 
98.72% identity to Escherichia coli plasmid pH2291-144 with 75% query coverage. 
pH2291-144 was isolated from a faecal sample from a healthy human in Switzerland 
(GenBank accession no. KJ484628)32. This plasmid did not contain the 
aminoglycoside phosphatases present in our sample, and it contained blaTEM-1 instead 
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of blaTEM-215. However, it contained a different streptomycin resistance gene aadA1. 
Thus, while the genes are different the resistance phenotype was the same.  
 
The other phage-like plasmid from sample B, pBC02.2 (Fig 6), was 42,654 bp in 
length with 49% GC content and belonged to the incompatibility group IncN. It 
contained aph(3’)-Ia, mef(B) and cmlA antibiotic resistance genes. These genes confer 
resistance to streptomycin, and both macrolides and chloramphenicol via efflux. It also 
contained a qacE quaternary ammonium compounds resistance gene, and cobalt-zinc-
cadmium and copper resistance genes. It matched to Escherichia coli strain HYEC7 
plasmid pHYEC7-110 with 99.56% identity and 62% query coverage. This plasmid 
was identified in a pig faecal sample from China and contained all of the resistance 
genes and IncN present in plasmid pBC02.2 (GenBank accession no. KX518744)38. 
Neither of these two plasmids contained a known plasmid mediated quinolone 
resistance gene, although the E. coli was phenotypically resistant to ciprofloxacin. 
However, as these plasmids contained many hypothetical genes any one of these could 
be a novel quinolone resistance gene which requires further investigation. 
  
While the plasmids from the broiler caecal samples were not an exact match to the 
plasmids previously identified, fragments were identical across plasmids. Based on 
these results, it show that these fragments are highly mobile. They have been seen in 
both animal and human gut microbiomes, and plasmids in locations worldwide. 
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3.5 DISCUSSION 
 
We obtained five plasmids from two transformants from a broiler caecal sample. Three 
plasmids were isolated from the first transformant, sample A. Sample B harboured two 
plasmids. Antibiotic resistance genes were identified on all of the plasmids. Both 
samples harboured multi-drug resistance plasmids. The ciprofloxacin resistance 
detected from the disk diffusion assay could be attributed to either a chromosomal 
mutation or a novel plasmid-mediated gene. An interesting thing to note, pBC02.2 
contained a qacE gene. Previous studies have found a strong correlation between the 
presence of the qacE gene with resistance to some antibiotics39. There was also the co-
occurrence of both heavy metal and antibiotic resistance determinants on pBC02.2. 
Copper and zinc are used in agriculture to support animal health and growth40. 
However, heavy metals are known to function as co-selecting agents in the spread of 
antibiotic resistance in human pathogens41. 
 
In sample A, two of the plasmids contained genes for conjugation, indicating their 
potential ability to transfer to other bacteria. Non-mobilisable plasmids have been 
known to transfer alongside self-transmissible plasmids42, leading to the possibility 
that all three plasmids could have the ability to disseminate further. This is equally 
plausible for sample B, where pBC02.1 had conjugative genes but not pBC02.2.  
 
Two of the plasmids identified in sample A matched to previously identified plasmids 
found in chicken meat32 and chicken faecal samples36. This shows the plasmid can 
persist through the gastrointestinal tract, into faeces and on chicken meat which could 
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be consumed by humans. The other plasmid present in the broiler caecal sample, 
pBC01.3, matched to a plasmid previously isolated from a patient with bacteraemia37. 
From a One Health perspective, the appearance of a highly similar plasmid in both a 
human and animal sample raises the question as to the route of transmission of the 
plasmid. It confirms that the plasmid can reside in the chicken gut as well as having 
the ability to persist in human pathogenic bacteria. The presence of antibiotic 
resistance plasmids in such cases can seriously limit the treatment options available. 
In sample B, one of the plasmids, pBC02.1, matched to a plasmid isolated from a 
faecal sample taken from a healthy human. While it is impossible to conclude as to 
how the human obtained this plasmid, it highlights that antibiotic resistance plasmids 
can reside within the commensal bacteria of humans. The other plasmid from this 
sample, pBC02.2, showed high similarity to a plasmid from a pig faecal sample. These 
results show that the same plasmid can persist in various gastrointestinal 
environments.  
 
From all the plasmids sequenced, they were found to originate from E. coli, S. enterica 
and K. pneumoniae, which are all known to be pathogenic to humans. Our 
experimental design for the direct extraction of the plasmids means the original host 
is unknown, but the S. enterica and K. pneumoniae plasmids were stabily maintained 
in E. coli. The sequenced plasmids match to plasmids previously isolated globally; in 
America, Switzerland, South Korea and China. The presence of these plasmids in 
broilers from the European Union raises the concern as to how these plasmids have 
disseminated worldwide, and their potential to transfer between animals and humans. 
It also demonstrates the ability of sections of mobile DNA containing antibiotic 
resistance genes on plasmids to move between plasmids; and that these plasmids move 
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between chicken faeces, chicken meat and animal and human gut microbiota even in 
different host bacteria. Thus the ability of fragments of DNA to move between 
plasmids is as important as the movement of plasmids between bacteria.  
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3.6 CONCLUSION 
 
Our results have highlighted the possibility of animal-to-animal and animal-to-human 
transfer of plasmids, and their ability to disseminate globally, driving the spread of 
antibiotic resistance. This study also demonstrated the presence of several plasmids 
containing the same AMR gene or genes conferring the same AMR phenotype within 
one chicken. Almost all of these plasmids were multi-drug resistant plasmids and may 
be selected due to the use of any number of antibiotics or in one case even quaternary 
ammonium compounds, which are frequently used as disinfectants. This study 
highlights the importance of analysing the depth and variety of plasmids present within 
a complex sample in addition to the national or global surveillance of AMR within 
animals.   
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3.7 FIGURES 
 
 
 
 
Fig 1. Agarose gel image of plasmid DNA extracted from E. coli transformants. 
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Fig 2. Plasmid pBC01.1 isolated from sample A. Antibiotic resistance genes are 
highlighted in red, conjugative genes in blue.  
  
78 
 
 
 
 
 
Fig 3. Plasmid pBC01.2 isolated from sample A. Antibiotic resistance genes are 
highlighted in red, conjugative genes in blue.  
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Fig 4. Plasmid pBC01.2 isolated from sample A. Antibiotic resistance genes are 
highlighted in red, phage proteins indicated in green.  
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Fig 5. Plasmid pBC02.1 isolated from sample B. Antibiotic resistance genes are 
highlighted in red, conjugative genes in blue. 
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Fig 6. Plasmid pBC02.2 isolated from sample B. Antibiotic resistance genes are 
highlighted in red, heavy metal genes in green and quaternary ammonium 
compounds genes in purple.   
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4.1 ABSTRACT  
 
The caecum plays host to the largest number of microorganisms within the broiler 
gastrointestinal tract. These microbial communities provide numerous benefits to the 
host, including playing a role in nutrition and immunity. We examined the caecal 
microbiome of broiler chickens over time. The phyla Firmicutes, Proteobacteria and 
Bacteroidetes were the most abundant; Clostridia and Bacteroidia the most abundant 
classes; and Faecalibacterium and Bacteroides were the most abundant genera. 
However, significant differences in the bacterial communities can be seen between 
birds at day 21 and 35, but also between individual birds from each group. We 
observed a stabilisation of the microbial communities within the caecum over time. 
Antibiotic resistance is an ever-growing concern worldwide, and we examined the 
presence of conjugative resistance plasmids within the broiler caecum. Plasmids 
harbouring resistance to ampicillin, tetracycline, trimethoprim, cefotaxime and 
chloramphenicol were detected at both time-points. Over half of the plasmids from 
day 35 were multi-drug resistant. The shifts in dominance within the bacterial 
communities over time may have contributed to the increase in resistance observed at 
the later time-point.  These plasmids could be captured and maintained by a human 
pathogen, and may have the potential to spread via the food chain.  
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4.2 INTRODUCTION 
 
Poultry is one of the most commonly consumed protein sources worldwide with over 
60 billion chickens produced annually1. The microbial population present in the 
gastrointestinal tract of chickens are thought to have a number of advantages for the 
host. These include influencing host nutrition via nutrient assimilation, adding 
metabolic potential, vitamin and amino acid production, influencing gut development 
and physiology, and prevention of colonisation by invading pathogens2. Poultry have 
a shorter gastrointestinal tract and a faster digesta transit, which selects for a highly 
diverse intestinal microbiome in comparison with other food-producing animals3. The 
diversity of the bacterial communities in the chicken gastrointestinal tract is to a great 
extent influenced by the age of the birds and location in the digestive tract4. Between 
days 15 and 22, microbiota maturation occurs and has been found to remain in a stable 
status5. However, the variation in the resistome remains unknown. The majority of 
these bacteria reside in the distal intestine which includes the caeca, where densities 
approach 1011 to 1012 cells/g, noted to be the highest density recorded for any microbial 
environment6. Bacteria can also be introduced to the caeca by reflux from the urodeum 
and cloaca7. 
 
It is estimated that less than 20% of bacterial taxa which inhabit the poultry 
gastrointestinal tract have been recovered by cultivation8. Culture-independent 
methods have allowed for more detailed information on microbial community 
composition and diversity9. High-throughput sequencing technologies have allowed 
for the identification of highly complex and diverse communities in the 
gastrointestinal tract with greater depth and coverage. Targeted 16S rRNA gene 
93 
 
amplicon sequencing is one of the main DNA-based methods currently used for the 
analysis of bacterial community profiling10.  
 
Poultry production is predicted to produce around 130 million tons of chicken meat in 
2020 (OECD/FAO11) to meet the demands of an increasing global population12. This 
is achieved through intensive farming, where antibiotics are used extensively. 
Antibiotics have been vital for decreasing the rates of morbidity and mortality from 
infectious diseases in both humans and animals since their discovery. However, the 
increasing rate of the development of antibiotic resistance has become a serious issue 
worldwide in both the areas of medicine and agriculture13. With treatment options 
limited, especially in the case of infections resistant to antibiotics of last-resort, it is 
resulting in reduced clinical efficacy, increased treatment costs and higher mortality 
rates14. In agriculture, antibiotics are given therapeutically to treat infections in sick 
animals. However, within intensive farming systems, it can be uneconomic to treat 
individual animals, which results in the treatment of an entire group, usually through 
the feed or water15. Antibiotics are also used for metaphylactic reasons to control 
disease, and prophylactically to prevent disease. In some countries, antibiotics are also 
administered at low and sub-therapeutic doses to improve  feed efficiency and promote 
animal growth of the animal16. It is this overuse of antibiotics that has contributed to 
the rapid increase in the rates of resistance in food-producing animals17. These 
resistant bacteria can then be transmitted to humans through the food chain18. 
However, changes in microbial community and bacterial resistome in the poultry 
gastrointestinal tract remain largely unknown. 
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All commensal, pathogenic and environmental bacteria form a reservoir of antibiotic 
resistance genes, of which pathogenic bacteria can acquire these genes by horizontal 
gene transfer. This has allowed for antibiotic resistance to spread from commensal and 
environmental bacteria to pathogens14. Plasmids have the ability to transfer genes to 
different species, genera, and kingdoms, dependent on the plasmid host range19. It has 
also been noted that plasmids lacking conjugative machinery could be mobilised by 
self-transmissible plasmids that are also present in the donor cell20, and therefore may 
also be obtained using this method. It is well-known that Escherichia coli is a part of 
the commensal flora of humans, but is also an opportunistic pathogen, and some can 
be highly virulent21. By using E. coli as the donor strain, it allowed for the 
determination of the resistance profile of plasmids that could be transferred to, and 
maintained in, a human pathogen.    
 
This study aimed to 1) characterise the changes in the structure and diversity of the 
bacterial communities; and 2) compare the conjugative plasmids harbouring antibiotic 
resistance genes at two growth stages in the caecum of broiler chickens. This work 
provides an insight in to the changing diversity of bacterial communities and plasmid-
mediated antibiotic resistance in animals entering the food chain. We hypothesise that 
changes in the bacterial community effects the mobile resistome present in the chicken 
caecal microbiome.  
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4.3 MATERIALS & METHODS 
 
4.3.1 Samples 
 
Broiler caecal samples were obtained from a commercial poultry production unit in 
the European Union. The samples were collected at two time-points, day 21 and day 
35 post-hatch. Samples were lyophilised and stored at -80°C before analysis. 
 
4.3.2 Microbiome Sequencing 
 
Twelve random caecal samples were chosen for sequencing, six from each time-point. 
Total DNA was extracted from 0.05 g of each caecal sample with the Mobio PowerSoil 
DNA Extraction Kit (now Qiagen), following the manufacturer's instructions. The 
concentration and purity of the extracted DNA was measured by spectrophotometry 
(DeNovix DS-11 spectrophotometer). The samples were prepared and sequenced as 
described by Do et al., 201922. The library was prepared according to the 16S 
Metagenomic Sequencing Library guidelines (Illumina-a. 16S Metagenomic 
Sequencing Library Preparation) and then pooled in the MiSeq v3 reagent cartridge. 
An Illumina chastity filter (Illumina-b. Miseq Reporter Software Guide (15042295)) 
filtered the sequenced data, with the cluster of reads that had no more than 1 base call 
and a chastity value of less than 0.6 in the first 25 cycles passing the filter. BaseSpace-
the Metagenomics workflow (16S Metagenomics app vesion 1.0.1.0 with Isis 
v2.5.35.6, Greengenes data base 13.5) (DeSantis et al., 200623; Illumina-c. 16s 
Metagenomics App) was used to demultiplex reads. It was also used to generate 
FASTQ files, with the 3’ portion of non-index reads with low quality scores being 
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trimmed by QualityScoreTrim. The RDP Naïve Bayesian classifier24 provided 
taxonomic level classification. The sequences are deposited in the European 
Nucleotide Archive (ENA) under the primary accession PRJEB37133 and secondary 
accession ERP120433. 
 
4.3.3 Microbiome Data Analysis 
 
Statistical analysis of the microbiome data was performed using Calypso 
(http://cgenome.net/calypso/)25. The data were normalized to render it suitable for 
statistical analysis. Samples with less than 1000 sequence reads were removed. Rare 
taxa, which had less than 0.001% relative abundance were also removed. Principal 
component analysis (PCA) and rarefaction analyses were carried out using default 
settings. The microbial community composition was quantitatively visualized by bar 
charts and heat maps. The relative abundances of phylum, class and genus taxonomic 
levels were compared between time-points by ANOVA. The calculated P-values 
(ANOVA) were adjusted for multiple testing and false discovery rate. Shannon index 
was used to estimate the bacterial alpha diversity and Chao1 to estimate richness.  
 
4.3.4 Exogenous Plasmid Isolation 
 
Plasmids harbouring antibiotic resistance genes were isolated from the caecal samples 
(n=34) using the exogenous plasmid isolation method, as previously described26. 
Briefly, plasmids from the ‘donor’ caecal samples were transferred to the ‘recipient’ 
Escherichia coli DH5α via biparental mating. Exogenous transconjugants were 
selected on Eosin Methylene Blue (EMB) agar (Sigma) with rifampicin (100 mg/L) 
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and ampicillin, tetracycline, gentamicin, colistin, cefotaxime or ciprofloxacin at 
breakpoint concentrations according to CLSI guidelines (2018)27. From each antibiotic 
selective plate with growth after exogenous isolation, a transconjugant from each was 
selected at random. If the same plate appeared to have bacteria with different features 
(colour, morphology), both were selected.  
 
4.3.5 Plasmid Analysis 
 
Plasmids were extracted from the putative recipient E. coli strains using the Macherey-
Nagel NucleoSpin Plasmid kit following the low-copy number protocol according to 
the manufacturer’s guidelines. The extracted plasmids were visualised on a 1% 
agarose gel stained with GelRed (Biotium), run at 70 volts for 60 minutes. Antibiotic 
susceptibility testing was performed on the exogenous transconjugant strains in 
duplicate via the disk diffusion method according to CLSI guidelines (2018)27 against 
9 antibiotics from 8 different classes. 
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4.4 RESULTS & DISCUSSION 
 
4.4.1 16S rRNA gene amplicon sequencing 
 
The number of quality controlled reads in each sample passing filters were between 
4,378 and 207,046, which were used for further analysis. 31 phyla, 65 classes, 128 
orders, 285 families and 867 genera were included. Rarefaction analysis was used to 
identify the quality of the sequenced data representing the diversity of the bacterial 
communities, which showed a sufficient sequencing depth was reached (Fig 1). One 
sample from the day 21 time-point had less than 1000 sequence reads, and was 
therefore excluded from further analysis.  
 
4.4.2 Microbial Community Composition 
 
The bacterial community was analysed by comparison of the 16S rRNA amplicon 
sequences. Firmicutes was the most predominant phyla, with up to 61.63% of all 
classified reads from the day 21 time-point and up to 48.96% from day 35 Fig 2(a). 
This was followed by Bacteroidetes (up to 36.73% from day 21 and 42.26% from day 
35), Proteobacteria (up to 33.89% from day 21 and 16.67% from day 35) and 
Actinobacteria (up to 23.26% from day 21 and 14.56% from day 35). The 
predominance of Firmicutes followed by Bacteroidetes and Proteobacteria has been 
previously identified in chicken faecal analysis28,29, however, variation in bacterial 
composition occurred between the two time-points (Fig 2(a)). Surprisingly, we 
identified higher proportions of Actinobacteria than previous studies into the poultry 
caecal microbiome. Xiao et al., found Actinobacteria to be almost absent in the 
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caecum, but found them to be dominant in the ileum30. Even studies noting 
Actinobacteria as a predominant phyla report much lower precentages compared to 
our findings of 23.26% and 14.56%. Xiong et al., reported 1.3% of Actinobacteria 
from broiler faecal samples31, Wei et al., report 3.2% from turkey caecal samples32 
and Thomas et al., report a still quite low 6.77% from chicken intestinal samples33. As 
these results are non-concurring, the increased proportions may be due to factors such 
as broiler breed, geographical location, feed or housing conditions34. A higher 
proportion of Firmicutes, Proteobacteria and Actinobacteria were present in the day 
21 group, while a larger amount of Bacteroidetes were present in the day 35 group.  
 
The relative abundance of the top 20 classes is displayed in Fig 2(b). Clostridia was 
the most abundant with up to 63.77% from day 21 and 46.24% from day 35 of all 
classified reads. The following dominant classes were Bacteroidia (up to 22.92% from 
day 21 and 39.53% from day 35), Actinobacteria (up to 23.44% from day 21 and 
14.69% from day 35) and Epsilonproteobacteria (up to 19.97% from day 21 and 
6.33% from day 35). Again, the variation between groups can be seen in Fig 2(b), with 
a higher proportion of Bacteroidia in the day 35 group compared to day 21.  
 
The heat-map (Fig 3) shows the relative abundances of the top 20 detected genera, 
ranging from most abundant (red) to least (blue). Faecalibacterium was the most 
dominant (up to 30.82% from day 21 and 15.38% from day 35), followed by 
Bacteroides (up to 4.75% from day 21 and 27.79% from day 35), Bifidobacterium (up 
to 26.87% from day 21 and 15.95% from day 35) and Megamonas (up to 12.81% from 
day 21 and 19.19% from day 35). The variation between groups can clearly be seen at 
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genus level, with the day 21 group dominated by Faecalibacterium, whereas 
Bacteroides is the most dominant from the day 35 group. The human pathogens 
Campylobacter spp., which cause foodborne gastroenteritic disease; and Helicobacter 
spp., which are associated with stomach cancer and duodenal ulcers35; were both 
detected within the top 20 genera. Broilers are considered to be the primary vector for 
transmission of Campylobacter to humans36. Helicobacter is known to reside in the 
poultry gut, with contamination of consumer meat products with the bacteria likely to 
occur during the slaughtering process35.   
 
As well as the variations between the two time-points, there were also differences 
among the microbiota of the chickens within the same time-point group at all 
taxonomic ranks. It has been demonstrated previously that there is a large individual 
variation in the microbiota amongst chickens of the same breed, with identical diets 
and under tightly controlled experimental conditions37. For example, at phylum level 
from the day 21 group, the number of classified reads for Proteobacteria varied from 
33.89% in one bird to 3.89% in another. This is also observed at class rank, with the 
percentage for Epsilonproteobacteria ranging from 19.97% in one bird to 0.02% in a 
different bird within the same day 21 group. Likewise, at genus level, Bifidobacterium 
ranged from 26.87% in one bird to 0.59% in another. Similar variations, albeit to a 
much lesser extent, can be seen within the chickens from the day 35 group. These 
results demonstrate the changes in the broiler microbiome, even over a short period of 
time, and perhaps the establishment of a more stabilised, less variable microbiota as 
the bird ages. However, this stabilisation is later than 3 weeks as previously described8.  
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ANOVA was used to compare the taxa abundance at phylum, class and genus levels 
between the two time-points (Fig 4). When P <0.05, the difference in relative 
abundance was considered significant. Pair-wise comparisons were performed by t-
test and annotated as *: p<0.05, **: p<0.01, ***: p<0.001. Four phyla showed a 
significant variance between day 21 and day 35 (Firmicutes, Bacteroidetes, 
Cyanobacteria and Chloroflexi), while 5 classes (Clostridia, Bacteroidia, 
Betaproteobacteria, Nostocophycideae and Anaerolineae) and 9 genera 
(Faecalibacterium, Bacteroides, Megamonas, Blautia, Flavobacterium, Sutterella, 
Ruminococcus, Oscillospira and Dysgonomonas) also showed a significant difference. 
Within both the phyla and class, variations occurred in two of the most abundant taxa, 
indicating a significant change in the microbiome composition over time. Broilers are 
typically administered a starter diet from days 0-21 and followed by a finisher diet 
until slaughter (between days 30-50)38. This may be a contributing factor towards the 
changes observed between groups.   
 
The relative abundance of operational taxonomic units (OTUs) at phylum, class and 
genus taxonomic levels were plotted using principal component analysis (PCA) (Fig 
5). Day 21 has a large intra-cluster distance along the PC1 axis at phylum level (Fig 
5). This displays the variation among the samples in this group. A similar pattern is 
observed at class and genus levels, also with a large intra-cluster distance along the 
PC2 axis. Data from the day 35 time-point had a smaller intra-cluster distance, 
indicating less variation between samples. The clusters from both time-points have a 
clearly defined inter-cluster distance with no overlap of the clusters at any taxonomic 
rank. This indicates that the microbiome across birds is more stable at day 35 than day 
21, and that there is significant variation in microbiome development from day 21 to 
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day 35. Interestingly, Sergeant et al., found Megamonas to be the most dominant 
genera in their study, from caecal samples taken from broilers at day 4239. We found 
Megamonas to be the third most prevalent genera in our study and was mainly detected 
in the older birds at day 35. This suggests that the variations in the microbial 
communities continue to occur as the birds age. While our findings are mostly 
concurrent with previous studies regarding the most dominant taxa in the broiler 
caecum, variations are still seen from study to study. Sakaridis et al., report 
Tenericutes as the third most prevalent phyla present40, whereas it was found in much 
lower proportions in our samples, as the seventh most prevalent. Numerous factors are 
recognised to have an effect on the diversity of the poultry microbiome in commercial 
facilities, including diet, stocking density, geographical location, bird environment, 
and pathogen presence41.  
 
4.4.3 Alpha Diversity, Richness and Evenness 
 
The microbial alpha diversity was analysed using Shannon index (Fig 6). A significant 
difference was identified at phylum, family and genus taxonomic levels, where P 
<0.05, demonstrating a few strongly dominating taxa. This was not seen at class or 
order taxonomic ranks, which had a more equal OTU distribution at these levels. The 
Shannon indices were higher for samples collected at day 35 for all taxonomic ranks. 
The bacterial community richness was assessed using Chao1 (Fig 7). Again, the Chao1 
indices were higher from the day 35 time-point than day 21, highlighting the 
differences between the two groups. The evenness of the microbial community is 
displayed in Fig 8. No significant differences were noted for any of the taxonomic 
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ranks, with P >0.05. Evenness indices were similar at class and order taxonomic levels, 
but were slightly higher for day 35 at phylum, family and genus levels. 
 
4.4.4 Mobile Resistomes 
 
A total of 43 antibiotic resistant transconjugants from 15 birds at day 21 (Fig 9) and 
52 antibiotic resistant transconjugants from 20 birds at day 35 (Fig 10) were selected 
for further analysis. No bird was free from antibiotic resistance plasmids.  
 
From the day 21 time-point, 98% of all transconjugants tested were resistant to 
ampicillin, 72% to tetracycline, 47% to trimethoprim, 23% to cefotaxime and 9% to 
chloramphenicol. 39.5% were multi-drug resistant, harbouring resistance to three or 
more different classes of antibiotics (Table 1). The most frequently isolated resistance 
plasmids conferred resistant to ampicillin or tetracycline. One transconjugant 
displayed intermediate resistance to imipenem and one transconjugant displayed 
intermediate resistance to gentamicin. No transconjugants were resistant to 
ciprofloxacin or kanamycin.  
 
From the day 35 group, all transconjugants were resistant to ampicillin, 81% were 
resistant to tetracycline, 44% to trimethoprim, 29% to cefotaxime, 15% to gentamicin, 
13% to chloramphenicol, 9.5% to kanamycin, 8% to ciprofloxacin and 2% to 
imipenem. 51.9% were multi-drug resistant (Table 2).  Resistance patterns were 
similar to those seen at day 21, again with the most resistance to ampicillin and 
104 
 
tetracycline. It could be that these are the same plasmids from day 21 that are being 
maintained, giving the bacteria harbouring them a survival benefit within the caecal 
microbiome. However, at day 35, resistance to kanamycin, gentamicin, ciprofloxacin 
and imipenem that was absent at the earlier time-point was observed. A higher 
percentage of transconjugants carried multi-drug resistance plasmids also. It appears 
that as the birds age, they obtain a greater variety of resistance plasmids.     
 
All of the plasmids isolated conferred resistance to at least one antibiotic. Over half of 
all transconjugants at day 35 were multi-drug resistant and almost 40% from day 21. 
From the day 21 group, transconjugants were found with resistance to 5 of the 9 tested 
antibiotics; whereas from the day 35 group, resistance to all the tested antibiotics was 
observed.  This could possibly be attributed to the changes in the microbiome. The 
highly variable microbiome present at day 21 may present less favourable conditions 
for the bacteria to obtain and maintain resistance plasmids. As the microbial 
communities stabilise as the bird ages, it may favour harbouring plasmids which 
would give them a survival advantage, and they may be better established to deal with 
any fitness cost associated with this.   
 
All of the plasmids isolated at day 21 have a similar resistance profile, mainly 
displaying resistance to beta-lactam, tetracycline and trimethoprim antibiotics. It is 
possible that the same plasmid or group of plasmids disseminated throughout the birds 
from this group. Chickens can ingest bacteria carrying resistance plasmids from litter, 
feed or water7. Kolar et al., found similarly high levels of resistance to tetracycline 
(97%) and ampicillin (51%) in E. coli strains isolated from poultry42. A similar 
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resistance profiling study also found high resistance to tetracycline in broilers on farms 
where no antibiotics had been used43. The authors concur that the plasmid-mediated 
resistance determinants originated from non-sampled sources, such as farm workers, 
farm run-off or wildlife. This reiterates the importance of One Health and identifying 
all of the potential sources of resistance, whether human, animal or environmental. 
Intensive farming practices such as overcrowding44 in high-throughput commercial 
facilities has also created an environment ideal for bacterial and plasmid transfer 
throughout an entire flock of birds.   
 
A greater variety of plasmids were identified in the day 35 group, with resistance to 
all tested antibiotics. Perhaps one of the most notable changes in the microbiome from 
day 21 to 35 was the shift from a Faecalibacterium dominated to a Bacteroides 
dominant microbiota at genera level. This may correlate with the changes observed in 
plasmid profile between the two groups. Bacteroides spp. resistant to tetracycline, 
beta-lactams, aminoglycosides, metronidazole and the macrolide-lincosamide-
streptogramin (MLS) group of antibiotics, with all their resistance determinants 
located on transmissible genetic elements, have all been previously reported45.  
Bacteroides spp. are opportunistic pathogens with highly promiscuous conjugation 
systems enabling other bacteria to obtain their resistance determinants46. This may 
explain the increase in resistance plasmids and our ability to readily capture these 
plasmids in our E. coli host. This worryingly also highlights the ability of multi-drug 
resistance plasmids to be transferred and maintained in human pathogenic bacteria. 
Studies such as Jakobsen et al., have already indicated the risk of transfer of resistance 
from animals to humans through the food chain and its potential to cause infection47. 
The presence of high amounts of multi-drug resistance plasmids we found in broilers, 
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which conferred resistance to antibiotics listed on the WHO’s list of critically 
important antimicrobials for human medicine48, would greatly limit treatment options 
in such circumstances.   Interestingly, sample E had a significantly higher percentage 
of Bifidobacterium (26.87%) (Fig 3) compared to the other samples (between 15.95%- 
0.59%). The corresponding exogenous transconjugant did not harbour a multi-drug 
resistance plasmid, and displayed resistance only to ampicillin. Bifidobacteria are 
considered beneficial as they are capable of producing positive impacts for host 
health49. Fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), and 
mannan-oligosaccharides (MOS) are administered as prebiotics, to increase the 
proliferation of Bifidobacteria which utilise them as substrates50. Bifidobacteria are 
also given as probiotics, to improve intestinal microbiota51. Our results demonstrate 
the possibility that a larger population of Bifidobacterium is associated with reduced 
antibiotic resistance in the broiler caecum, and the potential for prebiotics and 
probiotics to assist in reducing the spread of resistance. 
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4.5 CONCLUSION 
 
The broiler caecum was dominated by the phyla Firmicutes, Proteobacteria and 
Bacteroidetes. This is consistent with previous studies into the chicken microbiome. 
However, we found notable variations between the two time-points, highlighting the 
changes in the microbial communities over time. We also saw high levels of variation 
within the microbiome of chickens from the same group, which was more evident at 
day 21. This may indicate that the microbiome becomes more stabilised as the birds 
age, even beyond the currently reported stabilisation age. We identified multi-drug 
resistance plasmids within the broiler caecum at both time-points. There was a higher 
level and more varied resistance present at day 35, which may be attributed to the 
stabilisation of the microbiome, and therefore may be better established to harbour 
these plasmids that may incur high fitness costs. The shift from a Faecalibacterium to 
a Bacteroides dominant microbiota over time may also have contributed to the 
increase in resistance. If a particular group of bacteria appear to harbour high levels of 
resistance determinants, the use of pre- or probiotics may reducing the numbers of 
these bacteria by increasing beneficial bacteria. We have demonstrated that these 
plasmids can be captured and maintained by a human pathogen. These multi-drug 
resistance plasmids may have the ability to transfer to humans through the food chain, 
and limit the available treatment for infections.  
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4.6 TABLES 
 
Table 1. Resistance profile of exogenous transconjugant strains harbouring 
antibiotic resistance plasmids from caecal samples taken at day 21a,b,c,d.   
M-S 
Plasmid 
Sample AMP TET KAN CTX CIP CN W IMP C 
 1 AMP BC R S S S S S R S S 
 1 AMP SC R S S I S S R S S 
 1 TET R R S S S S R S S 
 1 GEN R S S S S S S S S 
A 2 AMP BC R R S R S S S S S 
A 2 AMP SC R R S R S S S S S 
A 2 TET BC R R S R S S S S S 
A 2 TET SC R R S R S S S S S 
A 2 CEF R R S R S S S S S 
 3 AMP R R S S S S S S S 
 3 TET R R S S S S S S S 
 4 AMP R R S S S S R S S 
 4 TET S R S S S S S S S 
 5 AMP R R S S S S R S S 
 5 TET R R S S S S R S S 
 6 AMP R R S R S S S S S 
 6 TET R R S S S S R S S 
 6 GEN R S S S S S S S S 
 7 AMP R R S S S S R S S 
 7 TET R R S S S S R S S 
 7 GEN R R S R S S R S S 
B 8 AMP BC R S S S S S R S S 
B 8 AMP SC R S S S S S R S S 
B 8 TET R R S S S S S S S 
 9 AMP R R S S S S R S S 
 9 TET R R S R S S S S S 
C 10 AMP R S S S S S R S I 
C 10 GEN R S S S S S S S S 
 
11 AMP 
LAWN R R S S S S R S S 
 
11 AMP 
COLONIES R R S R S S S S S 
 
11 TET 
LAWN R R S I S S R S S 
 
11 TET 
COLONIES R R S S S S R S S 
 12 AMP R R S I S S R S R 
 12 TET BC R R S I S S S S R 
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aM-S= corresponding microbiome sample. 
bAMP=Ampicillin, TET=Tetracycline, KAN=Kanamycin, CTX=Cefotaxime, 
CIP=Ciprofloxacin, CN=Gentamicin, W=Trimethoprim, IMP=Imipenem, 
C=Chloramphenicol. 
cR=Resistant, I=Intermediate, S=Susceptible; according to CLSI guidelines (2018). 
dSome transconjugants appeared to have different colony morphologies on the same 
antibiotic selective plate (BC=big colony; SC=small colony) or had both a lawn of 
growth (LAWN) with some distinct colonies (COLONIES). 
  
M-S 
Plasmid 
Sample AMP TET KAN CTX CIP CN W IMP C 
 12 TET SC R R S I S S S I R 
 12 CEF R R S R S I R S S 
D 13 AMP R S S S S S R S S 
D 13 TET R R S I S S S S R 
D 13 GEN R R S S S S S S S 
 14 AMP BC R S S S S S S S S 
 14 AMP SC R S S S S S S S S 
 14 TET R R S I S S S S S 
E 15 AMP R S S S S S S S S 
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Table 2. Resistance profile of exogenous transconjugant strains harbouring antibiotic 
resistance plasmids from caecal samples taken at day 35a,b,c,d. 
M-S Plasmid Sample AMP TET KAN CTX CIP CN W IMP C 
 1 AMP R R R R I R S I S 
 1 TET BC R R S S S S R S R 
 1 TET SC R R I R S S I S S 
 2 TET R R R R R R S S R 
F 3 AMP R R S S I S R S R 
F 3 TET R R S S S S S S S 
F 3 GEN R R S S S S S S S 
 4 COL PINK R S I I S S R S S 
 4 COL PURPLE R I S I S S R I S 
G 5 TET R R R R R R S S S 
 6 AMP BC R R S R S S R S S 
 6 AMP SC R R S R R S S S S 
 6 TET R R S R S S S S S 
 6 COL R R I R S S S S S 
 7 AMP R R R R S S R R S 
 7 TET R R I S S R R S S 
 7 COL R R I I S S R I S 
 8 AMP R R R R R I R S S 
 8 TET R R S S S S R S S 
H 9 AMP BC R S I S S R S S S 
H 9 AMP SC R R I I S S R I S 
H 9 TET R R S S S S R S S 
H 9 GEN R S S S S R S S S 
 10 AMP PINK R R S I S S S I R 
 10 AMP PURPLE R S S I S S S S S 
 10 CEF R R S R S S S S S 
I 11 AMP BC R R S I S S S S S 
I 11 AMP SC R R S I S S S I R 
I 11 TET R R I S S S S I R 
I 11 GEN R R I R S R R S S 
 12 AMP R R I I S S S S S 
 12 TET BC R R S I S S S I S 
 12 TET SC R R S S S S S S S 
 13 AMP R S S I S S R S S 
J 14 AMP BC R R S S S S R S S 
J 14 AMP SC R R S I S S R S S 
J 14 TET BC R R I I S S R I S 
J 14 TET SC R R I I S S S S S 
J 14 GEN R R I R S R R S S 
J 14 CEF R R S R S I R S S 
K 15 AMP R R I S S S S I S 
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M-S Plasmid Sample AMP TET KAN CTX CIP CN W IMP C 
K 15 TET R R I I S S S S S 
K 15 CEF R R I I S S S I S 
 16 AMP BC R R I R S S R I S 
 16 AMP SC R S S S S S R S S 
 16 TET BC R R S I S S R S S 
 16 TET SC R R S I S S R I S 
 17 AMP R S S S S S S S S 
 18 TET R R S S S S S S R 
 19 AMP BC R S S S S S S S S 
 19 AMP SC R S S S S S S S S 
 19 TET R R I S S S S I S 
 
aM-S= corresponding microbiome sample. 
bAMP=Ampicillin, TET=Tetracycline, KAN=Kanamycin, CTX=Cefotaxime, 
CIP=Ciprofloxacin, CN=Gentamicin, W=Trimethoprim, IMP=Imipenem, 
C=Chloramphenicol.  
cR=Resistant, I=Intermediate, S=Susceptible; according to CLSI guidelines (2018). 
dSome transconjugants appeared to have different colony morphologies on the same 
antibiotic selective plate (BC=big colony; SC=small colony) or different colours on 
EMB agar (pink/purple). 
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4.7 FIGURES 
 
 
 
Fig 1. Rarefaction curves at all taxonomic ranks. 
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Fig 2(a). Relative abundance of microbial communities at phylum taxonomic rank.
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Fig 2(b). Relative abundance of microbial communities at class taxonomic rank.
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Fig 3. Heat map showing the relative abundance of the top 20 genera present, ranging 
from highest abundance (red) to least (blue).
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Fig 4. Comparison of taxa abundance across sample groups using ANOVA.
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Fig 5. Principal component analysis of sample groups at phylum, class and genus taxonomic levels.  
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Fig 6. Microbial community alpha diversity assessed using Shannon index.  
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Fig 7. Microbial community richness assessed by Chao1.
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Fig 8. Microbial community evenness at all taxonomic ranks. 
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Fig 9. Plasmids isolated from the broiler caecal samples on day 21 visualised on an agarose gel. Samples are named after the bird the caecal sample 
was taken from and the antibiotic which the transconjugant was selected on, e.g. 6 TET= bird 6 selected on tetracycline. Some transconjugants 
appeared to have different colony morphologies on the same antibiotic selective plate (BC=big colony; SC=small colony) or had both a lawn of 
growth (LAWN) with some distinct colonies (COLONIES). Samples are labelled with the letter of their corresponding microbiome sample. 
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Fig 10. Plasmids isolated from the broiler caecal samples on day 35 and visualised on an agarose gel. Samples are named after the bird the caecal 
sample was taken from and the antibiotic which the transconjugant was selected on, e.g. 6 TET= bird 6 selected on tetracycline. Some 
transconjugants appeared to have different colony morphologies on the same antibiotic selective plate (BC=big colony; SC=small colony) or 
different colours on EMB agar (pink/purple). Samples are labelled with the letter of their corresponding microbiome sample. 
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5.1 ABSTRACT 
 
Antibiotic resistance is regarded as one of the most serious threats to human health 
worldwide. The rapid increase in resistance rates has been attributed to the extensive 
use of antibiotics since they became commercially available. The use of antibiotics as 
growth promotors has been banned in numerous regions due to this. Mannan rich 
fraction (MRF) has been reported to show similar growth promoting effects. We 
investigated the effect of MRF on the microbial community present within the caecum 
of commercial broilers at two different time points within the growth of the broiler, 
day 27 and day 35. At phylum level, Firmicutes and Bacteroides were the most 
abundant, while Clostridia and Bacteroidia were most dominant at class level. 
Mannan rich fraction did not appear to affect the most abundant taxa. Food-producing 
animals are known reservoirs of antibiotic resistance genes (ARGs) within their gut 
microbiomes. The resistome was comprised of 171 ARGs; 69 core and 102 accessory 
ARGs. The genes present at the highest abundance in all samples were tetW, lnuC and 
aadE. Differences were observed in the MRF supplemented group at day 27 compared 
with the untreated control. This highlights the potential of MRF to have an effect on 
ARG abundance. However, significant variability was seen from sample-to-sample. 
This study also demonstrated the presence of ARGs in the gut of food-producing 
animals even in the absence of antibiotic selective pressures. These genes could 
produce detrimental effects for both animal and human health.   
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5.2 INTRODUCTION 
 
Over 1,000 species of bacteria inhabit the gastrointestinal tracts of poultry and 
livestock. These bacteria enter the human food chain through the consumption of meat 
products, which are regarded as a major source of protein for humans1. Poultry is the 
fastest growing agricultural sub-sector, with continued growth expected as the global 
population increases2. This places enormous pressure on poultry producers, with 
production often being large-scale and highly intensive. Within such systems, large 
densities of birds are housed in close proximity to each other3, and are in constant 
contact with effluent and secretions from other birds4. This creates an ideal 
environment for bacteria, commensal or pathogenic, to spread throughout the flock. 
For example, bird-to-bird transmission of the enteric pathogen Campylobacter occurs 
rapidly within a flock, with almost the entire flock becoming colonised within a few 
days of when the first bird was colonised5. In the same manner, antibiotic resistant 
bacteria (ARB) and antibiotic resistance genes (ARGs) are also disseminated 
throughout poultry flocks. 
 
The threat of antibiotic resistance to global health is ever-increasing. The continued 
overuse and misuse of antibiotics in both humans and animals has drastically 
accelerated the development and spread of antibiotic resistance6. The link between the 
use of antibiotics in agriculture, whether for treatment or prevention of disease, or to 
promote the growth of animals, to increased resistance rates has been documented7,8,9. 
Antibiotic use creates a selective pressure that allows for the proliferation of ARB10. 
The gut microbiome of food-producing animals is a known reservoir of ARGs, with 
bacteria having the ability to harbour these genes even in the absence of selective 
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pressure from antibiotic use11. These ARGs can transfer to human and animal 
pathogens12.  
The caecum is the most densely populated region of the chicken gastrointestinal tract, 
and is known to harbour an assortment of microorganisms which are involved in 
processes such as the recycling of nitrogen, digestion of resistant carbohydrates, 
absorption of additional nutrients, prevention of colonisation with pathogens and 
detoxification of harmful substances13. However, it can also harbour pathogens such 
as Salmonella enterica and Campylobacter jejuni, which cause disease in humans.  
 
Prebiotics are described as non-digestible feed additives that benefit the host by 
selectively stimulating the growth or metabolic activity of a small number of intestinal 
microorganisms14. Supplementation of the diet of broilers with the prebiotic mannan-
oligosaccharide (MOS) has been reported to improve bird weight and feed 
efficiency15. Because of this, the use of MOS has been suggested as a viable alternative 
to antibiotic growth promotors16, which have been banned in the European Union since 
2006 and more recently in America in 201717. A study by Sims et al., found that MOS 
produced an equivalent result to zinc-bacitracin in terms of performance 
improvement18. Ao & Choct reported improved growth performance and flock 
uniformity in broilers that received MOS19. Mannan rich fraction (MRF) is a second-
generation MOS product, with increased activities in intestinal health and immune 
modulation20.  
 
Our study aimed to investigate the effect of MRF supplementation to the diet of 
commercial broiler chickens on the microbiome and resistome at two different days 
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within the growth of the broiler. A metagenomics based approach was employed to 
examine any MRF-induced changes in the structure and diversity of the microbial 
community. The resistome was also investigated to assess if MRF had an effect on 
ARG profiles within the broiler caecum.  
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5.3 MATERIALS & METHODS 
 
5.3.1 Samples 
 
Broiler caecal samples were obtained from a commercial poultry production unit in 
the European Union. Broilers received either a standard commercial diet or a standard 
diet plus MRF at the manufacturer’s recommended inclusion rates. The samples were 
collected at two time-points, on days 27 and 34 post-hatch. Samples were lyophilised 
and stored at -80°C before analysis. 
 
5.3.2 Total DNA Extraction 
 
Total DNA was extracted from 0.05 g of each caecal sample (n=16) using the Qiagen 
DNeasy PowerSoil kit according to the manufacturer’s guidelines. The concentration 
and purity of the extracted DNA was measured using an Invitrogen Qubit Fluorometer 
(dsDNA high-sensitivity assay kit) and a DeNovix DS-11 spectrophotometer.  
 
5.3.3 Metagenomic Sequencing 
 
The sequencing was performed at the Centre for Genomics Research, University of 
Liverpool. Illumina unamplified fragment libraries were prepared using the TruSeq 
PCR-free kit (350 bp inserts). The samples were paired end sequenced (2×150 bp) 
using an Illumina HiSeq 4000.  Between 60 and 80 million raw reads were obtained 
per sample. The raw Fastq files were trimmed for the presence of Illumina adapter 
sequences using Cutadapt version 1.2.1. The 3′ end of any reads which matched the 
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adapter sequence for 3 bp or more were trimmed. Sickle version 1.200 was used to 
further trim reads, with a minimum window quality score of 20. Reads which were 
shorter than 20 bp after trimming were removed.  
 
5.3.4 Bioinformatic Analysis 
 
The trimmed reads were uploaded to the European Nucleotide Archive (ENA). The 
files were then transferred to MGnify21 for analysis. InterProScan was used to generate 
matches against predicted CDS using Pfam, TIGRFAM, PRINTS, PROSITE patterns 
and Gene3d to provide gene ontology (GO) terms. MAPseq was used for SSU and 
LSU rRNA annotation, utilising SILVA SSU/LSU version 1.32 reference database to 
assign taxonomy and OTU classifications. 
Antimicrobial resistance annotation was performed using DeepARG. The machine 
learning solution which utilises CARD, ARDB and UNIPROT databases first removes 
low quality reads using TRIMMOMATIC. Reads are then merged into one file 
(VSEARCH) and submitted for classification to the DeepARG algorithm22. The 
relative abundance of ARGs was normalised to the 16S rRNA content of each sample 
using the following parameters: identity: 80%, e-value: 1e-10, coverage: 50% and 
probability: 0.8.  
  
5.3.5 Data Analysis 
 
Statistical analysis of the microbiome data was performed using Calypso 
(http://cgenome.net/calypso/)23. The data were normalized for statistical analysis and 
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samples with less than 1000 sequence reads and rare taxa, with less than 0.001% 
relative abundance were removed. Rarefaction analyses and Principal Component 
Analysis (PCA) of the microbiome were carried out using default settings. The 
microbial community composition was quantitatively visualized by bar charts. 
ANOVA was used to compare the relative abundances of phylum, class and genus 
taxonomic levels between treatment groups. Bacterial alpha diversity was estimated 
using the Shannon index and richness estimated using Chao1. 
 
ARGs were assigned to the core resistome if they were present in all samples. ARGs 
detected in at least one sample, but less than the total number of samples, were 
assigned to the accessory resistome. The statistical analysis and correlation analysis 
of the ARGs was performed using the PAleontological STatistics (PAST) version 
3.224. Samples were compared using ANOVA Mann–Whitney pairwise tests with 
Bonferroni correction for multiple comparisons. PCA were performed in PAST using 
default settings. Heat-maps were generated using Morpheus 
(https://software.broadinstitute.org/morpheus/).  
 
The sequences are deposited in the European Nucleotide Archive (ENA) under the 
primary accession PRJEB29033 and secondary accession ERP111299.  
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5.4 RESULTS & DISCUSSION 
 
The total reads per sample analysed after quality control and trimming ranged from 
57,465,201 reads to 82,809,780 reads. 
 
5.4.1 Microbiome Analysis 
 
Rarefaction analysis showed a sufficient sequencing depth was reached (Fig 1). 
Samples were compared based on treatment group (control vs. MRF) and time-point 
(day 27 vs. day 34). The microbiome was found to be dominated by Firmicutes across 
all samples, with up to 89.45% of all classified reads from day 27 control, up to 
80.22% for day 27 treated, 81.46% from day 34 control and 91.49% from day 34 
treated classified within the phylum Firmicutes (Fig 2A). This was followed by 
Bacteroidetes, with up to 9.55% of all classified reads from day 27 control, up to 7.7% 
for day 27 treated, 9.31% from day 34 control and 12.38% from the day 34 treated 
group. We then identified a number of unclassified reads in all samples ranging from 
2.45% of all classified reads up to 11.07%. Previous studies have also found 
unclassified reads within their samples25. This was followed by Tenericutes, 
Actinobacteria and Proteobacteria. Some sample variation was noted here, with 
16.45% of reads for Actinobacteria in sample A (day 34 treated), compared with the 
other samples which ranged from 0.5% to 3.86%. Similarly, sample G (day 34 control) 
contained 10.25% of reads for Proteobacteria, in comparison to the 5.23% to 0.21% 
range of the other samples. These findings are in keeping with other studies 
investigating the broiler microbiome26,27. Variation within samples has also been 
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observed previously, and has been attributed to factors such as farm workers, housing 
conditions, biosecurity level, litter, and feed access28.  
 
The microbiome was largely dominated by Clostridia at class level, with up to 70.45% 
of all classified reads from day 27 control, up to 73.23% for day 27 treated, 74.03% 
from day 34 control and 85.28% from day 34 treated (Fig 2B). We again identified 
high percentages of unclassified reads, ranging from 5.33% up to 18.56%. This was 
followed by Bacteroidia, with up to 7.63% of all classified reads from day 27 control, 
up to 9.41% for day 27 treated, 9.15% from day 34 control and 12.25% from day 34 
treated. Bacilli comprised up to 15.2% of all classified reads from day 27 control, up 
to 9.89% for day 27 treated, 7.03% from day 34 control and 7.19% from day 34 treated. 
Within group variations were seen in the next predominant class, Mollicutes, 
particularly at the day 34 time-point, with percentages ranging from 6.12% to 0.09% 
in the treated group; and 7.26% to 0.63% in the control group.  
 
Over half of all reads at genera level in all samples were unclassified (between 50.52% 
and 73.99%) (Fig 2C). Faecalibacterium was the next most dominant, with up to 
20.23% of all classified reads from day 27 control, up to 14.34% for day 27 treated, 
16.21% from day 34 control and 20.87% from day 34 treated. This was followed by 
Lactobacillus, with up to 13.64% from day 27 control, 7.09% for day 27 treated, 
6.03% from day 34 control and 5.93% from day 34 treated. Bacteroides was the next 
most dominant genera, with up to 2.37% from day 27 control, 6.81% for day 27 
treated, 6.71% from day 34 control and 3.42% from day 34 treated. 
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Taxa abundance at phylum to genera levels were compared using ANOVA (Fig 3). 
The difference in relative abundance was considered significant when P <0.05. Pair-
wise comparisons were performed by t-test and annotated as *: p<0.05, **: p<0.01, 
***: p<0.001. A significant variance between treatment groups was seen in 2 phyla 
(Verrucomicrobia, Candidatus_Melainabacteria), 2 classes (Verrucomicrobiae, 
Betaproteobacteria), 2 orders (Verrucomicrobiales, Burkholderiales), 3 families 
(Sutterellaceae, Burkholderiaceae, Akkermansiaceae) and 3 genera (Parasutterella, 
Burkholderia, Akkermansia). However, these taxa were all present in relatively low 
abundance, comprising less than 1% of classified reads in any of the samples within 
the broiler microbiome.  
 
Shannon index was used to assess the microbial alpha diversity (Fig 4A). No 
significant differences were observed. The bacterial community richness was assessed 
using Chao1, where a significant difference (where P <0.05) was seen at order level 
only (Fig 4B), indicating a greater number and therefore richer community at this 
taxonomic rank in the control group. The evenness of the microbial community is 
displayed in Fig 4C, where no significant differences were observed. Thus, there were 
no major changes in the diversity or evenness in the microbiome between treated or 
control groups.  
 
Principal Component Analysis (PCA) was used to plot the relative abundance of OTUs 
at phylum, class and genus levels (Fig 5). The observed patterns between treatment 
groups and time-points were similar. The day 34 time-point and treated group had 
large intra-cluster distances along both the PC1 axis and the PC2 axis at all taxonomic 
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levels. The day 27 time-point and control group had a small intra-cluster distance at 
phylum level, which increased slightly at class level. A much larger intra-cluster 
distance was observed along the PC2 axis at genus level. Both treatment groups (Fig 
5A) and time-points (Fig 5B) clustered together with the exception of a few samples 
at phylum, class and genera level. This shows that while there was some bird-to-bird 
variation present, the microbiome diversity and composition was overall consistent 
between the treatment and control groups.    
 
A previous study into the effect of MRF on the broiler microbiome found a shift from 
Firmicutes to Bacteroides at phylum level29. We did not observe this same change in 
microbiota, with ours remaining dominated by Firmicutes at phylum level. The 
authors also note a change to a Bacteroidia dominant microbiota at class level from 
Clostridia. We saw a slight increase in the relative abundance of Bacteroidia in the 
treatment group but this was not found to be significant. MOS, the predecessor to 
MRF, has been described to increase the abundance of Lactobacillus spp. in the 
caecum30. However, Lactobacillus was already dominant within our samples, and we 
did not observe notable changes between the control group and the group that received 
MRF. Numerous studies have shown that pathogenic bacteria which possess mannose-
specific fimbriae can bind to mannose which reduces the risk of pathogens including 
Salmonella and Escherichia coli in the gastrointestinal tract31. Interestingly, we did 
not detect Salmonella spp., E. coli or Campylobacter spp., which commonly colonise 
the poultry gut, in any of our samples. Thus, this may be why we did not observe any 
major changes within the treatment group compared to the control. This suggests that 
MRF would be beneficial for use in farms or production facilities with pathogen-
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challenged chickens, but would not have deleterious effects on the microbiomes of 
non-pathogen-challenged chickens.   
 
5.4.2 Resistome Analysis 
 
A total of 171 ARGs were identified. These were isolated from healthy broiler 
chickens which had not been administered antibiotics. From this, 69 ARGs were 
assigned to the core resistome as they were present in all 16 samples (Table S1). The 
remaining ARGs that were present in at least one, but not all samples, were assigned 
to the accessory resistome, totalling 102 ARGs (Table S2). The trends of resistance 
across all samples were investigated by summing the relative abundance of ARGs per 
sample by antibiotic class (Fig 6). All of the samples harboured resistance genes 
conferring resistance to the same classes of antibiotics. The greatest proportions of 
ARGs present in all samples included tetracycline, aminoglycoside, multi-drug, 
glycopeptide and macrolide-lincosamide-streptogramin B (MLSB), nucleoside and 
peptide resistance genes. Resistance to the remaining classes of antibiotics was 
relatively low. Variation was seen in the relative abundances of the identified classes 
both between the groups and between the samples. Overall, the day 27 samples had 
higher numbers of ARGs than the day 34 samples. Sample D from the day 34 treated 
group had a higher abundance of multi-drug resistance genes than the other samples 
within that group. Sample J from the day 27 treated group was shown to have a higher 
abundance of MLSB resistance genes than the remaining samples in the group.  
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The core resistome was composed of 69 ARGs that included a large number of efflux 
pumps (n=21), as well as porins (n=3), tetracycline (n=9), glycopeptide (n=10), beta-
lactam (n=2), aminoglycoside (n=5), peptide (n=4), MLSB (n=1), lincosamide (n=2), 
streptogramin (n=1), macrolide (n=1), unclassified (n=6), nucleoside (n=2), 
fluoroquinolone (n=1) and diaminopyrimidine (n=1) antibiotic resistance genes. The 
distribution of genes was reasonably consistent across all samples within the core 
resistome, with tetW, lnuC and aadE being the most abundant. It is represented in Fig 
7A, where the most abundant genes clustered together using the Bray–Curtis similarity 
matrix. Samples were also clustered based on the relative abundance of their core 
resistance genes by the Bray-Curtis similarity matrix (Fig 8A). None of the clustered 
groups contained all four samples from the day and treatment group of broilers. This 
demonstrates the variation in the abundances of ARGs even between samples from the 
same treatment or age group. For example, from the day 27 control group, samples M 
and N clustered together; and samples O and P, which had a higher number of ARGs 
clustered together; but neither of these clusters overlapped and they had a large 
distance between (labelled in green, Fig 8A). Samples with a higher abundance of 
ARGs clustered together towards the right of the chart, while samples with a lower 
abundance clustered together on the left of the chart. A review of the faecal resistome 
of pigs and broilers from nine European countries also found less consistency and far 
more variability in the relative proportions of resistance in the broiler samples. The 
highest abundance of resistance identified was to tetracycline, macrolide, beta-lactam 
and aminoglycoside antibiotics32.  
 
The accessory resistome was comprised of 102 ARGs. The ermF gene and rpoB2 were 
the most abundant accessory genes, which confer resistance to MLSB antibiotics via 
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efflux pump and rifamycin, respectively. Clustering analysis of the relative 
abundances of ARGs in the accessory resistome using the Bray-Curtis similarity 
matrix can be seen in Fig 7B, where the most abundant ARGs clustered together. 
Analysis of samples was performed also using the Bray-Curtis similarity matrix (Fig 
8B). The samples from the day 27 control group clustered into two groups beside each 
other (labelled in green). This indicates that similar abundances of ARGs were present 
in each of these samples. Three samples from the day 27 treated group clustered into 
two groups closely related but separate to sample L (labelled in pink). Overall, the 
abundance of ARGs present in the accessory resistome at day 27 were consistent. This 
was not seen at day 34, particularly within the treated group, where none of the 
samples clustered together (labelled in purple). The day 34 birds had a more varied 
abundance of ARGs within the accessory resistome. 
 
There were significant differences (P <0.05) observed between the relative 
abundances of ARGs among samples in the core resistome (Table 1). Samples in the 
day 27 control group showed the most differences to all other samples. In particular, 
samples P (day 27 control), D (day 34 treated) and O (day 27 control) were 
significantly different to all other samples, even within the same group. Again, the 
high levels of sample-to-sample variance was detected, with sample D being 
significantly different to all other samples within the day 34 treated group. Significant 
differences were also observed between samples within the accessory resistome (Table 
2). In particular, samples B, A, C (day 34 treated) and H (day 34 control) had 
significant differences to all other samples. Sample D was significantly different to all 
other samples within the same group (day 34 treated), again highlighting the variability 
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that can be seen between samples of the same group that was also observed in the core 
resistome.   
 
Principal component analysis was performed on the core (Fig 9A) and accessory (Fig 
9B) resistomes. An overlap in the core resistomes of all sampled groups was observed. 
The core resistomes of samples from the day 27 treated group had a large intra-cluster 
distance along the PC1 axis, while the core resistomes of other sample groups had a 
greater intra-cluster distance along the PC2 axis. The core resistomes of samples from 
the day 34 clustered together. Those from the day 27 groups had a defined inter-cluster 
distance, indicating the differences in the abundance of core ARGs between the treated 
and control groups. This was also observed within the accessory resistome, where the 
day 27 groups also had a large inter-cluster distance, with a clear separation between 
the control and treated groups. The day 34 treated group (purple) had a larger intra-
cluster distance along the PC1 axis but still clustered with the day 34 control samples 
(blue). It is therefore possible that MRF had an effect on ARG numbers at day 27. 
However, the variations seen in the samples from each group make this harder to 
definitively conclude. These ARGs may have been harboured by taxa present in lower 
abundances in the microbiome, and are therefore less likely to be detected, as no 
significant changes were observed within the most dominant taxa. It is also possible 
that some of these ARGs were present on broad-host range plasmids, and therefore 
changes in the plasmid population may be independent of changes within the 
microbiome.  
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5.4.3 Functional Analysis 
 
The functional profile of the broiler microbiome was derived from the GO (Gene 
Ontology) assignments from the metagenomics analysis. A total of 2706 genes were 
assigned GO terms in at least one sample. The GO terms were divided into three 
categories: biological processes (n=1111 GO terms), cellular components (n=327 GO 
terms) and molecular functions (n=1268 GO terms) (Fig 10).  
 
The cellular components with the highest presence were basic cellular components 
including membrane, ribosome, intracellular and cytoplasm. The presence of the 
fungal-type cell wall and the viral capsid and envelope indicates the presence and 
function of fungi and viruses within the broiler microbiome. Host cell components 
were also present. The molecular functions with the highest abundance in all samples 
were ATP binding, DNA binding, catalytic activity and oxidoreductase activity. 
Sample E had a higher presence of nucleotide binding, nucleic acid binding, DNA-
directed DNA polymerase activity and 3’-5’ exonuclease activity genes than all other 
samples, but has a slightly lower abundance of ATP binding and catalytic activity 
genes than the other samples.  
 
The biological process most prominent in all samples was oxidation-reduction 
processes, metabolic processes, carbohydrate metabolic processes and regulation of 
transcription DNA-templated. Again, sample E was found to have a significantly 
higher abundance of DNA replication genes than all other samples. A number of viral 
components were also identified including viral capsid assembly, viral genome 
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replication and viral life cycle. Antibiotic catabolic process genes, which result in the 
breakdown of an antibiotic, were present in all samples. Also, antibiotic metabolic 
process genes were present in 7 samples, while antibiotic biosynthetic process genes, 
which result in the formation of an antibiotic, were present in all samples except 
samples I and P.  
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5.5 CONCLUSION 
 
The advances in molecular technologies has allowed for more sensitive detection of 
the components of the metagenomes of numerous environments. We examined the 
metagenome of sixteen broiler chickens from a commercial production facility at two 
different time points. Half of the broilers received a MRF supplementation to their 
diets. We noted that significant variabilities were found between birds, even within 
the same group living in identical conditions. We did not observe any notable changes 
in the most dominant taxa in MRF supplemented groups, but suggest this may be due 
to the lack of pathogen-targets for the MRF in our samples. A large number of ARGs 
were identified (n=171) across all samples, displaying the presence of ARGs, even in 
the absence of selective pressures from antibiotics. A significant difference was 
detected in the relative abundance of ARGs between the MRF and control groups at 
day 27. As a similar difference was not observed in the most abundant taxa, these 
ARGs may be harboured by less dominant taxa within the microbiome or located on 
broad-host range plasmids, where changes may be independent of the microbiome. 
However, the samples were highly variable, even within the same group. The presence 
of high numbers of ARGs in food-producing animals could adversely affect both 
animal and human health.   
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5.6 TABLES 
 
Table 1. Mann-Whitney pairwise test, Bonferroni corrected p values, core resistome. 
 
Table 2. Mann-Whitney pairwise test, Bonferroni corrected p values, accessory resistome. 
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5.7 FIGURES 
 
 
 
Fig 1. Rarefaction analysis at all taxonomic ranks.
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Fig 2. Microbial community composition displaying the top 20 most dominant taxa at (A) phylum, (B) class and (C) genus taxonomic levels. 
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Fig 2. Microbial community composition displaying the top 20 most dominant taxa at (A) phylum, (B) class and (C) genus taxonomic levels. 
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Fig 2. Microbial community composition displaying the top 20 most dominant taxa at (A) phylum, (B) class and (C) genus taxonomic levels. 
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Fig 3. Comparison of taxa abundance across sample groups using ANOVA.
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Fig 4. (A) Microbial community alpha diversity assessed using Shannon index, (B) microbial community richness assessed by Chao1 and (C) 
microbial community evenness at all taxonomic ranks. 
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Fig 5. Principal component analysis of sample groups at phylum, class and genus taxonomic levels comparing treatment and time-points. 
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Fig 6. Relative abundance of ARGs present by antibiotic class.  
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Fig 7. Cluster analysis of ARGs present in the (A) core resistome and (B) accessory resistome using the Bray-Curtis similarity matrix. 
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Fig 7. Cluster analysis of ARGs present in the (A) core resistome and (B) accessory resistome using the Bray-Curtis similarity matrix. 
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Fig 8. Cluster analysis of samples based on the relative abundance of ARGs in the (A) core resistome and (B) accessory resistome using the Bray-
Curtis similarity matrix. 
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Fig 9. Principal Component Analysis of samples based on the relative abundance of ARGs in the (A) core resistome and (B) accessory resistome. 
Purple: day 34 treated, blue: day 34 control, pink: day 27 treated green: day 27 control. 
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Fig 10. Gene ontology content from GO slim.  
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5.9 SUPPLEMENTARY DATA 
 
Table S1. List of antibiotic resistance genes present in the core resistome.  
CORE RESISTOME 
TET44 
TET40 
TETO 
TET(W/N/W) 
TETX 
TETQ 
TETW 
TETM 
TET32 
VANS 
VANR 
VANU 
VANX 
VANB 
VANG 
VANH 
VANW 
VANVB 
VANRI 
EMRR 
EMRK 
EMRA 
EMRE 
ERMB 
ERMG 
MDTF 
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MDTE 
MDTH 
MDTM 
MDTL 
MDFA 
MDTP 
ACRB 
ACRA 
ACRF 
ACRS 
MARA 
GADW 
PATA 
BICYCLOMYCIN-MULTIDRUG_EFFLUX_PROTEIN_BCR 
CLASS_C 
CLASS_A 
MACB 
LNUA 
LNUC 
VATB 
LSA 
OMPF 
OMPR 
ESCHERICHIA_COLI_LAMB 
BACA 
YOJI 
UGD 
ARNA 
SAT-4 
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MDTO 
AADA 
AADE 
APH(3''')-III 
KDPE 
KASUGAMYCIN_RESISTANCE_PROTEIN_KSGA 
MDTK 
DFRF 
COB(I)ALAMIN_ADENOLSYLTRANSFERASE 
CAMP-REGULATORY_PROTEIN 
BACTERIAL_REGULATORY_PROTEIN_LUXR 
TRUNCATED_PUTATIVE_RESPONSE_REGULATOR_ARLR 
DNA-BINDING_TRANSCRIPTIONAL_REGULATOR_GADX 
TRANSCRIPTIONAL_REGULATORY_PROTEIN_CPXR_CPXR 
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Table S2. List of antibiotic resistance genes present in the accessory resistome.  
ACCESSORY RESISTOME 
LNUG 
VATE 
EPTA 
MSBA 
PORIN_OMPC 
ROSA 
ROSB 
APH(2'')-IF 
MEXE 
MDTG 
MDTD 
LLMA_23S_RIBOSOMAL_RNA_METHYLTRANSFERASE 
CPXA 
MDTN 
VANTG 
VANY 
VAND 
EMRY 
BAER 
BAES 
PMRF 
BIFUNCTIONAL_AMINOGLYCOSIDE_N-
ACETYLTRANSFERASE_AND_AMINOGLYCOSIDE_ 
PHOSPHOTRANSFERASE 
EMRB 
EMRD 
ERMF 
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ESCHERICHIA_COLI_MIPA 
ERMT 
TEM 
SERRATIA_MARCESCENS_OMP1 
SDIA 
CAT_CHLORAMPHENICOL_ACETYLTRANSFERASE 
MEXX 
16S_RRNA_METHYLASE 
VGAC 
EVGS 
ACRD 
MACA 
AADA13 
RPOB2 
DNA-BINDING_PROTEIN_H-NS 
KLEBSIELLA_PNEUMONIAE_OMPK37 
TOLC 
SAT-2 
LING 
APMA 
LNUB 
APH(6)-I 
MEFA 
NORA 
APH(2'')-IE 
DFRD 
LSAE 
ANT(9)-I 
DFRA14 
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EMRB-QACA_FAMILY_MAJOR_FACILITATOR_TRANSPORTER 
APH(3'')-I 
FOSB 
ERMX 
DFRA1 
SUL1 
SUL2 
QACH 
TETA 
TETL 
QACG 
TET(K) 
VANYG1 
APH(3')-VII 
APH(2'')-II 
MGRB 
MEL 
TET(40) 
AAC(6')-I 
APH(2'')-IV 
POXTA 
QACB 
CLBA 
ANTIBIOTIC_RESISTANCE_RRNA_ADENINE_METHYLTRANSFERASE 
OMP36 
KLEBSIELLA_PNEUMONIAE_OMPK36 
LNUF 
AAD(9) 
DFRA7 
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DFRA15 
CATD 
MDTA 
DFRA5 
ANT(3'')-IH-AAC(6')-IID 
LNUD 
DFRA16 
CATS 
APH(3')-IIA 
TETC 
MDTC 
APH(3')-I 
DFRA17 
DFRA12 
TETR 
APH(4)-I 
AAC(3)-IV 
AAC(3)-II 
VANA 
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6.1 ABSTRACT 
 
Antibiotic resistance has been declared by the WHO as one of the biggest threats to 
health worldwide. The ban on the use of antibiotics as growth promotors has seen the 
introduction of prebiotics as alternative products. Mannan rich fraction (MRF) has 
been described to improve bird weight and feed efficiency. The metagenomes of 
broilers were compared. The groups included those that received either a standard 
commercial diet (control) or a standard diet plus MRF (treated), and a group that were 
receiving MRF were also administered amoxicillin on days 22-24 (treated + 
antibiotic). The microbiome of all birds investigated was dominated by Firmicutes and 
Bacteroides at phylum level, while Clostridia and Bacteroidia were the most abundant 
classes across all samples. A total of 164 antibiotic resistance genes (ARGs) were 
identified, 19 of which were core and 145 were accessory genes. The most abundant 
genes across all samples were tetW, lnuC and aadE. In addition, the mobile resistome 
was specifically characterised using exogenous plasmid capture. The MRF treated 
group at both time-points had a lower and less varied resistance profile than the control 
or antibiotic treated group. We suggest that MRF may reduce the effects of antibiotic 
administration on the selection of antibiotic resistance via the plasmid populations 
present within the broiler caecum and may also reduce the effects of antibiotic 
administration microbiome change. In addition, the administration of MRF did not 
appear to have deleterious effects on the metagenomes of the broilers.   
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6.2 INTRODUCTION 
 
Antibiotic resistance leads to treatment failure and increased mortality1. Antibiotic 
resistance in food-producing animals can be spread to the human population through 
the food chain. This is transferred to humans through consumption of contaminated 
food products. Antibiotic resistance can be disseminated by both pathogenic and non-
pathogenic bacteria, with the resistances genes from the latter being transferred to a 
human pathogen after consumption of the food product2. The global population is 
expected to reach 9.6 billion by 20503. Correspondingly, the production of food-
producing animals will increase to meet this demand. Intensive farming practices 
would traditionally have relied heavily on antibiotics in the production process4. The 
routine addition of antibiotics into the diets of poultry has become less prevalent5, with 
many countries banning the practice due to increasing concerns over the increase of 
antibiotic resistance. Aarestrup et al., found that the use of avilamycin as a growth 
promotor in broilers led to avilamycin resistant Enterococcus faecium6,7.  However, 
the absence of growth promotors from poultry feed may increase bird disease rates. 
Thus, effective alternatives that improve chicken health while maintaining efficiency 
of production are required8.  
 
Mannan oligosaccharides (MOS) are prebiotics derived from the outer cell wall of 
Saccharomyces cerevisiae yeast cells9. MOS has been found to improve growth rate 
and feed conversion ratios10 and has been supplemented to the diet of broilers in recent 
years11. MOS has been shown to have a negative effect on pathogenic bacteria by 
stimulating beneficial bacteria in the gut microbiome12. Mannan Rich Fraction (MRF) 
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is the next generation of MOS technology, which can be included in diets at lower 
inclusion rates than MOS while still delivering all of the benefits to the animal13.  
 
Metagenomics is a technique described to have the ability to overcome the limitations 
of culture dependent studies14. These traditional culture-based methods are dependent 
on the growth of viable and culturable microbes in a laboratory environment, and will 
most often require further testing to confirm microbe identification15. Metagenomic 
sequencing techniques have resulted in the generation of large sequence datasets from 
various environments and given great insight into the enormous taxonomic and 
functional diversity of the microbial communities within these environments16. 
Plasmid detection and assembly from metagenomic samples is highly challenging. 
Sequences from plasmids are comprised of a large number of short fragments 
hindering their identification. Due to this many plasmids remain undetected in studies 
of such datasets17,18. We therefore employed a separate plasmid-based study alongside 
the metagenomic analysis. We targeted conjugative plasmids, thought to be the main 
drivers of antibiotic resistance due to their ability to transfer to different bacterial 
species19.  
 
Our work aimed to investigate the effect of MRF on the caecal microbiome of broiler 
chickens. As a group who received MRF were also administered amoxicillin for 3 
days, we also aimed to identify if MRF had an effect on the resistome with and without 
amoxicillin challenge. We also hypothesise that MRF may possess the ability to 
reduce the transfer of plasmids in the broiler gastrointestinal tract. 
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6.3 MATERIALS & METHODS 
 
6.3.1 Samples 
 
Broiler caecal samples were obtained from a commercial poultry production unit in 
the European Union. Broilers received either a standard commercial diet (control) or 
a standard diet plus MRF (treated) at the manufacturer’s recommended inclusion rates. 
A group that were receiving MRF were also administered amoxicillin on days 22-24 
(treated + antibiotic).  The samples were collected at two time-points, days 28 and 35 
post-hatch. Samples were lyophilised and stored at -80°C before analysis. 
 
6.3.2 Total DNA Extraction and Metagenomic Sequencing 
 
Total DNA was extracted from 0.05 g of each caecal sample (n=36) using the Qiagen 
DNeasy PowerSoil kit according to the manufacturer’s guidelines. The concentration 
and purity of the extracted DNA was measured using an Invitrogen Qubit Fluorometer 
(dsDNA high-sensitivity assay kit) and a DeNovix DS-11 spectrophotometer.  
Paired-end sequencing libraries were prepared using the Illumina Nextera XT Library 
Preparation Kit. The samples were paired-end sequenced (2 x 150 bp) on the Illumina 
NextSeq 500 platform using high-output chemistry (300 cycles). Delivered raw 
FASTQ sequence files were quality checked with poor quality and duplicate reads 
removed, and trimming implemented using a combination of SAM and Picard tools. 
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6.3.3 Bioinformatic Analysis 
 
The quality controlled reads were uploaded to the European Nucleotide Archive 
(ENA). The files were then transferred to MGnify20 for host decontamination and 
assembly of the primary metagenome. Samples were uploaded to MG-RAST21 using 
default parameters to perform quality control, protein prediction, clustering and 
similarity based annotation on nucleic acid sequence datasets. For each sample, the 
sum of reads per genera were extracted and further ranked taxonomic data was applied 
using NCBI taxonomy. A series of filters were applied to remove undesired and 
insignificant taxa; genera not annotated as bacteria were removed, genera with a 
cumulative n< 10 across the dataset were removed; and genera that were annotated as 
incertae sedis and with a cumulative n < 25 were removed. 
 
DeepARG22, was used to annotate antibiotic resistance. The pipeline first removes low 
quality reads using TRIMMOMATIC. Reads are then merged into one file 
(VSEARCH) and submitted for classification to the deepARG algorithm which 
applies CARD, ARDB and UNIPROT databases. The following parameters: identity: 
80%, e-value: 1e-10, coverage: 50% and probability: 0.8, were used to normalise the 
relative abundance of ARGs to the 16S rRNA content of each sample.  
 
6.3.4 Data Analysis 
 
Calypso (http://cgenome.net/calypso/)23 was used to statistically analyse the 
microbiome. The data were normalized for statistical analysis and rare taxa, with less 
than 0.001% relative abundance and samples with less than 1000 sequence reads were 
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removed. Rarefaction analyses and Principal Component Analysis (PCA) were 
performed using default settings. The microbial community composition was 
quantitatively visualized by bar charts. The relative abundances of taxonomic levels 
between treatment groups were compared by ANOVA between treatment groups. 
Shannon index was used to estimate bacterial alpha diversity and Chao1 was used to 
estimate richness. 
 
Antibiotic resistance genes (ARGs) detected in across samples were assigned to the 
core resistome. The accessory resistome comprised ARGs detected in at least one 
sample, but less than the total number of samples. The statistical analysis and 
correlation analysis of the ARGs was performed using the PAleontological STatistics 
(PAST) version 3.224. ANOVA Mann–Whitney pairwise tests with Bonferroni 
correction for multiple comparisons to compare samples were performed. PCA were 
performed using default settings. Heat-maps were generated using Morpheus 
(https://software.broadinstitute.org/morpheus/).  
 
The sequences are deposited in the European Nucleotide Archive (ENA) under 
primary accession PRJEB33644 and secondary accession ERP116454.  
 
6.3.5 Exogenous Plasmid Isolation 
 
Plasmids were isolated from the caecal samples (n=46) using the exogenous plasmid 
isolation method as previously described with the following modifications. Samples 
were resuspended in 5 ml Tryptic Soy Broth (TSB) (Sigma). We included both a 
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‘rinse’ step, where the supernatant was immediately used as the donor culture (denoted 
with an asterisk (*)); and an ‘enriched’ step, where the resuspended caecal sample was 
left rocking overnight before being used as the donor. 100 µL of both donor and 
recipient Escherichia coli DH5α RifR were combined, centrifuged and resuspended in 
100 µL of TSB before being applied to a 0.2 μm filter. Cells were resuspended from 
the filters in 10 ml 0.85% NaCl. Exogenous transconjugants were selected on Luria-
Bertani (LB) agar (Duchefa-Biochemie) with rifampicin (100 mg/L) and ampicillin, 
tetracycline, kanamycin, colistin, cefotaxime, ciprofloxacin or imipenem at breakpoint 
concentrations according to CLSI guidelines (2018)25. A transconjugant from each 
antibiotic selective plate with growth was selected at random. If bacteria from the same 
plate appeared to have different features (e.g. morphology), both were selected for 
further testing.  
 
6.3.6 Plasmid Analysis 
 
Plasmids were extracted from the putative recipient E. coli strains using the Macherey-
Nagel NucleoSpin Plasmid kit according to the manufacturer’s guidelines and 
following the low-copy number protocol. The extracted plasmid DNA was visualised 
on a 1% agarose gel run at 70 volts for 60 minutes and stained with 1X GelRed 
(Biotium). Antibiotic susceptibility testing was performed in duplicate via the disk 
diffusion method according to CLSI guidelines (2018)25 for 11 antibiotics (ampicillin, 
tetracycline, kanamycin, cefotaxime, ciprofloxacin, gentamicin, ceftazidime, 
meropenem, imipenem, trimethoprim and chloramphenicol) from 8 different classes. 
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6.4 RESULTS & DISCUSSION 
 
The total reads per sample analysed after quality control and trimming ranged from 
5,194,020 reads to 16,466,390 reads. 
 
6.4.1 Microbiome Analysis 
 
A total number of 28 phyla, 55 classes, 126 orders, 256 families and 600 genera passed 
the quality control. Rarefaction analysis was performed at each level to confirm that a 
sufficient depth of sequencing was reached (Fig 1).  Samples were compared based on 
treatment group (control vs. treated vs. treated + antibiotic) and time-point (day 28 vs. 
day 35).  
 
Firmicutes was the predominant phyla, the relative abundance ranged from 61.96% to 
83.33% across all samples (Fig 2A). This was followed by Bacteroidetes, ranging 
between 31.34% and 10.01% of all classified reads.  Proteobacteria ranged from 
7.34% to 1.78% and Actinobacteria had between 5.99% and 1.57% of all classified 
reads. Our findings are in line with previous studies of the most predominant phyla in 
the chicken microbiome, with Firmicutes known to represent 50–90% of all taxa in 
the caecum26.    
 
The most dominant class was Clostridia, with a range of 66.67% of all classified reads 
to 46.15% (Fig 2B). Bacteroidia was the next most dominant (31.14% to 8.89%), 
followed by Bacilli (17.88% to 4.01%) and Erysipelotrichia (4.65% to 1.83%). This 
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distribution is similar to a study by Ma et al., where broilers diets were supplemented 
with Bacillus subtilis27. Bacillus species are known to be beneficial to the host by 
balancing the properties of the native microbiota resulting in better growth 
performance28. Erysipelotrichia are less commonly detected with in the top 5 most 
dominant classes. Specific species within the Erysipelotrichia class have been linked 
to being of benefit to host energy metabolism29. 
 
Clostridium was the most dominant genus across all samples, with a range of 20.01% 
to 13.2% of classified reads (Fig 2C). Certain Clostridium species such as Clostridium 
islandicum have been associated with host benefits such as cellulytic activity and feed 
conversion30. This was followed by Bacteroides (30.52% to 8.32%), Ruminococcus 
(12.6% to 6.43%) and Lactobacillus (13.39% to 0.29%). MOS supplementation has 
previously been associated with increased in Lactobacillus community diversity31. 
While the overall relative abundance of taxa remained constant, variations within 
sample groups were evident. For example, Bacteroides in the day 28 treated group 
ranges from 9.97% of all classified reads to up 30.52%. Meanwhile, Lactobacillus at 
day 35 in the control group ranged from 0.29% up to 12.75% of all classified reads. 
  
Taxa abundance across treatments were compared using ANOVA at phylum through 
to genera levels (Fig 3). When P <0.05 the difference in relative abundance was 
considered significant. Pair-wise comparisons were performed by t-test and annotated 
as *: p<0.05, **: p<0.01, ***: p<0.001. A significant variance between treatment 
groups was seen at phylum level (Chlorobi), within 2 classes (Oligoflexia, Chlorobia), 
6 orders (Rhodocyclales, Rhodobacterales, Neisseriales, Desulfovibrionales, 
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Chlorobiales, Bdellovibrionales), 11 families (Rikenellaceae, Rhodobacteraceae, 
Psychromonadaceae, Neisseriaceae, Halobacteroidaceae, Desulfovibrionaceae, 
Comamonadacae, Chromatiaceae, Chlorobiaceae, Beutenbergiaceae, 
Bdellovibrionaceae) and 13 genera (Alistipes, Bilophila, Pelotomaculum, Neisseria, 
Dethiobacter, Moorella, Chlorobium, Acetohalobium, Beutenbergia, Thermus, 
Catonella, Flavobacterium, Micromonospora). These variations all occurred within 
the less predominant taxa in the caecal microbiome. Chlorobi was only the 17th most 
dominant phyla, while the significant variances seen at class level were in classes 
outside the top 20 most dominant. Alistipes was the 19th most dominant genera, with 
all others showing variance between treatment groups falling outside the top 20 most 
abundant genera.  
 
Microbial alpha diversity was assessed with Shannon index (Fig 4A) and bacterial 
community richness was assessed with Chao1 (Fig 4B). Microbial community 
evenness is represented in Fig 4C. No significant differences (where P <0.05) were 
observed for diversity, richness or evenness at any taxonomic rank. This indicates a 
highly consistent microbiota present among all the sampled birds, even between 
treatment groups. 
 
These results indicate that the addition of MRF may counteract the deleterious effects 
of the antibiotic amoxicillin on the caecal microbiome, while not significantly 
changing the normal microbiome of the caeca relative to the control. This suggests 
that MRF maintains the alpha-diversity and evenesss of the microbial community in 
the presence of antibiotic amoxicillin. Schokker et al., observed an increased diversity 
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in 5 day old chickens that had received amoxicillin at 1 day of age. This increase in 
diversity is more chaotic than a stable microbiota, and therefore less resilient32. The 
authors also found that the abundance of Lactobacillaceae was decreased in the 
antibiotic group. As Lactobacilli are involved in the competitive exclusion of 
pathogens, the antibiotic appears to have had a negative effect on gut health32.  
 
The relative abundance of OTUs at phylum, class and genus levels were plotted using 
Principal Component Analysis (PCA) (Fig 5). The patterns observed were similar 
between treatment groups and time-points. The control group had a small intra-cluster 
distance at phylum level. The treated group had a slightly larger intra-cluster distance 
along the PC2 axis, while the treated + antibiotic group had a similar distance along 
the PC1 axis. At class level, there was an increase in the intra-cluster distance along 
the PC1 axis at phylum level in the control group. The intra-cluster distance increased 
for the treated groups also. A more significant increase in intra-cluster distance is seen 
at genus level for all groups, highlighting a greater diversity at this taxonomic level. 
At all taxonomic levels, the groups cluster together, with no clearly defined inter-
cluster distances between them. This shows that while there is some variation present 
within each sample group, overall the microbiome is consistent across all samples.  
 
Both the MRF supplementation and the administration of antibiotics had the potential 
to significantly alter the caecal microbiome. Antibiotics reduce the gut microflora, 
however, the microbial community in the groups that received antibiotics and MRF 
were highly similar to those in the groups that did not. It is possible that the 
microbiome recovered after the antibiotic treatment which occurred before sampling. 
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This recovery may have been aided by the MRF supplementation, providing a 
substrate for selective beneficial commensal bacteria to recover and proliferate 
throughout the caecal microbiome. Previous studies summarised by Teng and Kim 
noted that Lactobacillus were the main species influenced by MOS, whereby their 
prevalence in the microbiome increased11. The benefits of this have been recognised, 
Lactobacillus salivarius was shown to limit Salmonella colonization, and 
Lactobacillus crispatus has been documented as having anti-E. coli and anti-
Salmonella properties33. We observed similar levels of Lactobacillus in the control 
group as the treated groups. The presence of Lactobacillus within the birds may have 
meant that the effect of MOS was as high as previously observed as it would have 
been in birds where Lactobacillus was present in much lower levels or absent. A study 
by Corrigan et al., investigating the effect of MOS on the broiler microbiome found 
an increase in Bacteroidetes from a Firmicutes dominated microbiota, while 
correspondingly observing a shift from a predominantly Clostridia populated 
microbiome to Bacteroidia at class level34. While our microbial community structure 
was similar at phylum and class levels, we did not observe these same changes in the 
microbiome with MRF supplementation. This suggests that the effect of MRF may be 
specific to certain genera or species which were not present in our samples. MOS are 
also recognised in their ability to bind enteric pathogens with type-1 fimbriae such as 
Salmonella and Campylobacter species35, neither of which were identified in our 
study. It is therefore likely that the effect of MRF and major changes in the 
microbiome is seen to a much greater extent in pathogen-challenged birds. From our 
results, we determine that MRF may play a role in maintaining a healthy microbiome 
within the broiler caecum. We also suggest it may assist with the recovery of the 
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microbiome after antibiotic administration and promote the development of a stable 
microbial community. 
        
6.4.2 Resistome Analysis 
 
A total of 164 antibiotic resistance genes (ARGs) were identified across all samples. 
The core resistome contained 19 ARGs, which were present in all 36 samples (Table 
S2). The remaining 145 ARGs that were present in at least one but not all samples 
were assigned to the accessory resistome (Table S3). The relative abundance of ARGs 
per sample by antibiotic class were summed to identify if the trends in ARGs were 
consistent across all samples (Fig 6). All samples contained resistance genes from the 
same classes of antibiotics. The greatest proportions of ARGs present in all samples 
comprised tetracycline, aminoglycoside, macrolide-lincosamide-streptogramin B 
(MLSB), glycopeptide and multi-drug resistance genes. The identified resistance to the 
remaining classes of antibiotics was relatively low. The relative abundances of the 
identified classes varied across the groups and between the samples. For example, 
sample 31 had a larger proportion of multi-drug resistance compared to the other 
samples (32-36) within the same group (Fig 6). Sample 7 from the day 28 treated + 
antibiotic group had the largest variety of ARGs with 124 different ARGs. 
Interestingly, sample 26 from the day 35 treated + antibiotic group had the lowest 
variety of ARGs overall (n=59).  
 
The core resistome was composed of 19 ARGs: tetracycline (n=6), glycopeptide (n=4) 
aminoglycoside (n=2), MLSB (n=2), beta-lactam (n=1), bacitracin (n=1), lincosamide 
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(n=1), streptogramin (n=1) and nucleoside (n=1) resistance genes. The distribution of 
genes within the core resistome was consistent across all samples, with tetW, lnuC and 
aadE being the most abundant. Both tetW and aadE were found to be the most 
abundant core ARGs in the pig faecal metagenome36. A study into the faecal resistome 
on nine European broiler farms found blaTEM, tetW, dfrA1, ermB and aadA to be the 
most abundant genes37. In Fig 7A, it can be seen where the most abundant genes in 
our study clustered together using the Bray–Curtis similarity matrix. Samples were 
also clustered based on the relative abundance of their core resistance genes by the 
Bray-Curtis similarity matrix (Fig 8A). Interestingly, there were variations where 
samples from the same group (control, treated or treated + antibiotic) did not cluster 
together. Most notably was the day 28 treated + antibiotic group, (samples 7-12, 
labelled pink in Fig 8A), where the samples were distributed throughout the cluster. 
Similarly, within the day 28 treated group, half of the samples clustered together while 
half did not (samples 1-6, labelled blue in Fig 8A). This highlights the differences 
between samples of the same group based on core ARG abundance. Meanwhile, the 
five of the six samples in the day 35 treated + antibiotic group (samples 25-30, labelled 
red in Fig 8A) clustered quite closely together and closely with three control samples 
from D28 (n= 2) and D35 (n= 1), indicating a more consistent population of core 
ARGs within this group.    
 
The accessory resistome comprised 145 different ARGs. The most abundant accessory 
genes were rpoB2, tetX, ermX, ugd and ermF. The ugd gene is also known as pmrE. 
Mutations in the pmrE gene are associated with colistin resistance, but the gene itself 
is part of several bacterial genomes. Clustering analysis of the relative abundances of 
ARGs in the accessory resistome using the Bray-Curtis similarity matrix can be seen 
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in (Fig 7B) A similar pattern to the core resistome was observed, but with more 
variation between samples within each group (Fig 8B). For example, within the day 
35 group, samples 32 and 36 clustered closely together, and samples 34 and 35 
clustered together, but the two clusters were far away from each other (labelled orange 
in Fig 8B). This pattern is evident among all groups, where two or three samples 
cluster together, but away from the other samples within that group. This highlights 
the variations in ARGs present in bird samples of the same group.  
 
There were no significant differences (P <0.05) between the relative abundances of 
ARGs between samples in the core resistome. However, within the accessory 
resistome significant differences were observed between samples (Table S1). The 
contrast between time-points was the most striking here, with significant differences 
observed between the day 28 and day 35 samples, indicating a very different 
distribution of ARGs in the accessory resistome as the broilers age. As we did not 
observe any significant changes in the most dominant taxa within the microbiome, it 
is possible that the ARGs from the accessory resistome may be harboured by taxa 
present in lower abundances. PCA analysis of the core (Fig 9A) and accessory (Fig 
9B) resistomes was performed.  There was a general overlap of all sampling groups in 
the analysis of the core resistome, with a greater intra-cluster distance observed for the 
day 35 treated + antibiotic group (red) and the day 28 treated + antibiotic (pink) group. 
Within the analysis of the accessory resistome, larger intra-cluster distances are seen 
for all sampling groups. The inter-cluster distances are also more clearly defined 
between groups, particularly between the day 35 treated + antibiotic group (red), day 
28 treated + antibiotic (pink) and day 28 treated group (blue). This displays both the 
variation between samples but also between groups. 
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Our most notable results were within the groups of birds that received both MRF and 
the antibiotic. The broilers were administered amoxicillin on days 22-24. This did not 
appear to increase the abundance of beta-lactamases within those birds. A class A beta-
lactamase gene was identified but it was not the most abundant in the core resistome. 
Sample 7 had much higher numbers of ARGs present, which could be attributed to the 
administered antibiotics creating a selective pressure and encouraging proliferation of 
ARGs throughout the caecum. However, as this was not seen in the other birds in this 
group, it seems that other factors are involved in determining ARG numbers in this 
complex environment. While high abundances of ARGs were present in the day 28 
treated + antibiotic group, the lowest observed ARGs were within the day 35 treated 
+ antibiotic group. It could be that the withdrawal from antibiotic over time removed 
the selective pressure which had created the ideal environment ARGs would have 
favoured, thus resulting in lower abundances.  
 
6.4.3 Functional Analysis 
 
The functional profile of the broiler microbiome was derived from the KO (KEGG 
Orthology) assignments in MG-RAST. Genes were assigned to six functions:  Cellular 
Processes, Human Diseases (which contain infectious diseases and pathogen 
interaction), Genetic Information Processing, Environmental Information Processing, 
Organismal Systems or Metabolism (Fig 10). Samples within the day 28 control group 
had the highest abundance of genes assigned to all functions. To again highlight the 
sample-to-sample and within-group variations, samples 2 and 3 from the day 28 
treated group had high abundances of genes corresponding to all functions, while 
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sample 1 had the lowest abundance of assigned functional genes overall. Similarly, 
samples 32 and 35 from the day 35 control group had higher abundances of assigned 
function genes than the others from the same group. However, these two samples were 
not identical, with sample 35 having a lower abundance of organisational systems 
genes and higher abundance of environmental information processing and metabolism 
genes.     
 
6.4.4 Mobile Resistomes 
 
A total of 139 transconjugants from 24 birds at day 28 (control n=8, treated n=8, 
treated + antibiotic n=8) and 105 transconjugants from 22 birds at day 35 (control n=6, 
treated n=7, treated + antibiotic n=8) were analysed (Fig S1-S6).  
 
Within the day 28 samples, the control group displayed resistance to the greatest 
number of antibiotics with 58.69% of all transconjugants resistant to ampicillin, 
52.17% to tetracycline, 13.04% to trimethoprim, 8.88% to gentamicin, 4.34% to 
kanamycin and 2.17% to cefotaxime (Table 1). Overall, 10.86% of transconjugants 
within this group were multi-drug resistant, conferring resistance to three or more 
classes of antibiotics. From the day 28 treated + antibiotic group, 78.86% were 
resistant to ampicillin, 53.84% to tetracycline, 28.84% to trimethoprim and 7.69% to 
kanamycin and chloramphenicol respectively (Table 2). No resistance was observed 
to gentamicin or cefotaxime antibiotics, which was present in the control group. 
26.92% of transconjugants in this group were multi-drug resistant. Resistance to a 
lower number of antibiotics was observed in the day 28 treated group, with 46.15% of 
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transconjugants resistant to ampicillin and 12.82% resistant to tetracycline, kanamycin 
and trimethoprim, respectively (Table 3). Only 2.56% displayed a multi-drug resistant 
phenotype. Overall, the highest proportion of plasmid mediated resistance was 
observed towards ampicillin and tetracycline antibiotics followed by trimethoprim.   
 
Within the day 35 control group, 65.51% of transconjugants were resistant to 
ampicillin, 51.72% to tetracycline, 34.48% to kanamycin, 31.03% to trimethoprim, 
24.13% to gentamicin, 10.34% to ceftazidime and 3.44% to cefotaxime, 
chloramphenicol and imipenem respectively (Table 4). This group had the greatest 
variation in resistance profiles of all the sampled groups, indicating that this group 
harboured the greatest variety of plasmids. 34.48% of transconjugants were multi-drug 
resistant. From the day 35 treated + antibiotic group, 72.72% of transconjugants were 
resistant to ampicillin, 50% to tetracycline, 40.90% to trimethoprim and 2.27% to 
kanamycin (Table 5). 34.09% of transconjugants were multi-drug resistant. In the day 
35 treated group, 59.37% of transconjugants were resistant to ampicillin, 21.87% to 
tetracycline, 9.37% to trimethoprim and 3.12% were resistant to kanamycin (Table 6). 
Only 3.12% were found to exhibit a multi-drug resistant phenotype.  
 
The highest proportion of resistance overall was observed towards ampicillin and 
tetracycline antibiotics, as was seen in the day 28 groups. Only the plasmids from the 
control group at day 28 (cefotaxime only) and day 35 conferred resistance to 
chloramphenicol, ceftazidime, cefotaxime or imipenem. Thus, the inclusion of MRF 
either with or without amoxicillin did not result in the detection of plasmids conferring 
resistance to these antibiotics of importance for human medicine. Plasmid mediated 
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resistance mechanisms to the third generation cephalosporins (cefotaxime or 
ceftazidime), and imipenem also confer resistance to the antibiotic amoxicillin. 
However, in the presence of MRF these plasmids were not detected at day 28 or day 
35 even when amoxicillin was administered to the birds.        
 
Overall, the highest levels and greatest variety in resistance profiles was seen in the 
control groups in the plasmid study. This was more evident at day 35, with resistance 
to 9 of the 11 tested antibiotics identified, indicating that the birds obtained and 
harboured a greater variety of plasmids as they aged. Some of the greatest number of 
transconjugants that were resistant to trimethoprim was seen in the treated + antibiotic 
groups, which were administered amoxicillin on days 22 to 24. A class A beta-
lactamase was identified in the core resistome after sequencing, and dfr genes were 
detected in the accessory resistome. The link between ampicillin-based antibiotic use 
and trimethoprim resistance has been documented since the 1980s38. Amoxicillin and 
trimethoprim resistance genes may be linked on the same mobile genetic element39. 
Pouwels et al., found that co-selection by use of amoxicillin or ampicillin antibiotics 
is a more important driver of trimethoprim resistance levels than trimethoprim use 
itself40. The lowest range of resistance was seen in the treated groups from both time-
points. They displayed resistance to fewer classes than the control group or the groups 
that received the antibiotic. Only one transconjugant from each of the day 28 and the 
day 34 treated groups were found to display a multi-drug resistant phenotype. 
 
This may be attributed to the addition of MRF to the diet of broilers. The effect may 
be specific to plasmid populations. MOS, the predecessor to MRF, is known for its 
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capability to bind pathogens via mannose specific type-I fimbriae41. Type-3 fimbriae 
have been linked to an increased frequency of conjugation42 but also to mannan-
binding43. There is the possibility therefore that MRF reduces the conjugative ability 
of plasmids, and thus lower resistance is detected. Plasmids are not easily detected 
within complex samples as they are present in lower abundances than chromosomal 
DNA, meaning they can often be missed in total DNA extractions. Likewise, they can 
also be easily lost in the metagenomic sequencing process, as short-read sequencing 
is not ideal for the assembly of the small pieces of plasmid DNA that can possess 
numerous repeat regions. This may explain why the same differences were not 
observed between the transconjugant data and the data gathered from the core and 
accessory resistomes. Broad host range plasmids are capable of being transferred and 
maintained in a wide range of bacteria44. Therefore, if the plasmids present in our 
samples were mainly broad-host range, changes in the plasmid population may not 
necessarily be seen alongside changes in the microbial community. Further 
investigations to characterise the isolated plasmids will provide a better understanding 
of the observed changes in the mobile resistome.  
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6.5 CONCLUSION 
 
The effect of MRF on broilers from a commercial production unit was assessed. A 
sub-set of treated birds were also administered antibiotic. We did not detect any major 
changes in the dominant taxa between the sampled groups, and identified a highly 
consistent caecal microbiome. We characterised the core and accessory resistome, 
where we saw notable variation between samples of the same group. We also 
examined the mobile resistome, where a lower and less varied resistance profile was 
observed in the treated groups at both time-points. We suggest that MRF may have an 
effect on plasmid populations and encourage further investigation into the possible 
impact of the use of MRF on the control of mobile antibiotic resistance in the digestive 
tracts of food animals.    
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6.6 TABLES 
 
Table 1. Resistance profile of exogenous transconjugant strains from the day 28 
control groupa,b,c,d.   
M-S 
Plasmid 
Sample 
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S13 *1 LB S S S S S S S S S S S 
S13 1 LB R R S S S S S S S S S 
S13 1 AMP R R S S S S S S S S S 
S13 *1 TET S R S S S S S S S S S 
S13 1 TET R R S S S S S S S S S 
 *2 LB S S S S S S S S S S S 
 2 LB S S S S S S S S S S S 
 *2 AMP R S S S S S S S S S S 
 2 AMP R S S S S S S S S S S 
 *2 TET BC R R S S S S R S S S S 
 *2 TET SC R R S S S S R S S S S 
 2 KAN S R R S S S S S S S S 
S14 *3 LB S S S S S S S S S S S 
S14 3 LB S S S S S S S S S S S 
S14 *3 AMP R R S S S S S S S S S 
S14 3 AMP R S S S S S S S S S S 
S14 3 TET R R S S S S S S S S S 
S14 3 KAN R S I R S R R S S S S 
 *4 LB S S S S S S S S S S S 
 
4 LB 
LAWN S S S S S S S S S S S 
 
4 LB 
COLONIES R R S S S S S S S S S 
 *4 AMP R R S S S S S S S S S 
 4 AMP BC R R S S S S S S S S S 
 4 AMP SC R R S S S S S S S S S 
 
*4 TET 
LAWN R R S S S S S S S S S 
 
*4 TET 
COLONIES R R S S S S S S S S S 
 4 TET R R S S S S S S S S S 
S15 *5 LB S S S S S S S S S S S 
S15 5 LB S S S S S S S S S S S 
S15 *5 AMP R R S S S S S S S S S 
S15 5 AMP R R S S S S S S S S S 
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M-S 
Plasmid 
Sample 
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S15 *5 TET R R S S S S S S S S S 
S15 5 TET R R S S S S S S S S S 
S16 *6 LB S S S S S S S S S S S 
S16 *6 AMP R S S S S S S S S S S 
S16 6 AMP R S S S S S S S S S S 
S17 *7 LB S S S S S S S S S S S 
S17 7 LB S S S S S S S S S S S 
S17 7 TET S R S S S S R S S S S 
S17 7 KAN S S R S S R S S S S S 
S18 *8 LB S S S S S S S S S S S 
S18 8 LB S S S S S S S S S S S 
S18 *8 AMP R S S S S S S S S S S 
S18 8 AMP BC R S S S S S S S S S S 
S18 8 AMP SC R R S S S S S S S S S 
S18 *8 TET S R S S S R R S S S S 
S18 8 TET S R S S S R R S S S S 
 
aM-S= corresponding sequenced sample. 
bPlasmid samples with an asterisk (*) were isolated from the ‘rinsed’ sample; the 
remaining plasmids were isolated from the sample after enrichment. 
cAMP=Ampicillin, TET=Tetracycline, KAN=Kanamycin, CTX=Cefotaxime, 
CIP=Ciprofloxacin, CN=Gentamicin, W=Trimethoprim, CAZ=Ceftzidime. 
MER=Meropenem, IMP=Imipenem, C=Chloramphenicol. 
dR=Resistant, I=Intermediate, S=Susceptible; according to CLSI guidelines (2018). 
eSome transconjugants appeared to have different colony morphologies on the same 
antibiotic selective plate (BC=big colony; SC=small colony) or had both a lawn of 
growth (LAWN) with some distinct colonies (COLONIES). 
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Table 2. Resistance profile of exogenous transconjugant strains from the day 28 
treated + antibiotic groupa,b,c,d.  
 
Plasmid 
Sample  
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S7 *1 LB R S S S S S S S S S S 
S7 1 LB S S S S S S S S S S S 
S7 
1 AMP 
BC R S S S S S R S S S S 
S7 
1 AMP 
SC R S S S S S S S S S S 
S7 *1 TET R R S S S S R S S S S 
S7 1 TET R R S S S S S S S S S 
S8 *2 LB R S S S S S S S S S S 
S8 2 LB R S S S S S S S S S S 
S8 
*2 TET 
BC R R S S S S S S S S S 
S8 
*2 TET 
SC R R S S S S S S S S S 
S8 2 TET R R S S S S S S S S S 
S9 *3 LB S S S S S S S S S S S 
S8 3 LB S S S S S S S S S S S 
S9 *3 AMP R R S S S S S S S S S 
S9 
3 AMP 
BC R R S S S S S S S S S 
S9 
3 AMP 
SC R R S S S S R S S S S 
S9 
*3 TET 
BC R R S S S S S S S S S 
S9 
*3 TET 
SC R R S S S S S S S S S 
S9 
3 TET 
BC R R I S S S R S S S S 
S9 
3 TET 
SC R R S S S S R S S S S 
S10 *4 LB S S S S S S S S S S S 
S10 4 LB R S S S S S S S S S S 
S10 *4 AMP R S S S S S S S S S S 
S10 
4 AMP 
BC R R S S S S R S S S R 
S10 
4 AMP 
SC R R S S S S R S S S R 
S10 
4 TET 
BC R R S S S S R S S S R 
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M-S 
Plasmid 
Sample 
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S10 
4 TET 
SC R R S S S S R S S S R 
 *5 LB S S S S S S S S S S S 
 5 LB S S S S S S S S S S S 
 *5 AMP R S S S S S S S S S S 
 
5 AMP 
BC R S S S S S R S S S S 
 
5 AMP 
SC R R S S S S R S S S S 
 5 TET R R S S S S S S S S S 
S11 6 LB R R S S S S S S S S S 
S11 6 AMP R S S S S S S S S S S 
S11 6 TET R R R S S S S S S S S 
S11 6 KAN R R R S S S S S S I S 
S12 *7 LB S S S S S S S S S S S 
S12 7 LB R R S S S S S S S S S 
S12 *7 AMP R R S S S S S S S S S 
S12 7 AMP R R S S S S R S S S S 
S12 *7 TET R R S S S S S S S S S 
S12 7 TET R R S S I S R S S S S 
S12 7 KAN S S R S S I S S S S S 
 *8 LB S S S S S S S S S S S 
 8 LB S S S S S S S S S S S 
 *8 AMP R S S S S S S S S S S 
 
8 AMP 
BC R S S S S I R S S S S 
 
8 AMP 
SC R S S I S S S S S S S 
 *8 TET R R S S S S S S S S S 
 8 TET R R S S S S R S S S S 
 8 KAN S S R S S S S S S S S 
 
 aM-S= corresponding sequenced sample. 
bPlasmid samples with an asterisk (*) were isolated from the ‘rinsed’ sample; the 
remaining plasmids were isolated from the sample after enrichment. 
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cAMP=Ampicillin, TET=Tetracycline, KAN=Kanamycin, CTX=Cefotaxime, 
CIP=Ciprofloxacin, CN=Gentamicin, W=Trimethoprim, CAZ=Ceftzidime. 
MER=Meropenem, IMP=Imipenem, C=Chloramphenicol. 
dR=Resistant, I=Intermediate, S=Susceptible; according to CLSI guidelines (2018). 
eSome transconjugants appeared to have different colony morphologies on the same 
antibiotic selective plate (BC=big colony; SC=small colony).  
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Table 3. Resistance profile of exogenous transconjugant strains from the day 28 
treated groupa,b,c,d.  
M-S 
 Plasmid 
Sample 
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S1 *1 LB S S S S S S S S S S S 
S1 1 LB S S S S S S S S S S S 
S1 *1 AMP R S S S S S S S S S S 
S1 
1 AMP 
BC R S S S S S R S S S S 
S1 
1 AMP 
SC R S S S S S S S S S S 
S1 *1 TET R R S S S S R S S S S 
S1 1 KAN S S R S S I S S S S S 
 *2 LB S S S S S S S S S S S 
 2 LB S S S S S S S S S S S 
 2 AMP R S S S S S S S S S S 
 2 KAN S S R S S I S S S S S 
S2 *3 LB S S S S S S S S S S S 
S2 3 LB S S S S S S S S S S S 
S2 *3 AMP R S S S S S S S S S S 
S2 3 AMP R S S S S S S S S S S 
S3 *4 LB S S S S S S S S S S S 
S3 4 LB S S S S S S S S S S S 
S3 *4 AMP R S S S S S R S S S S 
S3 4 AMP R S S S S S R S S S S 
S3 
4 KAN 
BC S S R S S I S S S S S 
S3 
4 KAN 
SC S S R S S S S S S S S 
S4 *5 LB R R S S S S S S S I S 
S4 5 LB S S S S S S S S S S S 
S4 *5 AMP R R S S S S S S S I S 
S4 5 AMP R R S S S S S S S S S 
S4 *5 COL S R S S S S S S S I S 
 *6 LB S S S S S S S S S S S 
 6 LB S S S S S S S S S S S 
 *6 AMP R S S S S S S S S S S 
 6 AMP R S S S S S R S S S S 
 6 KAN S S R S S I S S S S S 
S5 *7 LB S S S S S S S S S S S 
S5 7 LB S S S S S S S S S S S 
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M-S 
 Plasmid 
Sample 
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S5 *7 AMP R S S S S S S S S S S 
S5 7 AMP R S S I S S S S S S S 
S6 *8 LB S S S S S S S S S S S 
S6 8 LB S S S S S S S S S S S 
S6 *8 AMP R S S S S S S S S S S 
S6 8 AMP R S S S S S S S S S S 
 
aM-S= corresponding sequenced sample. 
bPlasmid samples with an asterisk (*) were isolated from the ‘rinsed’ sample; the 
remaining plasmids were isolated from the sample after enrichment. 
cAMP=Ampicillin, TET=Tetracycline, KAN=Kanamycin, CTX=Cefotaxime, 
CIP=Ciprofloxacin, CN=Gentamicin, W=Trimethoprim, CAZ=Ceftzidime. 
MER=Meropenem, IMP=Imipenem, C=Chloramphenicol. 
dR=Resistant, I=Intermediate, S=Susceptible; according to CLSI guidelines (2018). 
eSome transconjugants appeared to have different colony morphologies on the same 
antibiotic selective plate (BC=big colony; SC=small colony). 
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Table 4. Resistance profile of exogenous transconjugant strains from the day 35 
control groupa,b,c,d.  
M-S 
 Plasmid 
Sample 
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S31 *1 LB S S S S S S S S S S S 
S31 1 LB S S S S S S S S S S S 
S31 *1 AMP R R I S S S S S S I S 
S31 1 AMP R R S S S S S S S S S 
S31 1 TET R R R S S R R S S S S 
S32 *2 LB S S S S S S S S S S S 
S32 2 AMP R S S S S S S S S S S 
S33 5 LB S S S S S S S S S S S 
S33 *5 AMP R S S S S S S S S S S 
S33 5 AMP R R S S S S S S S S S 
S34 *6 LB S S S S S S S S S S S 
S34 6 LB S S S S S S S S S S S 
S34 6 AMP R R S S S S S S S S S 
S34 *6 TET R R S S S S S S S S S 
S34 6 TET R R R S S R R S S S S 
S34 6 KAN R R R I I R R S S S S 
S35 *9 LB S S S S S S S S S S S 
S35 9 LB S S S S S I S R S R S 
S35 *9 AMP R S R R S I R R I S S 
S35 9 AMP R R R S I R R S S S S 
S35 9 TET R R R S I R R S S S S 
S35 9 KAN R R R S I S S S S S S 
S36 *12 LB S S S S S I S R S S S 
S36 12 LB S S S S S S S S S S S 
S36 12 AMP R R S S S S S S S S S 
S36 
12 TET 
BC R R S S S S S S S S S 
S36 
12 TET 
SC R R R S I R R S S S S 
S36 *12 KAN R S R S I R R S S S R 
S36 12 KAN R R R S I I R S S S S 
 
aM-S= corresponding sequenced sample. 
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bPlasmid samples with an asterisk (*) were isolated from the ‘rinsed’ sample; the 
remaining plasmids were isolated from the sample after enrichment. 
cAMP=Ampicillin, TET=Tetracycline, KAN=Kanamycin, CTX=Cefotaxime, 
CIP=Ciprofloxacin, CN=Gentamicin, W=Trimethoprim, CAZ=Ceftzidime. 
MER=Meropenem, IMP=Imipenem, C=Chloramphenicol. 
dR=Resistant, I=Intermediate, S=Susceptible; according to CLSI guidelines (2018). 
eSome transconjugants appeared to have different colony morphologies on the same 
antibiotic selective plate (BC=big colony; SC=small colony). 
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Table 5. Resistance profile of exogenous transconjugant strains from the day 35 
treated + antibiotic groupa,b,c,d.  
M-S 
Plasmid 
sample  
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S25 *2 LB R R S S S S R S S S S 
S25 2 LB R R S S S S R S S S S 
S25 *2 AMP R R S S S S R S S S S 
S25 2 AMP R R S S S S R S S S S 
S25 *2 TET R R S S S S R S S S S 
S25 2 TET R R S S S S R S S S I 
 3 LB S S S S S S S S S S S 
 *3 AMP R R S S S S S S S S S 
 *3 TET R R S S S S S S S S S 
S26 *4 LB S S S S S S S S S S S 
S26 4 LB S S S S S S S S S S S 
S26 *4 AMP R S S S S S S S S S S 
S26 4 AMP R R S S S S R S S S S 
S26 *4 TET R R S S S S S S S S S 
S26 4 TET R R S S S S R S S S S 
 *5 LB S S S S S S S S S S S 
 5 LB R S S S S S S S S S S 
 5 AMP R S S S S S S S S S I 
 5 TET R R S S S S S S S S S 
 5 KAN S S S S S S S S S S S 
S27 *7 LB S S S S S S S S S S S 
S27 7 LB R S S S S S S S S S S 
S27 *7 AMP R S S S S S S S S S S 
S27 7 AMP R S S S S S S S S S S 
S27 *7 TET S R S S S S R S S S S 
S27 
7 TET 
BC R R S S S S R S S S S 
S27 
7 TET 
SC S R S S S S R S S S S 
S28 *8 LB S S S S S S S S S S S 
S28 8 LB S S S S S S S S S S S 
S28 *8 AMP R S S S S S S S S S S 
S28 8 AMP   R R S S S S S S S S S 
S29 *9 LB S S S S S S S S S S S 
S29 9 LB R S S S S S R S S S S 
S29 *9 AMP R S S S S S S S S S S 
S29 9 AMP R S S S S S R S S S S 
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M-S 
Plasmid 
sample  
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S29 *9 TET R R S S S S R S S S S 
S29 
9 TET 
BC R R S S S S R S S S S 
S29 
9 TET 
SC R R S S S S S S S S S 
S30 *10 LB S S S S S S S S S S S 
S30 10 LB R S S S S S R S S S S 
S30 
*10 
AMP R R S S S S S S S S S 
S30 10 AMP R S S S S S S S S S S 
S30 *10 TET R R S S S S R S S S S 
S30 10 TET R R S S S S R S S S S 
aM-S= corresponding sequenced sample. 
bPlasmid samples with an asterisk (*) were isolated from the ‘rinsed’ sample; the 
remaining plasmids were isolated from the sample after enrichment. 
cAMP=Ampicillin, TET=Tetracycline, KAN=Kanamycin, CTX=Cefotaxime, 
CIP=Ciprofloxacin, CN=Gentamicin, W=Trimethoprim, CAZ=Ceftzidime. 
MER=Meropenem, IMP=Imipenem, C=Chloramphenicol. 
dR=Resistant, I=Intermediate, S=Susceptible; according to CLSI guidelines (2018). 
eSome transconjugants appeared to have different colony morphologies on the same 
antibiotic selective plate (BC=big colony; SC=small colony). 
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Table 6. Resistance profile of exogenous transconjugant strains from the day 35 
treated groupa,b,c,d.  
M-S 
Plasmid 
Samples  
AMP TET KAN CTX CIP CN W CAZ MER IMP C 
S19 *1 LB S S S S S S S S S S S 
S19 1 LB S S S S S S S S S S S 
S19 *1 AMP R S S S S S S S S S S 
S19 1 AMP R S S S S S S S S S S 
S19 1 KAN S S R S S S S S S S S 
 *2 LB S S S S S S S S S S S 
 2 LB S S S S S S S S S S S 
 *2 AMP R S S S S S S S S S S 
 2 AMP R S S S S S S S S S S 
S20 *3 LB S S S S S S S S S S S 
S20 3 LB S S S S S S S S S S S 
S20 *3 AMP R R S S S S S S S S S 
S20 3 AMP R R S S S S S S S S S 
S20 *3 TET R R S S S S S S S S S 
S20 3 TET R R S S S S S S S S S 
S21 *4 LB S S S S S S S S S S S 
S21 4 LB S S S S S S S S S S S 
S21 *4 AMP R S S S S S S S S S S 
S21 4 AMP R S S S S S S S S S S 
S22 *6 LB R S S S S S S S S S S 
S22 6 LB R R S S S S S S S S S 
S22 *6 AMP R S S S S S S S S S S 
S22 6 AMP R S S S S S S S S S S 
S22 *6 TET R R S S S S R S S S S 
S22 6 TET R R S S S S S S S S S 
S23 *11 LB S S S S S S S S S S S 
S23 11 LB S S S S S S S S S S S 
S23 *11 AMP R S S S S S R S S S S 
S23 11 AMP R S S S S S R S S S S 
S24 *12 LB S S S S S S S S S S S 
S24 12 LB S S S S S S S S S S S 
S24 12 AMP R S S S S S S S S S S 
 
aM-S= corresponding sequenced sample. 
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bPlasmid samples with an asterisk (*) were isolated from the ‘rinsed’ sample; the 
remaining plasmids were isolated from the sample after enrichment. 
cAMP=Ampicillin, TET=Tetracycline, KAN=Kanamycin, CTX=Cefotaxime, 
CIP=Ciprofloxacin, CN=Gentamicin, W=Trimethoprim, CAZ=Ceftzidime. 
MER=Meropenem, IMP=Imipenem, C=Chloramphenicol. 
dR=Resistant, I=Intermediate, S=Susceptible; according to CLSI guidelines (2018). 
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6.7 FIGURES 
 
 
 
Fig 1. Rarefaction analysis at all taxonomic levels. 
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Fig 2. Microbial community composition at (A) phylum, (B) class and (C) genus taxonomic levels. 
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Fig 2. Microbial community composition at (A) phylum, (B) class and (C) genus taxonomic levels. 
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Fig 2. Microbial community composition at (A) phylum, (B) class and (C) genus taxonomic levels.
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Fig 3. Comparison of taxa abundance across sample groups using ANOVA.
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Fig 4. (A) Microbial community alpha diversity assessed using Shannon index, (B) microbial community richness assessed by Chao1 and (C) 
microbial community evenness at all taxonomic ranks. 
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Fig 4. (A) Microbial community alpha diversity assessed using Shannon index, (B) microbial community richness assessed by Chao1 and (C) 
microbial community evenness at all taxonomic ranks. 
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Fig 4. (A) Microbial community alpha diversity assessed using Shannon index, (B) microbial community richness assessed by Chao1 and (C) 
microbial community evenness at all taxonomic ranks. 
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Fig 5. Principal component analysis of sample groups at phylum, class and genus taxonomic levels comparing treatment and time-points.
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Fig 6. Relative abundance of ARGs present by antibiotic class. 
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Fig 7. Cluster analysis of ARGs present in the (A) core resistome and (B) accessory resistome using the Bray-Curtis similarity matrix. 
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Fig 7. Cluster analysis of ARGs present in the (A) core resistome and (B) accessory resistome using the Bray-Curtis similarity matrix.
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Fig 8. Cluster analysis of samples based on the relative abundance of ARGs in the (A) core resistome and (B) accessory resistome using 
the Bray-Curtis similarity matrix.  
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Fig 8. Cluster analysis of samples based on the relative abundance of ARGs in the (A) core resistome and (B) accessory resistome using 
the Bray-Curtis similarity matrix.
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Fig 9. Principal Component Analysis of samples based on the relative abundance of ARGs in the (A) core resistome and (B) accessory resistome. 
Blue: day 28 treated (S1-6), pink: day 28 treated + antibiotic (S7-12), green: day 28 control (S13-18), purple: day 35 treated (S19-24), red: day 35 
treated + antibiotic (S25-30), orange: day 35 control (S30-36).  
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Fig 10. Functional profile based on the KEGG Orthology (KO).
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6.9 SUPPLEMENTARY DATA 
 
Table S1. Mann-Whitney pairwise test, Bonferroni corrected p values,  
accessory resistome. 
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Table S2. List of antibiotic resistance genes present in the core resistome.   
CORE RESISTOME 
LNUC 
BACA 
CLASS_A 
VATB 
VANS 
VANR 
VANW 
VANG 
ERMB 
ERMG 
SAT-4 
APH(3''')-III 
AADE 
TET32 
TET44 
TET40 
TETW 
TETQ 
TETM 
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Table S3. List of antibiotic resistance genes present in the accessory resistome.  
ACCESSORY RESISTOME 
LNUA 
COB(I)ALAMIN_ADENOLSYLTRANSFERASE 
OMPF 
LING 
EPTA 
MSBA 
OMPR 
PORIN_OMPC 
MDFA 
APH(6)-I 
MDTK 
CLASS_C 
MEFA 
CPXA 
ROSB 
CAMP-REGULATORY_PROTEIN 
YOJI 
MDTP 
DFRF 
LSA 
UGD 
MDTG 
MDTF 
MDTE 
MDTD 
MDTH 
MDTO 
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MDTN 
MDTM 
MDTL 
VANTG 
VANU 
VANY 
VANX 
VANB 
APH(3')-I 
EMRY 
BAER 
BAES 
EMRR 
PMRF 
EMRK 
EMRA 
EMRB 
EMRD 
EMRE 
APH(3'')-I 
ERMF 
MGRB 
VANH 
ESCHERICHIA_COLI_MIPA 
ESCHERICHIA_COLI_LAMB 
TETX 
TEM 
SUL1 
QACH 
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TETO 
TETA 
KDPE 
SDIA 
AADA 
CAT_CHLORAMPHENICOL_ACETYLTRANSFERASE 
BICYCLOMYCIN-MULTIDRUG_EFFLUX_PROTEIN_BCR 
KASUGAMYCIN_RESISTANCE_PROTEIN_KSGA 
TRUNCATED_PUTATIVE_RESPONSE_REGULATOR_ARLR 
CLBA 
MARA 
ARNA 
GADW 
PATA 
DNA-BINDING_TRANSCRIPTIONAL_REGULATOR_GADX 
APH(4)-I 
MEXX 
16S_RRNA_METHYLASE 
VGAC 
EVGS 
TOLC 
TRANSCRIPTIONAL_REGULATORY_PROTEIN_CPXR_CPXR 
ACRD 
AAC(3)-IV 
MACB 
MACA 
ACRS 
RPOB2 
DNA-BINDING_PROTEIN_H-NS 
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ACRB 
ACRA 
ACRF 
KLEBSIELLA_PNEUMONIAE_OMPK37 
BACTERIAL_REGULATORY_PROTEIN_LUXR 
APMA 
VANVB 
VANRI 
ROSA 
APH(2'')-IE 
TET(W/N/W) 
VAND 
DFRA14 
ERMX 
DFRA1 
SUL2 
MEL 
AAC(6')-I 
AADA13 
VATE 
ANTIBIOTIC_RESISTANCE_RRNA_ADENINE_METHYLTRANSFERASE 
LNUG 
SERRATIA_MARCESCENS_OMP1 
APH(2'')-IF 
LSAE 
QACB 
APH(2'')-IV 
APH(2'')-II 
ADP-RIBOSYLATING_TRANSFERASE_ARR 
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CATD 
VANYG1 
AAD(9) 
LLMA_23S_RIBOSOMAL_RNA_METHYLTRANSFERASE 
ANT(9)-I 
TETL 
LNUD 
CATS 
LNUB 
MPHC 
BIFUNCTIONAL_AMINOGLYCOSIDE_N-
ACETYLTRANSFERASE_AND_AMINOGLYCOSIDE_ 
PHOSPHOTRANSFERASE 
TETP 
EMRB-QACA_FAMILY_MAJOR_FACILITATOR_TRANSPORTER 
CMLA 
CATB 
QACG 
DFRA12 
CMX 
MDTC 
MDTB 
MDTA 
AAC(3)-VI 
CATA 
DFRA15 
TETJ 
MEXI 
DFRA17 
TETR 
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OQXB 
OMP36 
TETC 
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Fig S1. Plasmids from the ‘Day 28 Control’ group visualised on an agarose gel. Samples are named after the bird the sample was taken from and 
the antibiotic which the transconjugant was selected on, e.g. 6 TET= bird 6 selected on tetracycline. Plasmid samples with an asterisk (*) were 
isolated from the ‘rinsed’ sample; the remaining plasmids were isolated from the sample after enrichment. Some transconjugants appeared to have 
different colony morphologies on the same antibiotic selective plate (BC=big colony; SC=small colony) or had both a lawn of growth and distinct 
colonies on the same plate (LAWN/COLONIES). Samples are labelled with their corresponding sequenced sample.  
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Fig S2. Plasmids from the ‘Day 28 Treated +Antibiotics’ group visualised on an agarose gel. Samples are named after the bird the sample was 
taken from and the antibiotic which the transconjugant was selected on, e.g. 6 TET= bird 6 selected on tetracycline. Plasmid samples with an 
asterisk (*) were isolated from the ‘rinsed’ sample; the remaining plasmids were isolated from the sample after enrichment.  Some transconjugants 
appeared to have different colony morphologies on the same antibiotic selective plate (BC=big colony; SC=small colony). Samples are labelled 
with their corresponding sequenced sample.  
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Fig S3. Plasmids from the ‘Day 28 Treated’ group visualised on an agarose gel. Samples are named after the bird the sample was taken from and 
the antibiotic which the transconjugant was selected on, e.g. 6 TET= bird 6 selected on tetracycline. Plasmid samples with an asterisk (*) were 
isolated from the ‘rinsed’ sample; the remaining plasmids were isolated from the sample after enrichment. Some transconjugants appeared to have 
different colony morphologies on the same antibiotic selective plate (BC=big colony; SC=small colony). Samples are labelled with their 
corresponding sequenced sample.  
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Fig S4. Plasmids from the ‘Day 35 Control’ group visualised on an agarose gel. Samples are named after the bird the sample was taken from and 
the antibiotic which the transconjugant was selected on, e.g. 6 TET= bird 6 selected on tetracycline. Plasmid samples with an asterisk (*) were 
isolated from the ‘rinsed’ sample; the remaining plasmids were isolated from the sample after enrichment. Some transconjugants appeared to have 
different colony morphologies on the same antibiotic selective plate (BC=big colony; SC=small colony). Samples are labelled with their 
corresponding sequenced sample.
247 
 
 
Fig S5. Plasmids from the ‘Day 35 Treated +Antibiotics’ group visualised on an agarose gel. Samples are named after the bird the sample was 
taken from and the antibiotic which the transconjugant was selected on, e.g. 6 TET= bird 6 selected on tetracycline. Plasmid samples with an 
asterisk (*) were isolated from the ‘rinsed’ sample; the remaining plasmids were isolated from the sample after enrichment. Some transconjugants 
appeared to have different colony morphologies on the same antibiotic selective plate (BC=big colony; SC=small colony). Samples are labelled 
with their corresponding sequenced sample.
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Fig S6. Plasmids from the ‘Day 35 Treated’ group visualised on an agarose gel. Samples are named after the bird the sample was taken from and 
the antibiotic which the transconjugant was selected on, e.g. 6 TET= bird 6 selected on tetracycline. Plasmid samples with an asterisk (*) were 
isolated from the ‘rinsed’ sample; the remaining plasmids were isolated from the sample after enrichment. Samples are labelled with their 
corresponding sequenced sample.
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7 DISCUSSION 
 
Antibiotic resistance will continue to maintain its position as one of the great threats 
to human and animal health unless alternatives and interventions are instigated. As it 
stands, antibiotic resistance is estimated to cause more deaths than cancer by 205059. 
The use of antibiotics in agriculture has been regarded as a major contributor to the 
increase in resistance rates that have been observed since the commercial availability 
of antibiotics.     
 
While there is great academic support towards limiting the use of antibiotics in 
agriculture, it is not enough to simply cease their use. While the use of antibiotics must 
be maintained for the therapeutic treatment of infected animals as per animal welfare 
guidelines, it is their use as prophylactic, metaphylactic and growth promoting agents 
that is targeted for reduction. Increasing numbers of regions are banning the use of 
antibiotics as growth promotors daily, but without antibiotics to reduce pathogen load, 
this may cause an increase in disease to the animals. Therefore, products which 
produce a similar effect to growth promotors, while also maintaining the health of the 
animals to reduce infection are required. Mannan-oligosaccharide (MOS) is a 
prebiotic which has been shown to meet these criteria. Unpublished preliminary data60 
found a reduction in antibiotic gene numbers in broilers whose diet had been 
supplemented with MOS. With the growing concern of antibiotic resistance transfer 
to humans through the food chain, a product capable of reducing resistance, while also 
providing additional benefits to host health, is highly desirable. We hypothesised that 
this reduction was due to the ability of mannan rich fraction (MRF), the next 
generation of MOS technology, to reduce the variety or transfer of plasmids. Plasmids 
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are small, self-replicating, extrachromosomal elements that are ubiquitous in bacteria. 
They often harbour genes that provide a benefit to the host cell, such as antibiotic 
resistance. Many plasmids are conjugative and have the ability to transfer to other 
bacteria, even those of other species. For this reason, plasmids are thought to play a 
key role in the dissemination of antibiotic resistance.  
 
To test our hypothesis, the isolation of plasmids harbouring antibiotic resistance genes 
(ARGs) from the caecum of broiler chickens was required. The caecum contains the 
largest density of bacterial cells than any other section of the chicken gastrointestinal 
tract. Due to this, it is a highly complex environment, where plasmids only comprise 
a small proportion of the total DNA present. Therefore, an investigation into a method 
that could adequately capture the greatest range of resistance plasmids present from 
this complex sample was required. We examined six methods of plasmid extraction 
within our study. As we wished to analyse the total plasmid population, we did not 
want to specifically culture certain strains of bacteria that would strongly bias the 
selection of plasmids from just the cultivable bacteria present in the sample. Current 
plasmid extraction kits are designed to extract from pure culture and were not well 
tolerated to the complexity of the sample. A traditional alkaline lysis method also 
resulted with the same difficulties. We did not obtain any intact plasmid DNA from a 
kit designed for extraction from complex samples. The transposon-aided capture of 
plasmids (TRACA) method did permit for the attainment of resistance plasmids, 
however, they were highly similar to each other. Multiple Displacement Amplification 
(MDA) provided us with the greatest range of resistance plasmids from our sample. 
However, this method had numerous time-consuming difficulties, and therefore would 
be less than ideal for studies involving a large number of samples. We concluded that 
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the exogenous isolation method would allow for the most efficient and effective 
acquirement of resistance plasmids. Plasmids isolated by this method are also 
conjugative, and therefore highly likely to contribute to the spread of antibiotic 
resistance, and are also capable of being maintained in a human pathogen, highlighting 
the serious threat to human health that they may possess.      
 
To gain a better understanding of the genetic sequences of the plasmid-mediated 
antibiotic resistance in the broiler caecum, further analysis into the types of plasmids 
present was performed. Plasmid DNA from two transformants obtained after the MDA 
method from a single broiler caecal sample was sequenced using MinION technology. 
From these transformants, five plasmids were identified. The plasmids varied in size 
from 151,806 bp to 42,654 bp in length. All of the plasmids carried ARGs, with four 
of the five plasmids being multi-drug resistant. The plasmids carried genes conferring 
resistance to tetracycline, aminoglycoside, macrolide, trimethoprim, chloramphenicol 
and beta-lactam antibiotics. One plasmid contained genes for resistance not only 
towards antibiotics, but also heavy metals, which function as co-selecting agents in 
the spread of antibiotic resistance, and quaternary ammonium compounds, which are 
frequently used as disinfectants. Only three of the plasmids were found to have been 
previously reported as originating from Escherichia coli. The others were reported 
previously as having originated from Salmonella enterica and Klebsiella pneumoniae, 
but were capable of being maintained in our E. coli host. Three of the plasmids 
contained genes for conjugation and may have the potential to transfer to other 
bacteria. Most notable from our results was the similarity of our plasmids to other 
plasmids identified from a variety of sources, both animal and human, worldwide. One 
plasmid matched to a plasmid previously isolated from a chicken meat sample in 
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America, while another matched to a plasmid from a chicken faecal sample from 
Switzerland. We also characterised a plasmid that was previously identified in a pig 
faecal sample in China. One of the isolated plasmids was highly similar to a plasmid 
found in the faeces of a healthy human from Switzerland, while another was identified 
in a patient with bacteraemia in South Korea. This raises the concern as to how these 
plasmids have disseminated worldwide. Our results reveal what is potentially only a 
small subset of the plasmids that are present in the caecum of a single broiler chicken 
from within the European Union. We demonstrate the ability of plasmids to survive 
through the broiler gastrointestinal tract, in chicken faeces and on meat products; while 
also displaying the ability of plasmids to spread and be maintained in other food-
producing animals and human hosts. We highlight the need for interventions to reduce 
the transmission and spread of plasmid-mediated antibiotic resistance.  
 
We assessed the mobile resistome present in the caecum of broiler chickens over time. 
The exogenous plasmid isolation method was employed to isolate antibiotic resistance 
plasmids at days 21 and 35 post-hatch. Ninety five transconjugants displaying a 
resistance phenotype were identified. Plasmids harbouring resistance to ampicillin, 
tetracycline, trimethoprim, cefotaxime and chloramphenicol were detected at both 
time-points. Multi-drug resistance plasmids were identified at both time-points, but a 
higher level of resistance and more varied resistance profile overall was evident at day 
35. The effect of the microbial community present in these caecal samples was also 
considered using 16S rRNA gene based analysis. We observed significant differences 
in the most dominant taxa in the microbiome between time-points. For example, a 
clear shift is seen from a Faecalibacterium dominated microbiota at day 21 to a 
Bacteroides dominant microbiome at day 35 at genus level. In contrast to the mobile 
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resistome results, higher levels of variability were observed in the microbiome at day 
21. The relative abundance of certain bacteria could differ greatly from bird-to-bird. 
Epsilonproteobacteria ranged from 19.97% of all classified reads in one bird to just 
0.02% in another at the same time-point, for example. We determined that a more 
stabilised and less variable microbiota is established as the birds age. We noted this 
stabilisation to occur later than previous reports. We concluded that the highly variable 
microbiota present at day 21 is less favourable for the capture and maintenance of 
resistance plasmids. The stabilisation of the microbiome as the bird ages allows the 
better established microbial community to harbour plasmids which would give them 
a survival advantage, and to deal with any fitness cost associated with this. We also 
noted that a sample with a high abundance of Bifidobacterium did not harbour any 
multi-drug resistance plasmids. We suggest that a larger population of 
Bifidobacterium is associated with reduced antibiotic resistance in the broiler caecum. 
MRF increases the proliferation of Bifidobacteria, and therefore has the potential to 
assist in reducing the spread of resistance. 
 
Continual advances are being made with molecular techniques to study complex 
environments. We employed a metagenomics-based approach to assess the effect of 
MRF as an additive to the diet of broiler chickens. This allowed for characterisation 
of both the microbiome and resistome of the broiler caecum at day 27 and 34 post-
hatch. We identified a stable microbiome at both time-points, with Firmicutes and 
Bacteroides comprising the most abundant phyla while Clostridia and Bacteroidia 
were the most dominant classes in all samples. We did not observe any significant 
changes in the most dominant taxa in MRF supplemented groups compared to the 
control. This may be due to the lack of bacterial targets for MRF, such as those which 
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possess mannose-specific fimbriae upon which MRF is known to have an effect. These 
include the enteric pathogens Salmonella or Campylobacter, which were absent in our 
samples. This suggests that the effects of MRF would be more evident in pathogen-
challenged chickens and may be beneficial for use in farms and production facilities 
dealing with such issues. A total of 171 ARGs were identified, with 69 of these present 
in all samples. The genes present at the highest abundance were tetW, lnuC and aadE, 
which confer resistance to tetracycline, lincosamide and aminoglycoside antibiotics. 
A difference was detected between the MRF supplemented and control groups at day 
27. However, there were immense variabilities between samples, even those within 
the same group, making it difficult to definitively attribute any observed effect to 
MRF. We draw attention to the presence of ARGs in the caecum of broilers even 
without antibiotic selective pressures, highlighting the scale of the resistance crisis. 
While the progression in sequencing technology and bioinformatic analysis has 
allowed for insights into these complex environments that has been previously 
unachievable, this area still requires further development. A large number of reads 
within our samples were unclassified, with other studies having reported this too. Also, 
it is difficult to ascertain if the entire plasmid population is detected using these 
methods, as they are present in small quantities compared to the total DNA, and their 
assembly is difficult with short-read technology. These gaps hinder the attainment of 
a full understanding of the interactions within these complex environments.     
 
To this end, we embarked on a study that would utilise both a metagenomics-based 
and a plasmid-based approach. We investigated the effect of MRF as a dietary additive 
in broiler chickens on the microbiome, resistome and mobile resistome at days 28 and 
35. A group that were receiving MRF were also administered amoxicillin on days 22-
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24, and were also included in the study. A highly consistent microbial community was 
identified across all sampled groups. We did not identify any significant changes in 
the most dominant taxa; or in diversity, richness or evenness at any taxonomic level. 
As in the previous study, Salmonella or Campylobacter were not detected, and 
therefore our samples may lack the specific bacterial target for MRF and may be a 
reason why more significant changes are not observed. Lactobacillus is noted as being 
the main species on which MOS and MRF have an effect, by increasing their 
abundance in the microbiome. As Lactobacillus was already present in our samples, 
the effect of MRF was not observed as it would have been in birds where Lactobacillus 
is in lower abundance or absent. Interestingly, no major changes were observed in the 
group that received antibiotics. We suggest that MRF may have assisted in the 
recovery of the microbiome by providing a substrate for selective beneficial 
commensal bacteria to proliferate within the microbiome. In the resistome, 164 ARGs 
were identified, 19 of which were present in all samples. Similar to the previous study, 
tetW, lnuC and aadE were the ARGs present in the highest abundance. No significant 
changes were seen in the abundance of genes in the core resistome, however within 
the accessory resistome, significant differences were observed, particularly between 
time-points. The difference in the abundance of ARGs as the birds age could possibly 
be attributed to changes in the less dominant taxa in the microbiome. Resistance genes 
might also be located on broad-host range plasmids, and therefore changes in the 
resistome may be difficult to trace back to specific changes in the microbiome.  
 
A total of 349 plasmid-harbouring transconjugants were isolated in the plasmid-based 
study. The highest levels and greatest variation in resistance profiles were seen in the 
control groups. This was more evident at day 35, which corresponds to our previous 
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finding that higher and more varied levels of resistance are present as the birds increase 
in age. The lowest range of resistance was identified in the treated groups at both time-
points. The treated group also had the lowest percentage of multi-drug resistance 
strains from all groups. We conclude that MRF may have a specific effect on the 
plasmid populations present in the caecum. We suggest that this may possibly be 
linked to the ability of MRF to bind to mannose-specific fimbriae. While MRF is well-
characterised in its ability to bind to type-1 fimbriae, it may also be able to bind type-
3 fimbriae which have been linked to an increase in frequency of conjugation. By 
binding to the fimbriae, MRF may therefore decrease the conjugative ability of 
plasmids, and thus reduce the spread of antibiotic resistance within the broiler caecum. 
Further plasmid based studies are required to provide a better understanding of this 
potential mechanism.  
 
Without action, antibiotic resistance will continue to endanger the efficacy of 
antibiotics, and lead to increased mortality. The widespread use of antibiotics in 
agriculture has been scrutinised for contributing to the spread of resistance. Products 
which are capable of reducing the risk of resistance transfer are required but remain 
elusive. The potential of MRF in reducing resistance when added to the diets of 
broilers was examined. A reduction in plasmid-mediated resistance was identified in 
MRF treated groups. This may be due to the ability of MRF to decrease the conjugative 
capability of the plasmids. Future work is required to establish the mechanisms by 
which this occurs.    
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